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STABILIZATION OF HYPOXIA INDUCIBLE FACTOR BY COBALT CHLORIDE
CAN ALTER RENAL TRANSEPITHELIAL TRANSPORT

SUBHRA SANKAR NAG
ABSTRACT
Kidney cyst expansion, stagnant fluid accumulation, and insufficient vascular
supply can result in localized chronic ischemia-hypoxia in kidney cysts, as well as in
normal renal epithelia adjacent to a cyst. We hypothesize that in normal epithelia near a
cyst, the stabilization of Hypoxia Inducible Factor 1α (HIF1α), a major regulator of cellular
response to hypoxia, can cause altered paracellular and transcellular transport,
transforming a normal absorptive phenotype to a secretory and paracellularly leaky
phenotype, leading to cyst expansion.
Using 100 µmol/L cobalt chloride (CoCl2), HIF1α was stabilized in cellular nucleus
of a mouse cortical collecting duct cell line (mCCD 1296 (d)), which resulted in an
increased level of erythropoietin, an effector and reporter molecule of HIF1α. The mCCD
monolayers have a high transepithelial resistance (TER) value (̴ 3000 Ω-cm2) and around
95% amiloride-sensitive voltage value. Equivalent current was calculated to compare
active ion transport. Our results showed that TER values decreased significantly after 48
and 72 hours of HIF-stabilization. The decrease of TER value was consistent with the
increase in the permeability of 70 kDa FITC-dextran molecules, supporting the hypothesis
that HIF-stabilization altered paracellular transport. Stabilization of HIF caused a
significant decrease in the protein level of zonula occludin 1 (ZO1), which controls
paracellular transport through tight junctions. Decrease in the ZO1 protein level was
viii

consistent with the decreased TER value and the increased paracellular permeability.
Similarly, HIF-stabilization was found to increase paracellular permeability in MardinDarby Canine Kidney (MDCK) epithelial monolayers. In mCCD monolayers, HIFstabilization for 48 hours caused loss of active sodium ion (Na+) transport, and very
interestingly, 72 hours of HIF-stabilization caused a switch in the direction of net active
ion transport. HIF-stabilization caused a significant decrease of protein level of sodiumpotassium-ATPase (Na+/ K+-ATPase) α1 subunit, the catalytic subunit of the enzyme
responsible for active Na+ transport, consistent with the loss of active transport of Na+.
Our results indicate that HIF-stabilization can transform a normal absorptive
epithelium to a paracellularly leaky and cyst-like secretory epithelium by reversing net Na+
transport and increasing monolayer permeability due to alterations of tight junctions, and
thereby HIF-stabilization may contribute to cyst expansion.
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CHAPTER I
INTRODUCTION
1.1 General Introduction
The function of a kidney is to maintain electrolyte (ion) and pH balance in our body.
Excess ions are removed from the blood in the form of urine and thereby the kidney helps
in controlling blood pressure. A kidney is made of around a million of filtering units, called
nephrons (Pitts 1968). As shown in figure 1, kidney tubules are lined with epithelial cells
having primary cilia. A renal cilium senses fluid flow and helps in maintaining normal
function and physiology of the kidney. Thus, cilia, fluid flow, and epithelial cells are
related to each other to maintain kidney anatomy and physiology, and thereby kidney
homeostasis.

1

Figure 1: Kidney physiology maintained by epithelial cells containing primary cilia
which sense fluid flow. The diagram A shows fluid flow through a cylindrical kidney
tubule lined with epithelial cells having primary cilia. The diagram B shows an
immunocytochemistry of renal epithelial cell and red protruding structure shows a primary
cilium.
Around 600,000 people in the United States alone have polycystic kidney disease
(PKD), which is characterized by the formation of fluid-filled pouch like structures called
cysts, as shown in figure 2. The cysts expand over the years and finally causes kidney
failure. Kidney cysts can compress onto blood vessels and can create kidney localized
ischemic-hypoxic condition (Bernhardt, Wiesener et al. 2007). Kidney cystic epithelium
was shown to have altered epithelial physiology and kidney localized hypoxia may affect
the normal epithelia near a cyst (Yu, Kanzawa et al. 2008; Wilson 2011).

2

Figure 2: Polycystic kidney disease and epithelial physiology. Kidney cysts have altered
epithelial physiology and kidney cysts may affect physiology of normal non-cystic
epithelia.
As shown in figure 3, kidney cysts can block fluid flow. Renal cilia sense fluid flow
and are believed to play an important role in maintaining normal kidney function. Blockage
of kidney fluid flow can affect the cilia. Kidney localized ischemic-hypoxic condition can
affect normal epithelial physiology. Kidney localized hypoxia can affect renal cilia.
Hypoxia can affect renal ciliary length and ciliary biomechanics and thereby may affect
ciliary flow-sensing (Verghese, Zhuang et al. 2011; Resnick 2016). Alterations of renal
cilia can affect normal renal epithelial physiology. Ciliary length and fluid flow were found
to control active transport of sodium ions (Resnick and Hopfer 2007; Resnick 2011).
Hypoxia can affect renal epithelial transport (Husted, Lu et al. 2010). Thus, cyst and cyst
induced hypoxia may affect normal renal fluid flow and cilia, thereby affecting ion
transport and physiology of normal epithelial cells. The different aspects are discussed in
detail in this section of introduction.

3

Figure 3: Effect of kidney cysts and cyst-induced localized hypoxia on normal renal
epithelial physiology.
1.2 Overview of Kidney Anatomy and Function
1.2.1 Kidney Anatomy
A kidney, which is a compound organ made of tubules, can be divided into three
major sections: 1) outer medulla, 2) inner medulla, and 3) cortex. Inner and outer medulla
together is called the medulla (Layton 2012). Functional and structural identical units of a
kidney are called nephrons (Pitts 1968). A kidney is composed of around one million to
one and one fourth of a million nephrons in humans and around 38,000 nephrons in rats
(Pitts 1968; Layton 2012). As shown in figure 4, a nephron is composed of a renal
corpuscle consisting of glomerulus and Bowman’s capsule, a proximal convoluted tubule,
a loop of Henle and the distal convoluted tubule (Pitts 1968). Inside the glomerulus, blood
plasma first goes through endothelial fenestrations and fluid enters Bowman’s capsule,
followed by the fluid traveling through the nephron (figure 4). During this fluid flow
through nephrons, water and solutes are actively and passively transported across epithelial
4

cell layers with the help of transporters and ions channels. Many nephrons put their
contents into a multibranched collecting duct. Numerous collecting ducts combine and pass
their contents through a duct of Bellini, finally disposing into a renal calyx (Pitts 1968).
The collecting duct is considered as the terminal part of the nephron and acts as an osmotic
exchanger to control hypertonicity of urine (Pitts 1968).

Figure 4: Structure of a nephron. Figure credit: Pearson Education.
1.2.2 Function of Kidney
A kidney performs various essential regulatory functions in our body. The most
well-known function is to remove metabolic wastes and toxins from our blood and excrete
5

them in the form of urine. The kidney also helps in maintaining homeostasis in our body
by regulating water, electrolytes, and acid-base balance. The kidney is also known to be
responsible for

synthesis or activation of hormones

that

are associated with

erythropoiesis, metabolism of calcium, and control of pressure and flow of blood (Layton
2012).
1.2.3 Mechanisms Involved in Urine Production
Three separate mechanisms result in the production of urine: 1) glomerular
ultrafiltration 2) tubular reabsorption 3) tubular secretion.
1) Glomerular ultrafiltration removes or filters colloidal matters such as, proteins and
lipids and other particulates. However, this process cannot prevent molecules with
small dimensions such as crystalloidal solutes (Pitts 1968).
2) In tubular reabsorption, glucose is completely reabsorbed in this process while
traveling through the first half of the proximal tubule (Walker and Hudson 1936).
Sodium ions are thought to be actively reabsorbed, whereas chloride ions are
thought be passively reabsorbed in the proximal tubule. The tubule is known to be
freely permeable to water. Reabsorption of ions creates an osmotic gradient which
drives the reabsorption of water to maintain the osmotic balance(Pitts 1968). In the
distal tubule, ions are reabsorbed faster than water, thereby urine is diluted. Thus,
without proportionally high loss of ions, water is removed in the distal tubule (Pitts
1968).
3) Reabsorption of water does not account for increased concentration of certain
molecules in the urine (Pitts 1968). For example, the increased concentration of
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urea in the urine can be caused by the process of tubular secretion (Marshall Jr and
Crane 1924; Pitts 1968).
1.2.4 Urine Concentrating Mechanism
The actual mechanism by which a mammalian kidney is able to concentrate urine
when deprived of consumption of water still remains an unsolved mystery and have
hypothetical predictions even after many decades of research attempts (Sands and Layton
2000; Layton 2012). The urine concentrating mechanism is known in the outer medulla of
the kidney where counter-current multiplication can concentrate urine by absorbing salt in
between parallel and opposing flows in descending and ascending tubes which stay in
direct contact with each other. However, the urine concentrating mechanism in the kidney
inner medulla, which is known to be the site for main urine concentrating function in
mammals, is still vaguely understood (Layton, Layton et al. 2009; Layton 2012). Normal
blood plasma osmolality is around 300 mOsm/kg H2O. The capability of the kidney to
concentrate urine during deprivation of water consumption varies among different animal
species. For example, humans can concentrate urine up to a maximum at around 3.8 times
higher osmolality than blood plasma and normal mice and rats around 9-10 times; whereas
the Australian hopping mouse, which lives in the desert, can concentrate urine at around
30 times higher osmolality than blood plasma (Beuchat 1996; Layton 2012). For this
reason, the sea water should be avoided for human consumption to quench thirst since sea
water is known to have osmolality around 2,000 to 2,400 mOsm/kg H2O (Layton 2012).
1.3 Fluid Flow in the Kidney
Hydrodynamic pressure gradients are known to drive fluid flow through kidney
tubules (Layton 2012). Fluid flow in the kidney may be quantified as volumetric flow rates
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in terms of single nephron glomerular filtration rate (SNGFR), or flow can also be
expressed as wall shear stress (Nag and Resnick 2017). Micropuncture studies reported
SNGFR rates in kidney proximal tubule around 25-45 nl/ min in rats and 60-85 nl/ min in
dogs and around 125 nl/min in humans (Gottschalk and Mylle 1959; Nag and Resnick
2017). Similarly, using fluorescence markers, SNGFR was measured to be around 32 nl/
min in rats(Kang, Toma et al. 2006). A rise in the blood pressure within the glomerulus
can result in the increased SNGFR and can cause increased fluid flow rate throughout the
tubule(Layton 2012). Fluid flow through kidney is not a steady flow, rather it has timedependent oscillatory or pulsatile flow pattern (Layton 2012; Nag and Resnick 2017). In
the glomerulus, endothelial fenestrations and podocyte slit diaphragm can absorb high
frequency pressure oscillations. Rhythmic contractions of pelvicalyceal wall around the
inner medulla creates unsteady fluid flow pattern within the nephron (Young and Marsh
1981; Sakai, Craig et al. 1986; Holstein-Rathlou and Marsh 1989; Pruitt, Knepper et al.
2006; Nag and Resnick 2017). Pressure, flow, and solute concentrations in the proximal
tubule show oscillatory patterns with frequencies in the range of 0.015-0.2 Hz (Young and
Marsh 1981; Sakai, Craig et al. 1986; Holstein-Rathlou and Marsh 1989; Pruitt, Knepper
et al. 2006; Nag and Resnick 2017). Tubular flow was found to show oscillatory pattern
with oscillations of 0.1 to 0.02 Hz (Kang, Toma et al. 2006; Rosivall, Mirzahosseini et al.
2006). In mouse kidney, green fluorescent protein (GFP) expressing cilia in the proximal
tubule region showed ciliary oscillation having frequency of 4.8 Hz (O’Connor, Malarkey
et al. 2013; Nag and Resnick 2017). Thus, oscillatory fluid flow in the kidney tubule can
cause oscillatory motion of renal cilia (Nag and Resnick 2017).
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Fluid flow was found to decrease active sodium transport in cultured epithelial
monolayers derived from kidney cortical collecting duct as compared to no flow. The cell
cultures under dynamic or variable fluid flow culture conditions showed dedifferentiated
pro-growth like phenotype, whereas cells under stable flow conditions maintained
differentiated cellular phenotype (Resnick 2011). Therefore, fluid flow seems to be
important in maintaining the normal functional phenotype of renal epithelial cells.
Normal function of kidney is maintained by a narrow range of fluid flow through
glomerulus and nephron. The tubular fluid flow rate is important in maintaining the
balance of water and sodium in our body and gets adjusted according to the body’s
requirements. The flow rate in the tubules is mainly controlled by glomerular filtration rate
which includes tubuloglomerular feedback (TGF) and myogenic mechanism (Layton
2012).
1.3.1 Tubuloglomerular Feedback
The TGF mechanism plays a crucial role in the regulation of glomerular filtration
rate. The TGF system is controlled by the chloride concentration in the macula densa, a
bundle made of specialized cells located in the thick ascending limb of the Henle’s loop,
named the “Juxtaglomerular apparatus” (Layton 2012). When the chloride concentration
in the macula densa is very low, this feedback mechanism induces vasodilation (i.e.,
widening of blood vessels) of afferent arterioles leading to a rise in the pressure of
glomerular filtration. A rise in blood pressure in the glomerulus increases the rate of fluid
flow in the kidney tubule. Increased flow results in decreased tubular transport period and
allows less absorption of sodium chloride (NaCl). Similarly, when chloride concentration
in the macula densa is very high, then vasoconstriction of afferent arteriole is induced, and
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followed by decreased flow rate and increased NaCl absorption (Layton 2012). This TGF
mechanism can cause a continuous oscillation of around 30 mHz in nephron fluid flow
(Leyssac and Baumbach 1983).
1.3.2 Myogenic Effect
Vascular smooth muscle in the afferent arteriole in the glomerulus develops active
forces and compensatory vasoconstriction to adjust to the increased stretch generated by
transmural pressure. This intrinsic feature or response of vascular smooth muscle to be able
to constrict when intraluminal pressure increases is known as the myogenic effect. This
myogenic response is known to be important in the autoregulation of blood flow and
capillary blood pressure (Layton 2012). The renal afferent arteriole is known to have
rhythmic activity, also referred as vasomotion as seen in other arterioles and small arteries.
This vascular oscillation is independent of heart beat or respiration. This oscillatory pattern
is believed to be controlled by resident cells in the arterial wall. Myogenic responses are
known to be blocked by membrane channel blockers, such Ca2+ and K+ channel blocker
(Layton 2012). Mathematical models to study myogenic response predict that voltagegated channels and voltage-calcium-gated channels control Ca2+ and K+ fluxes
respectively, these two ion fluxes interact and a rhythmic transport pattern of these two
ions result (Chen, Sgouralis et al. 2010; Sgouralis and Layton 2012). Ion flux interactions
and rhythmic transport process can lead to periodic variation in the cytoplasmic calcium
concentration and can cause myosin light chain phosphorylation, and finally result in the
development of muscle stress. Therefore, rhythmic oscillations in cytosolic calcium
concentration can cause sudden vasomotion in the afferent arteriole, and the findings of the
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mathematical models were reported to be consistent with the experimental results
(Steinhausen, Endlich et al. 1997; Layton 2012).
1.3.3 Fluid Flow Related Forces Acting on Kidney Tubule
Fluid flow through elastic kidney tubules can generate three different forces, two
forces (normal and shear stress) acting on tubular walls lined with epithelial cells and the
third force (hydrodynamic drag) acts on protruding renal primary cilia (Nag and Resnick
2017). Hydrodynamic drag acts only on a primary cilium whose distal end is free to move,
and cilia can bend in response to fluid flow. This ciliary bending mechanism is believed to
be responsible for ciliary mediated intracellular calcium influx and cellular signaling (Nag
and Resnick 2017).
1.4 Overview of Primary Cilia Anatomy and Function
Epithelial cells in the kidney control transport of solutes and water using ion
channels and transporters. Primary non-motile cilia are found on epithelial cells in renal
duct and renal tubule and these protruding or antenna-like structures are made of
microtubules. Renal cilia act as the cellular fluid flow sensor and also regulate cellular
differentiation (Praetorius and Spring 2003; Zhang, Taulman et al. 2004). Ciliary defects
can lead to dysregulation of proliferation and differentiation of epithelial cells and
polycystic kidney disease (Calvet 2002; Deane and Ricardo 2007).
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Figure 5: Structural components of a primary cilium. Figure credit (Smith and
Rohatgi 2011)
1.4.1 Major Structural Components of a Primary Cilium
The microtubule-based cytoskeleton in the inner core of a cilium is called the
axoneme, which remains covered by a lipid bilayer membrane continuous with the cellular
plasma membrane. Ciliary membrane is known to contain a different subset of receptors
and cell signaling molecules as compared to cellular plasma membrane (Veland, Awan et
al. 2009). The basal body of a cilium helps in keeping the cilium connected to a cell as well
as provide the platform for 9-fold symmetry formation of the ciliary axoneme. As shown
in figure 5, the ciliary ‘necklace’ is a structure which keeps the ciliary and plasma
membrane compartment separated (Gilula and Satir 1972; Veland, Awan et al. 2009).
Transition fibers connect the ciliary necklace to the transition zone of the basal body of a
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cilium. These fibers are believed to form ‘ciliary pore complex’, which selectively allows
proteins to get inside the ciliary compartment (Rosenbaum and Witman 2002). A renal
cilium is non-motile and is designated as (9+0) as compared to designation of (9+2) for a
motile cilium, where ‘9’ shows the number of outer doublet microtubules in the axoneme
and ‘0’ or ‘2’ shows the number of central microtubules that are present (Veland, Awan et
al. 2009). Central microtubule pair and structures, such as dynein arm and radical spokes
which are responsible for motility, are absent in a non-motile renal cilium (Veland, Awan
et al. 2009). Intraflagellar transport (IFT) is a very conserved mechanism in a cilium and
involves bidirectional passage of IFT particles (i.e., protein complexes) within the axoneme
of the cilium (figure 5). Anterograde (base to tip of a cilium) movement is driven by motors
of kinesin-2 and retrograde movement is guided by cytoplasmic dynein 2 (KozMINSKI,
Johnson et al. 1993; Scholey 2008; Veland, Awan et al. 2009). Mutations of IFTs, such as
ift88, in mice showed formation of kidney cysts along with a number of developmental
defects (Lehman, Michaud et al. 2008).
1.4.2 Mechanosensory Functions of a Cilium
1.4.2.1 Ciliary Flow Sensing and Calcium Influx
The mechanical links connecting bending of a cilium to increased levels of
intracellular Ca2+ influx is not clearly understood. Bending of the cilia by fluid flow is
known to increase cytosolic levels of calcium, a second messenger, and lead to calcium
induced calcium release (Praetorius and Spring 2001; Praetorius, Frokiaer et al. 2003;
Praetorius and Spring 2003). Increase in the cilioplasmic Ca2+ concentration results in the
increase in cAMP and cytosolic concentration of Ca2+, causing activation of protein kinase
A (PKA) and initiate downstream signalling pathways (Jin, Mohieldin et al. 2014; Nag and
Resnick 2017). Loss of renal cilia was found to cause uncontrolled influx of intracellular
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Ca2+ (Siroky, Ferguson et al. 2006). A study, contradicting the existing ciliary calcium
influx model, reported that the application of fluid flow increases cytoplasmic Ca2+
concentration rather than cilioplasmic Ca2+ concentration and non-ciliary site was the initial
site for increased levels of Ca2+ in response to fluid flow (Delling, Indzhykulian et al.
2016). Previous studies did not specifically isolate and study the effect of hydrodynamic
drag force which acts on protruding cilia and is responsible for ciliary bending. In
experimental set up involving fluid flow, the shear and stretch act on renal epithelial cells
and initiate cell signalling responses which can mask the ciliary flow sensing response
(Nag and Resnick 2017).
Major suspects responsible for ciliary mechanosensation are believed to be the
polycystin and polycystin-like proteins encoded by PKD1/PKD2 and PKD1L1/PKD2L2
genes respectively. Polycystin 2 (PC2) proteins form the calcium channel (Luo, Vassilev
et al. 2003) and Polycystin 1 (PC1) has been suggested to be a G-protein coupled receptor
(GPCR) and acts as a sensor (Patel and Honoré 2010; Trudel, Yao et al. 2016). Renal cilia
are known to contain several transient receptor potential (TRP) proteins acting as ion
channels, such as TRP melastatin-4 (TRPM4), TRP vanilloid 4 (TRPV4), and TRPP2
(polycystin) (PKD2) (Flannery, Kleene et al. 2015; Phua, Lin et al. 2015; Pablo, DeCaen
et al. 2016; Nag and Resnick 2017). Fluid flow sensing occurs by opening of divalent cation
channel PKD2 along with opening of the TRPV4 (Lee, Guevarra et al. 2015).
1.4.2.2 Effect of Cilia on Active Sodium Transport
In kidney cortical collecting duct cells, application of fluid flow using an orbital
shaker was found to enhance movement of angiotensin receptor type 1 to the apical surface
and suggested that ciliary mechanosensation play some role in regulating flow dependent
reabsorption of sodium (Na+) ions and water in kidney proximal tubule (Kolb, Woost et al.
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2004; Resnick and Hopfer 2007). The presence of an intact cilium was found to be crucial
in the active Na+ ion transport through epithelial Na channels (ENaC), since the removal
of cilia caused cellular monolayer to become non-responsive to fluid flow induced changes
of ENaC current (Resnick and Hopfer 2007). Presence of fluid flow in renal epithelial
monolayers caused around 60% drop in the sodium current and around 30% decrease in
the length of the cilium (Resnick and Hopfer 2007). Thus, the active sodium transport in
renal epithelial cells is believed to be regulated by functional renal cilia. The proteins PC1 and PC2 encoded by PKD1 and PKD2 genes respectively (Nauli, Alenghat et al.
2003), Polaris encoded by Tg737 (Taulman, Haycraft et al. 2001), and cystin encoded by
cpk gene (Hou, Mrug et al. 2002) are all found to be localized in the cilia (Yoder, Hou et
al. 2002), and mutations of these genes cause an absorptive epithelia to transform into a
secretory cystic epithelia as seen in polycystic kidney disease (Brown and Murcia 2003;
Nauli, Alenghat et al. 2003).
1.4.3 Renal Ciliary Length Alterations
Cell signaling molecules were found to affect the length of cilia. Activation of PKA
by cyclic AMP (cAMP) was shown to increase ciliary length and inhibition of PKA caused
decrease in ciliary length (Besschetnova, Kolpakova-Hart et al. 2010). In contrast, ciliary
length altered inversely with intracellular calcium concentration (Besschetnova,
Kolpakova-Hart et al. 2010; Nag and Resnick 2017). Renal ciliary length was found to
increase in response to injury in mouse models (Verghese, Weidenfeld et al. 2007; Wang,
Weidenfeld et al. 2008) and human kidney transplant with acute form of tubular necrosis
(Verghese, Weidenfeld et al. 2007). The absence of fluid flow in renal epithelial cell culture
caused elongation of renal cilia (Resnick and Hopfer 2007). Stabilization of hypoxia
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inducible factor (HIF) by cobalt chloride was shown to increase the lengths of the cilia
(Verghese, Zhuang et al. 2011). Another study with similar experimental approach showed
that HIF-stabilization decreased the effective bending modulus of a cilium and hence the
cilium became more flexible (Resnick 2016). A mouse model of polycystic kidney disease,
orpk/Tg737 showed formation of much shorter cilia (Cano, Murcia et al. 2004; Liu, Murcia
et al. 2005).
The change in cilia lengths could be assumed as a cellular mechanism to adapt to
adverse physiological conditions, such as lack of fluid flow or hypoxia. Therefore, it is
tempting to speculate that the ciliary length alterations can reflect altered ciliary
biomechanical properties, such as bending modulus, and can lead to altered ciliary flow
sensing and calcium signaling.
1.5 Renal Epithelial Transport
1.5.1 Epithelial Cells
An epithelial cell separates complimentary transport proteins in apical and
basolateral membranes, maintaining cell polarity. An epithelial tissue has the ability to
transport electrolytes and non-electrolytes in a specific direction (vectorial), since this
tissue is composed of polarized cells and cellular tight junctions. Epithelial cells can
perform selective transport (absorption or secretion) of electrolytes and non-electrolytes
against their electrochemical gradient (Lewis 1996).
1.5.2 Overview of Cellular Transport
Transport of ions and molecules across cellular layers is crucial to maintain tissue
function and homeostasis. From a thermodynamic point of view, transport of molecules
and ions can be divided into two categories: active transport and passive transport
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(Srivastava 2005). If the transport process is driven by cellular environment, the transport
is called passive transport, which does not utilize any cellular energy. On the other hand,
if the transport process uses energy generated by cellular metabolism, the transport is then
called active transport (Srivastava 2005). Chloride ions having a smaller size, with
diameter of 0.3 to 0.4 nm, can easily diffuse through the pores on a cellular membrane
having diameter of 0.5 to 0.8 nm (Srivastava 2005). Na+ ions in an aqueous solution
maintain hydrated form with diameter of 0.51 nm, whereas hydrated form of K+ ions
maintain diameter of 0.39 nm (Srivastava 2005). Therefore, hydrated K+ ions diffuse easily
through cellular membrane pores as compared to Na+ ions. Moreover, the interior of pores
contains positively charged ions such as Ca2+, therefore anions such Cl- can pass through
the pores easily, whereas the passage of positively charged cations such as Na+ and K+ is
prevented (Srivastava 2005). Active transport can occur even if there is no electricpotential gradient and can also occur against the electrochemical gradient (Srivastava
2005).
Active transport can be divided into two categories: 1) Primary active transport 2)
secondary active transport. In the primary active transport, normally hydrolysis of ATP by
the transporter, e.g., ion pump or ATPase, generates the energy required to drive the
transport process. All epithelia are known to have one or more ATPases, such as Na+/ K+ATPase and H+-ATPase (Reuss, Wills et al. 1996). On the other hand, secondary active
transport uses the energy formed by the electrochemical gradient created due to transport
one substance to drive the transport of other substance or substances. Normally the
secondary active transport is coupled to active Na+ transport. The electrochemical gradient
created by Na+ pump acts as the energy source to transport of Na+ and other substances
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(Reuss, Wills et al. 1996). The sodium-coupled secondary active transport is called
cotransport, when Na+ ion and the other substance both move along the same direction of
electrochemical gradient of Na+, and the transport proteins are referred to as the
cotransporters or symporters. For example, in the kidney proximal tubule, sodium/ glucose
cotransporter (SLGT1) transports 2 Na+ ions along with 1 glucose molecule into the cell.
When the transport of a substance occurs in the opposite direction of Na+ electrochemical
gradient, then the secondary active transport is called counter-transport, and the transport
proteins are referred to as the exchangers or antiporters. For example, Na+/Ca2+ exchanger
(NCX) 1, which is found in kidney distal tubule, is known to move 3 Na+ ions inside the
cell in exchange for moving 1 Ca2+ ion out of the cell (Magyar, White et al. 2002).
1.5.3 Epithelial Transport Pathways
The epithelial transport pathway can be divided into two categories:
1) Intercellular or paracellular pathway: This process involves transport across
cellular tight junction and then movement along the intercellular spaces in between
two adjacent cells.
2) Transcellular pathway transport: This mode of transport begins by the entrance of
ions or molecules through apical membrane and existing through basolateral
membrane of a cell (Reuss, Wills et al. 1996).
1.5.4 Properties of Epithelial Cells
The basic building block of an epithelium consists of 1) epithelial cells 2) tight
junctions 3) Basement membrane. The basement membrane provides structural support
and acts as the site for cellular attachment. Tight junctions help in keeping cells bound
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together and can also restrict passage of substances among epithelial cells. Tight junctions
keep the apical membrane separated from the basolateral membrane (Lewis 1996).
1.5.4.1 Epithelial Junctional Complex
Other than tight junction, the junctional structure consists of 1) gap junction 2)
desmosomes, and 3) zona adherens (Lewis 1996). Cell to cell communication occurs via
gap junctions. Spot junctions, also known as desmosomes, provide integrity of cellular
structures. The cellular actin filaments from lateral membrane bind to the site in the
junctional region, called zona adherens. The space that exists between cells is referred as
the lateral intercellular space. The lateral intercellular space can be very small, around 10
nanometers (nm), and can be as large as 1-3 micrometers (µm) depending on the specific
type of epithelia. The transport through paracellular space is determined by the tight
junctions and lateral intercellular space (Lewis 1996).
The junctional complex has three major functions:
1) The tight junction in the junctional complex separates the apical membrane and the
basolateral membrane. The junctional complex creates a barrier that prevents migration
of apical membrane protein to basolateral side and basolateral membrane protein to
apical side. Thus, the junctional complex helps in maintaining the cell membrane
polarity (Lewis 1996).
2) The junctional complex provides epithelial structural integrity by keeping epithelial
cells bound together.
3) The junctional complex controls paracellular route of transport of electrolytes and nonelectrolytes. Hydrophilic substances can move transcellularly using ion channels and
membrane proteins on apical and basolateral membranes. The junctional complex
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selectively allows passage of hydrophilic substances on the basis of charge and size
(Lewis 1996).
Leaky and Tight Epithelia
Electrical resistance is the inverse of electrical conductance. An epithelium belongs
to one out of the two categories based on the electrical resistance by tight junctions. An
epithelium having low tight junction resistance (less than 100 Ω-cm2) is called a leaky
epithelium, whereas an epithelium having high tight junction resistance (more than 500 Ωcm2) is termed as the tight epithelium (Fromter and Diamond 1972).
A leaky epithelium has low transepithelial (combined transcellular and paracellular)
voltage for two possible reasons:
1) Voltage generated by active ion transport can be leaked through the low resistance
epithelial junctions.
2) A leaky epithelium can actively transport ions in an electroneutral process. For
example, cotransport of a cation and anion together or absorption of a cation
causing secretion of another cation does not develop any electrical current (Lewis
1996).
A leaky epithelium cannot maintain an ion concentration gradient for two possible reasons:
1) Epithelial junctions have high permeability for ions since the junctional electrical
resistance is low. Ions can freely move from high concentration gradient to low
concentration gradient by the process of diffusion, resulting in the loss of ion
concentration gradient (Lewis 1996).
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2) A leaky epithelium cannot maintain an ion concentration gradient because water
molecules easily pass through the epithelial layer through osmosis (Fromter and
Diamond 1972).
A tight epithelium due to high junctional resistance can maintain high voltage. The
tight epithelium’s junction is very less permeable to solutes and the passive transport does
not have any significant effect on the ion concentration gradient created by the active
transport. Due to low water permeability and low junctional solute permeability, a tight
epithelium can create and maintain ionic gradients. A leaky epithelium can transport large
amounts of electrolytes, non-electrolytes, and water as compared to a tight epithelium,
whereas a tight epithelium can maintain high concentration gradients of electrolytes and
non-electrolytes. The transport process across a tight epithelium is known to be hormone
regulated but not in case of a leaky epithelium (Lewis 1996).
In a tight epithelium, such as kidney cortical collecting duct, Na+ ions are known
to be transported actively and Cl- is known to be transported passively. In this tight
epithelium, Na+ ions enter the cells through apical epithelial Na channels (ENaC). With the
help of Na+/ K+-ATPase 3 Na+ go to the basolateral side and 2K+ ions enter cells. This
transport is a transcellular or active transport process (figure 6). There are low conductance
K+ channels, which help in removing intracellular K+ build up. Movement of Na+ ions
actively produce negative value of equivalent (short circuit) current. Using sodium channel
blocker 95% of current can be blocked (Resnick and Hopfer 2007; Resnick 2011). By
active sodium transport sodium ions are reabsorbed from urine back to blood. Active Na+
transport creates electrochemical gradient which drives passive transport of negatively
charged Cl- ions through tight junctions as shown in figure 6. In some epithelia, such as
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frog skin epithelia or sweat gland, Cl- can pass transcellularly since those epithelial apical
and basolateral membrane have chloride conductance (Lewis 1996).

Figure 6: Epithelial transport in a tight epithelium (e.g., kidney cortical collecting
duct). Na+ ions are known to be transported through transcellular route using epithelial
sodium channels (ENaC) and Na+/ K+-ATPase. Cl- ions are known to be transported
paracellularly.
1.5.4.2 Epithelial Na+ and K+ Transport
In almost all types of epithelial cells, Na+/ K+-ATPase is found to be present in the
basolateral membrane (Lewis 1996). As discussed previously, the Na+/ K+-ATPase
transports 3 Na+ ions from cellular cytoplasm to the serosal solution, and during this
process 2 K+ ions are transported from serosal solution to the cellular cytoplasm. The
process is called electrogenic, since during one cycle one positive charge moves out of the
cell. In this process, one ATP molecule is utilized in each cycle. This process is called
primary active transport since Na+ and K+ ions are transported against their concentration
gradient. The basolateral membrane is known to maintain a negative voltage between -30
and -80 mV. The concentration of K+ ions inside the cells is higher as compared to the
extracellular fluid. For example, cellular K+ concentration is > 100 mmol/L and
extracellular K+ concentration is 5 mmol/L in mammals (Lewis 1996). The concentration
of Na+ is known to be lower inside the cell as compared to the extracellular fluid. Cellular
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concentration of Na+ is around 10-20 mmol/L and extracellular fluid concentration of Na+
is around 135-145 mmol/L in humans (Lewis 1996; Wills, Reuss et al. 2012; Staruschenko,
Ilatovskaya et al. 2016). Each kidney glomeruli can filter 25,000 mEq of Na+ ions per day
(Staruschenko, Ilatovskaya et al. 2016). The glomerulus freely allows Na+ ions to pass
through, and the epithelial cells of different segments of nephron reabsorb the majority of
Na+ during the fluid flow and urine formation (Staruschenko, Ilatovskaya et al. 2016).
1.5.5 Epithelial Transport Mechanisms
A hydrophobic or lipid soluble substance can pass through lipid bilayer by a process
known as solubility-diffusion, a passive transport process. A hydrophilic solute can be
transported by primary or secondary active transport or passive transport process (Reuss,
Wills et al. 1996).
1.5.5.1 Passive Transport
Passive transport can occur in two ways: 1) through lipid layer of cell membrane
2) using transport proteins such as channels and carrier proteins. Passive transport is
driven by an already existent electrochemical gradient and result in the transport of a
single substrate.
The driving force for the passive transport is the electrochemical potential
difference (Δµj) which is denoted as:
𝐶j 𝑖
Δµj = zj VmF + RT ln ( 𝑜 )
𝐶j
Where zj = valency of ion j, Vm = membrane voltage= Vi – V0 , i= inside of membrane,
o= outside of membrane, F= Faraday’s constant, R= Gas constant, T= temperature, C j 0 =
concentration of ion j outside of the membrane, and Cj i = concentration of ion inside of the
membrane (Reuss, Wills et al. 1996).
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1.5.5.2 Epithelial Transporters
The transporters onto epithelial cellular membrane can be categorized into three types:
1) Ion pumps 2) Carriers 3) Channels.
1) Ion Pumps
The ion pumps include ATPase which is known to use the energy produced due to
hydrolysis of ATP and transport ions against the electrochemical gradient. Thus, ion pumps
drive active ion transport. The ion pumps can transport around 100-200 molecules per
second, referred to as the turnover number. ATP hydrolysis causes conformational change
of the subunit of ATPase and dissociation of substrate which was previously associated
(Läuger 1991; Reuss, Wills et al. 1996). In this section, among the different ion pumps,
primary emphasis will be given on Na+/ K+-ATPase.
Major Epithelial Ion Pumps
a) H+ pumps: H+-ATPases are expressed in the kidney proximal tubule and distal nephron
and helps in maintaining acid-base homeostasis (Gluck, Underhill et al. 1996). This
pump causes K+ reabsorption and H+ secretion and is known to be present in the
intercalated cells from cortical collecting duct and distal regions of nephrons. The
activity of H+,K+-ATPase acts independent of Na+, is stimulated by K+, and can be
blocked by vanadate (Reuss, Wills et al. 1996).
b) Ca2+-ATPase: This ATPase drives the active transport of Ca2+ from cellular cytoplasm
to the interstitial fluid and this pump is found in renal tubule cells. Each transport cycle
with Ca2+-ATPase pump causes removal of 2 Ca2+ ions. This ATPase pump is known
to be inhibited by vanadate (Carafoli 1994).
c) Na+/ K+-ATPase: This ion pump helps in maintaining high concentration of K+ and low
concentration of Na+ inside the cells. The Na+/ K+-ATPase maintains the membrane
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potential and osmotic balance of cells (Blanco and Mercer 1998). In the kidney, Na+/
K+-ATPase helps in the reabsorption of Na+ ions and water and thus this enzyme is
crucial in maintaining homeostasis of water and electrolytes in our body (Glynn 1985;
Jørgensen 1990). The turnover number for Na+, K+-ATPase is around 100-200/ second.
Ouabain is known to block the pump activity and aldosterone, a hormone, is known to
increase the pump density (Lingrel, Van Huysse et al. 1994).
Table I: Intracellular and extracellular Na+ and K+ concentrations.
Intracellular

Extracellular [Na+]

Intracellular [K+]

[Na+]

Extracellular
[K+]

10-20 mmol/L

135-145 mmol/L

> 100 mmol/L

5 mmol/L

Subunits of Na+/ K+-ATPase
The Na+/ K+-ATPase pump is an oligomer and is made of two subunits, α and β in
a 1:1 stoichiometric ratio (Reuss, Wills et al. 1996). Another subunit γ of Na+/ K+-ATPase
has been identified whose function is controversial and not clearly understood (Blanco and
Mercer 1998). The three isoforms of α: α1, α2, and α3 have molecular mass of around 120
kDa and two isoforms of β: β1 and β2 have molecular mass around 50 kDa (Reuss, Wills
et al. 1996). The α and β isoforms show tissue specific expression patterns (Blanco and
Mercer 1998). The expression of α1 isoform along with β1 isoform is normally seen in all
tissue (Lingrel 1992; Levenson 1994). In the kidney α1β1 is the major isozyme (Jørgensen
1990; Blanco and Mercer 1998). The presence of other isoforms of Na+/ K+-ATPase such
as α2 and α3 and their functional contributions have been debatable (Farman, CorthesyTheulaz et al. 1991; Ahn, Madsen et al. 1993; Blanco and Mercer 1998). The mRNA and
protein level detection of α2 and α3 isoforms suggested that they are equivalent to 0.01%
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of α1β1 enzyme in the kidney tissue (Lucking, Nielsen et al. 1996). The α subunit is the
catalytic subunit and is mainly responsible for ATPase activity and transport of ions
(Lingrel, Van Huysse et al. 1994; Reuss, Wills et al. 1996; Wills, Reuss et al. 2012). The
α subunit is known to contain the site to bind cations, ATP, inhibitor, and ouabain (Mercer
1993; Pressley 1996; Blanco and Mercer 1998). The β subunit is needed to assemble and
target the pump to be delivered onto the basolateral membrane of epithelial cells (Lingrel,
Van Huysse et al. 1994; Reuss, Wills et al. 1996; Wills, Reuss et al. 2012). The β subunit
is crucial in the function of Na+/ K+-ATPase and it regulates the affinity of the enzyme for
Na+ and K+ (Eakle, Kabalin et al. 1994; Eakle, Lyu et al. 1995; Blanco and Mercer 1998).
The β subunit acts as a chaperone and guides correct folding of the α subunit to be correctly
directed to the basolateral membrane (McDonough, Geering et al. 1990).
Regulation of Na+/ K+-ATPase
Different isoforms of Na+/ K+-ATPase have different affinities for Na+, K+, and
ATP (Blanco and Mercer 1998). Intracellular Na+ concentration, a rate limiting step,
controls Na+/ K+-ATPase function. Intracellular Ca2+ and endogenous ouabain may control
sodium pump activity for a short period (Blaustein 1993; Blanco and Mercer 1998).
Intracellular cAMP and exogeneous derivatives of cAMP can inhibit this pump (Bertorello
and Katz 1993; Blanco and Mercer 1998). Phosphorylation/ dephosphorylation process can
regulate activity of this pump. Protein kinase A (PKA) mediated phosphorylation of serine
residue at the position of 943 of α subunit causes inhibition of this pump’s activity (Fisone,
Cheng et al. 1994). Activation of protein kinase C (PKC) causes phosphorylation of serine
residue at the position 16 of α subunit and can result in the inhibition of the pump activity
(Beguin, Beggah et al. 1994). In the kidney, protein kinase G (PKG) and cGMP shows an
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inhibitory effect on the active sodium pumping (McKee, Scavone et al. 1994); (Scavone,
Scanlon et al. 1995). Thus, activation of PKA, PKC, and PKG can regulate the function of
Na+/K+ pump isozymes. Digoxin and ouabain obtained from plants are known block
activity of Na/K-ATPase by binding to an extracellular region of the α subunit of this pump
(Lingrel, Van Huysse et al. 1994). Ouabain was found to cause endocytosis of Na+/ K+ATPase in porcine renal epithelial cells (Liu, Kesiry et al. 2004). Different isoforms of α
of Na+/ K+-ATPase have different affinity for ouabain. The α3β1 and α3β2 isozymes show
high level, α2β1 and α2β2 isozymes show intermediate level, and α1β1 isozymes show
low level of reactivity or sensitivity for ouabain (Obrien, Lingrel et al. 1994; Bamberg and
Schoner 2012).
2) Carriers
The carriers are known to cause secondary active transport or passive transport. The
carrier which transports one substance is called uniporter. The carriers can also transport
multiple substances. Electrochemical gradient created by transport of one substance can
drive the transport of another substance or substances. The carrier can be either symporters
(cotransporters) i.e., the movement of two substances in the same direction, or exchangers
(countertransporters) i.e., the movement of two substances in the opposite direction. The
turn over numbers of carriers are around 102-104 molecules per second (Stein and Litman
2014). Normally carriers act in conjunction with a pump. Carriers and/ or channels act in
series or in parallel with a pump. For example, Na+- glucose cotransporter or amiloridesensitive sodium channel acts in series with the Na+/ K+-ATPase located in the basolateral
membrane of an epithelium which absorbs Na+ (Reuss, Wills et al. 1996).
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Major Renal Epithelial Carriers
a) Sodium-glucose cotransporter: These apical cotransporters belonging to SGLT
gene family are used in the absorption of salt and water in the kidney proximal
tubule (Reuss, Wills et al. 1996). Outward passage of glucose through basolateral
membrane occurs using glucose uniporters belonging to GLUT gene family
(Thorens 1993).
b) Sodium-chloride cotransporter: This cotransporter (NCC) is normally present in the
apical membrane distal convoluted tubule (DCT) and is known to reabsorb 5-10%
of Na+ and Cl- (Reilly and Ellison 2000). In the DCT, this cotransporter is known
to interact and regulate epithelial Na+ channels (Mistry, Wynne et al. 2016).
c) Other Na+ organic solute transporters: Na+ electrochemical gradient generated by
Na+, K+ pump drives secondary active transport i.e., intracellular uptake of
vitamins, bile salts, and anions (Reuss, Wills et al. 1996).
d) Na+/H+ exchanger: This NHE is the carrier which causes exchange of a Na+ for a
H+. This is an electroneutral process. The NHE has two functions: 1) apical NHE
causes Na+ absorption and H+ secretion 2) basolateral NHE maintains cellular pH
and volume. The expression of NHE3 is majorly noticed in the kidney proximal
tubule (Pouysségur 1994; Reuss, Wills et al. 1996).
e) Na+-K+-Cl- cotransporter: The NKCC cotransporter has important roles in the
function of chloride transporting epithelia. This cotransporter performs transport
of Cl-, Na+, and K+ in a stoichiometric ratio of 2:1:1 in an electroneutral manner.
The NKCC driven transport can be inhibited by loop diuretics, such as furosemide
and bumetanide. NKCC is normally found in the Cl- transporting epithelium in the
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opposite of the membrane in which Cl- channel is expressed (Haas 1994). In the
thick ascending loop of Henle, NKCC is found in the apical membrane. Cl- ions
exit the basolateral membrane through Cl- channel and Na+ ions go out using the
Na+/ K+-ATPase. NKCC2 is seen in the mammalian kidney (Haas 1994).
f) Anion exchangers: The anion exchangers (AE) cause exchange of Cl- and HCO3in an electroneutral process. AE1b, a truncated AE1 protein, is found in the
basolateral membrane of intercalated cells in the kidney collecting duct (Reuss,
Wills et al. 1996).
g) Na+-HCO3- cotransporter, Na+ dependent Cl-/ HCO3- exchanger: The Na+-HCO3cotransporter is known to be expressed in the proximal tubule and contribute to
90% of HCO3- transport through basolateral membrane of the epithelia (Boron and
Boulpaep 1989). The Na+ dependent exchange of Cl-/ HCO3- is an electroneutral
process and is also seen in the basolateral membrane of cells in the kidney proximal
tubule. This exchanger contributes to a much less extent in the HCO3- transport as
compared to the Na+-HCO3- cotransporter (Reuss, Wills et al. 1996).
3) Channels
Ion-channels are formed by pore-forming proteins and allow the passage of ions
according to cell’s electrochemical gradient (Nadeau 2017). The process of the passage of
ions through channels is a passive transport. The channels are maintained in either one of
two states: open or closed. The transition in between these two states is called gating
(Reuss, Wills et al. 1996). Thus, in addition to selectivity, ion channels also show gating
effect, i.e., these channels open in response to a stimulus. For example, voltage-gated
channels open in response to transmembrane potential (Nadeau 2017). Channels in open
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state allows free passage of ions. The typical turnover number for channels is around 106
to 107 ions per second (Reuss, Wills et al. 1996). Numerous ion pumps are needed to match
up with the flow of ions through a channel. It has been suggested that there are around 5000
to 10000 Na+ pumps per one K+ ion channel present (Hille 2001). In this section, among
the various epithelial ions channels, a major emphasis will be given on the epithelial
sodium channel (ENaC).
Major Epithelial Channels
a) Sodium channels: The sodium channels can be classified into three categories:
Highly selective Na+ channel: These Na channels have high Na+ selectivity over

i.

K+ i.e., PNa/ PK≥ 10, low conductance (ca. 5 pS), and the channel open and close
times are long (0.5 second to 5 second).
ii.

Moderately selective Na+ channel: These Na+ channels have relatively low
selectivity for Na+ as compared to highly selective Na+ channels, i.e., PNa/ PK=
3-4; higher conductance (7-15 pS), and very short open or closed times (≤ 50
ms).
iii.

Non-selective channel: These channels show little selection preference or
no selection preference for Na+ over K+ i.e., PNa / PK ≤ 1.5; high conductance
23-28 pS or low conductance ≥ 3 pS (Reuss, Wills et al. 1996).

All these three types of Na+ channels are amiloride-sensitive (Garty 1994). The
channel blockage occurs by a plug-type process. Highly selective Na+ channels are
expressed in the tight epithelia having high electrical resistance, such as the ENaC present
in the renal distal tubule and cortical collecting duct (Palmer 1995). The aldosteronesensitive and vasopressin-sensitive epithelia showed increase in the open channel
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probability and numbers of sodium channels in response to hormones. Channel activity is
known to decrease by intracellular Na+ concentration, which may be due to activation of
PKC. The moderately selective Na+ channels are known to coexist along with highly
selective Na+ channels in epithelial cells cultured onto impermeable supports. These
moderately selective Na+ channels are controlled by G proteins and cellular actin filaments.
Non-selective Na+ channels were reported to be present in the primary cell cultures of inner
medullary collecting ducts. The increased level of cGMP is known to cause
phosphorylation of channels and can decrease the open probability of these non-selective
Na+ channels (Garty 1994; Palmer 1995; Reuss, Wills et al. 1996).
Epithelial Na+ Channel (ENaC)
The final stages of Na+ reabsorption occur in the convoluted and collecting
tubules and collecting duct using the epithelial Na+ channel (ENaC). Sodium reabsorption
is known to control extracellular fluid volume and regulate blood pressure (Pratt 2005;
Rotin and Schild 2008; Hamm, Feng et al. 2010). ENaCs are distinct compared to Na+
channels of excitable membrane (Reuss, Wills et al. 1996). The ENaC forms a
heterotetramer and consists of two α, one β, and one γ homologous subunits (Canessa,
Schild et al. 1994; Kellenberger, Hoffmann-Pochon et al. 1999). Each subunit is known
to have two transmembrane domains: M1 and M2, short intracellular N and C termini of
9-10 kDa, and large extracellular loops of around 50 kDa with numerous sites for Nlinked glycosylation. The αENaC (78 kDa) subunit helps in forming the Na+ ion selective
and amiloride sensitive conductive pore. The β and γ subunits are needed in the
enhancement of channel expression (Garty 1994; Palmer 1995; Reuss, Wills et al. 1996).
All three, α, β, and γ ENaC subunits on a single channel level show a higher selection for
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Na+ than K+ and relatively low value of conductance (~5pS) and also exhibit channel
gating with long channel opening time (Butterworth 2010). Thus, ENaCs act as the
highly selective Na+ channel. Half-life of ENaC in the apical side was found to be
around 20-30 minutes using cell culture studies (Balda and Matter 2000; Hanwell,
Ishikawa et al. 2002; Butterworth 2010).
Regulation of ENaC
ENaC is known to control the Na+ absorption rate in the distal nephron (Bhalla and
Hallows 2008; Loffing and Korbmacher 2009; Butterworth 2010; Hamm, Feng et al. 2010).
The ENaC mutations and conditions can result in upregulation and downregulation of
ENaC activity, such as seen in Liddle syndrome, type I Pseudohypoaldosteronism (PHAI), and cystic fibrosis (CF) (Bhalla and Hallows 2008). Glycosylation, cleavage by
proteolysis, and other post translational modifications are important in the expression and
activity of ENaC (Bhalla and Hallows 2008). Sodium reabsorption through ENaC can be
altered by two different mechanisms: i) the variation of surface density or number of
channels on the apical surface and ii) a change in the open probability of channels by gating
the channel or by proteolytic cleavage of the extracellular loops α and γ (Butterworth 2010).
i) Variation of ENaC Surface Density
The downregulation of apical ENaC involves ubiquitination of ENaC by ubiquitin
ligase Nedd4-2 and removal from apical surface by the process of endocytosis (Kabra,
Knight et al. 2008). Endocytosed ENaC can go back to apical surface after removal of
ubiquitin molecules and recycling or these ubiquitinated ENaC molecules are degraded
(Butterworth 2010). Aldosterone is known to bring ENaC from intracellular and
cytoplasmic region to apical surface of principal cells from the distal nephron area. With
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long term application of aldosterone, ENaC production and protein half-life are increased
(Niisato, Taruno et al. 2007; Bhalla and Hallows 2008; Frindt, Ergonul et al. 2008;
Butterworth 2010). Short term application of aldosterone increases numbers of ENaC on
the surface (Frindt, Ergonul et al. 2008). The cAMP agonist was found to increase channel
density of ENaC in the apical side of kidney collecting duct epithelial cells (Morris and
Schafer 2002; Butterworth, Edinger et al. 2005).
ii) Change in Channel Open Probability
Intra and extracellular concentrations of Na+ regulate ENaC activity. A rapid
change of channel activity, which is seen within seconds due to increased extracellular Na+
concentration, is known as Na self-inhibition (Fuchs, Larsen et al. 1977). Noncleaved
channels maintain low channel opening probability (Po) when extracellular Na+
concentration is high (Sheng, Carattino et al. 2006). The Na-self inhibition mechanism is
relieved by proteolytic cleavage of extracellular loops of ENaC α and γ subunits (Bhalla
and Hallows 2008).
Feedback inhibition is a slow change in channel activity that occurs after a few
minutes to hours due to increased intracellular Na+ concentration (MacRobbie and Ussing
1961). The application of Na+/ K+-ATPase inhibitors does not cause swelling of cells
(Sheng, Carattino et al. 2006; Bhalla and Hallows 2008) and indicates the importance of
feedback inhibition.
Na-self inhibition and feedback inhibition of ENaC are especially important
specially in high-salt environments or diets (Bhalla and Hallows 2008).
b) Potassium Channels: Epithelial potassium channels are responsible for three functions:
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High intracellular concentration of K+ ions as compared to extracellular fluid

i.

concentration of K+, which creates the negative potential and provides the
electrochemical gradient to move other ions.
ii.

These channels allow transepithelial absorption or secretion of K+ ions.

iii.

During cellular swelling, these K+ channels get activated to control cellular volume
(Wang, Sackin et al. 1992; Taglialatela and Brown 1994).
ROMK1 channel: This channel is an inwardly rectifying K+ channel, i.e., it allows

easier movement of K+ ions into the cells than out of. It is an ATP sensitive K+ channel,
which is known to have conductance around 39 pS and high sensitivity to K+ than Na+.
This channel shows increased open probability at membrane potential, which is at a more
positive value than -60 mV. The ROMK1 expression is seen in the renal cortex and outer
medulla (Ho, Nichols et al. 1993).
Other Maxi-K+ channels have been found in the apical membrane in the areas of
renal proximal tubule and cortical collecting duct (Reuss, Wills et al. 1996).
c) Chloride Channels: Chloride channels play a crucial role in the epithelia, such secretion
of Cl-, absorption of NaCl, and regulation of cell volume. Major chloride channels
include: cystic fibrosis transmembrane conductance regulator (CFTR) and swelling
activated Cl- channels. CFTR is an ATP-dependent and cAMP regulated channel and
can be blocked by 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB) and
glibenclamide (Fong and Jentsch 1995; Reuss, Wills et al. 1996). CFTR is found in the
apical membrane of most exocrine glands. The intracellular cAMP-controlled opening
of CFTR channels is diminished in the individuals with cystic fibrosis. In the kidney
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cysts, CFTR channels are believed to be associated with active chloride secretion (Brill,
Ross et al. 1996; Hanaoka, Devuyst et al. 1996).
Swelling activated Cl- channels are found in the culture of cortical collecting
duct and inner medullary cells. The permeability preference of this channel is PCl>
PHCO3 > P gluconate > PNa, and these channels can be blocked by the chloride channel
blocker NPPB (Fong and Jentsch 1995; Reuss, Wills et al. 1996; Wills, Reuss et al.
2012).
d) Calcium Channels: The calcium channels play crucial roles in Ca2+ absorption by renal
epithelial cells, and are thereby important in intracellular signalling. The voltagedependent calcium channels get activated due to the depolarization of membrane
potentials and can be inhibited by Co2+. These channels are similar to L-type Ca2+
channels. The role of these Ca2+ channels in the kidney epithelial cellular function is
unknown (Friedman and Gesek 1993; Reuss, Wills et al. 1996).
e) Non-selective Cation Channels: These channels have been reported to be present in the
renal inner medullary collecting duct, renal distal tubule cells, and M-1 cortical
collecting duct cell line (Reuss, Wills et al. 1996).
f) Water Channels (Aquaporins): Lipid membranes are known to have high water
permeability by osmosis and do not actually require water channels or pores. An
epithelium with high osmotic water permeability, such as a leaky epithelium and
antidiuretic hormone (ADH) stimulated epithelium, is known to have pores or water
channels called aquaporins. The aquaporin 1 (AQP) 1 is a tetramer in which each
subunit is known to act as a pore. The AQP1 has high selectivity for water molecules
and almost no permeability for electrolytes or non-electrolytes. AQP1 is known to
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express in the apical and basolateral membranes of the epithelial cells from kidney
proximal tubule and in the descending thin limb belonging to loop of Henle. Some other
water channel proteins have also been identified, such as ADH regulated water
channels: AQP-CD or AQP2 in the apical membrane of the renal collecting duct cells.
The water channel AQP3 is found in the basolateral membrane of renal collecting
tubule (Engel, Walz et al. 1994; Sabolic and Brown 1995; Reuss, Wills et al. 1996).
1.5.6 Overview of Renal Epithelial Na+ Transport
In the kidney, along with Na+, other ions, such as chloride and bicarbonate ions,
also get reabsorbed heavily (Staruschenko, Ilatovskaya et al. 2016). The main mode of
sodium reabsorption in the kidney is the active transport through transcellular pathways.
Passive transport is also known to contribute partially in the total Na+ transport in the
kidney. Sodium reabsorption in known to occur through both active and passive transport
mechanisms in proximal convoluted tubules (PCT) and the thick ascending limb (TAL) of
Henle’s loop (Breiderhoff, Himmerkus et al. 2012; Muto, Furuse et al. 2012). Passive
transport of Na+ ions is majorly seen in the PCT, where the paracellular resistance is low.
(Staruschenko, Ilatovskaya et al. 2016). Claudin-2 in the tight junction is known to be
responsible for reabsorption of Na+ (Kiuchi-Saishin, Gotoh et al. 2002). Around 30% of
Na+ ions, absorbed from urine to blood by transcellular transport mechanisms, are known
to go back to the urine in the proximal tubule by paracellular transport process
(Staruschenko, Ilatovskaya et al. 2016). The electrogenic pump Na+/ K+-ATPase is known
to be localized in the basolateral membrane of kidney epithelial cells. This pump is found
in abundance in the TAL of Henle’s loop, distal convoluted tubule (DCT), collecting tubule
(CT), and principal cells belonging to collecting duct (CD) (Staruschenko, Ilatovskaya et
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al. 2016). The kidney segments having high active transport is generally known to have
increased level of Na+/ K+-ATPase activity (Féraille and Doucet 2001). The absorption of
Na+ is known to be maximum in the region of kidney proximal tubule and decrease as the
fluid travels through the distal segments of the kidney tubule. As shown in figure 7, the
SGLT cotransporter and NHE3 exchanger account for transcellular reabsorption of Na+ ion
in the proximal tubule and Na+-K+-Cl- cotransporter NKCC2 accounts for the transcellular
reabsorption of Na+ ions in Henle’s loop. The Na+-Cl- cotransporter NCC drives
transcellular Na+ reabsorption in the distal convoluted tubule, and ENaC channels in the
collecting duct allow transcellular entry of Na+ ions for reabsorption. Proximal tubule
reabsorbs around 60-70% of Na+ ions, and distal convoluted tubule and collecting duct are
each known to contribute to around 5% of Na+ ion reabsorption and are known to be
precisely controlled by physiological factors (Féraille and Doucet 2001).

Figure 7: The percentage of Na+ transport involving major ion channels and
transporters in the different segments of a nephron. Image credit (Staruschenko,
Ilatovskaya et al. 2016). SGLT= Sodium-glucose cotransporter, NHE= Na+/H+ exchanger,
NKCC= Na+-K+-Cl- cotransporter, NCC=Na+–Cl- cotransporter, ENaC= Epithelial sodium
channel.
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1.5.7 Regulation of Epithelial Permeability by Cellular Tight Junctions
1.5.7.1 Epithelial Tight Junctions
In epithelia, tight junctions act as barriers and form morphological and functional
boundaries between apical and basolateral sides and regulate selective movement of solutes
through paracellular pathways (Balda and Matter 2000; Cereijido, Shoshani et al. 2000;
Anderson 2001; Denker and Sabath 2011). Epithelial tight junctional complex is made of
tight junction, adherens junction, and desmosomes (Farquhar and Palade 1963). The
paracellular permeability is mainly determined by the unique tight junction composition of
specific claudin types, which occupy and control the paracellular space (Furuse, Fujita et
al. 1998). Signalling proteins and pathways are important in maintaining the function of
tight junctions to regulate permeability. Zonula occludens 1 (ZO1), a scaffolding protein,
acts

as a connector which links tight junction protein to each other and to actin

cytoskeleton, and also to signal transduction molecules (Denker and Sabath 2011). Tight
junctions can regulate signals for gene expression by transporting DNA binding proteins
from tight junction to the cellular nucleus (Denker and Sabath 2011). Through tight
junction signalling process involving ZO1 associated nucleic acid binding proteins, cells
can estimate cellular density and accordingly initiate cell proliferation (Balda and Matter
2000; Lima, Parreira et al. 2010).
1.5.7.2 Transepithelial Resistance
Transepithelial resistance (TER), also known as transepithelial electrical resistance
(TEER), is the inverse of electrical conductance. TER is a combined value of transcellular
and paracellular resistance arranged in parallel and is therefore calculated as: 1/TER =
[1/TER

transcellular

+ 1/TER

paracellular](Matter

and Balda 2003). In epithelia with low TER

values, the paracellular resistance is much larger than transcellular resistance (Cereijido,
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Gonzalez-Mariscal et al. 1983; Stefani and Cereijido 1983; Gonzalez-Mariscal, De
Ramirez et al. 1989). Therefore, the TER values of low resistance epithelia, such as MadinDarby Canine Kidney Epithelial Cells II (MDCKII), mostly indicate paracellular resistance
which is a combination of junctional resistance and resistance by the paracellular space
(Matter and Balda 2003). Permeability of ions through epithelial cells can be roughly
estimated by measuring TER values (Matter and Balda 2003). TER of cellular monolayers
using cell culture media primarily indicates Na+ permeability (Matter and Balda 2003).
Measurement of TER is a convenient method to test for cellular monolayer formation onto
permeable support membrane, and TER values indicate integrity of tight junctions.
Therefore, TER is useful in determining barrier functions of epithelial monolayers (Lea
2015).
1.5.7.3 Renal Epithelial Tight Junctions and TER
Major tight junction proteins of kidney epithelial cells are shown in figure 8A.
Claudins are the major integral membrane proteins which help in maintaining barrier
function and allow paracellular transport selectively. Proteins, such as ZO1 and occludin,
also help in the maintenance of epithelial tight junction barrier. Tissue injury causes
phosphorylation of tight junction proteins and disruption of epithelial barrier function. As
shown in figure 8A, tight junction disruption or injury causes loss of selective paracellular
permeability and increase in TER values. Recovery of tight junction proteins help in
restoring barrier function by regaining selective paracellular permeability and decrease of
TER values (Denker and Sabath 2011).
TER values of different segments of nephron are inversely proportional with
permeability as shown in figure 8B. In the nephron of a mammalian kidney, the paracellular
permeability decreases from proximal tubule to the collecting duct as the unique
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composition of different claudin changes (Kiuchi-Saishin, Gotoh et al. 2002), and higher
ZO1 and occludin protein levels are expressed in the lower segments of the nephron
(Gonzalez-Mariscal, Namorado et al. 2000). A major claudin normally found in the
proximal tubule is claudin-2 which creates high conductance pores for cations, such as
sodium ion, and therefore proximal tubule shows low electrical resistance (Muto, Hata et
al. 2010). Proximal tubule is known as the leaky region of the nephron and one third of the
fluid reabsorption occurs by paracellular pathway. Thus, starting from glomerulus, the
lower segments of nephrons are less and less permeable and show more selective transport
and high TER values (figure 8B). The distal region of the nephron, such as collecting duct,
is considered as a tight epithelium with high resistance and very selective permeability i.e.,
low cation permeability due to the presence of cation barrier forming claudins such as
claudin-4 and 8 (Denker and Sabath 2011). The permeability difference between proximal
tubule and collecting duct is around 100 fold (Denker and Sabath 2011).
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Figure 8: Epithelial tight junctions and TER of a nephron. Image credit (Denker and
Sabath 2011). (A). Major Tight junction proteins in kidney epithelial cells. (B) Different
segments of the nephron with major claudins.
1.5.7.4 Tight Junction Integrity and Paracellular Transport
Tight junctions maintain two functions 1) as a fence and 2) as a gate. The junction
fence prevents the intermixing of lipid molecules in the outer phospholipid layer of the cell
membrane (Matter and Balda 2003). Fluorescence conjugated lipids such as sphingomyelin
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or glycolipids are commonly used to label outer leaflet of plasma membranes in order to
estimate to “fence function” (Meer and Simons 1986; Mandel, Bacallao et al. 1993; Balda,
Whitney et al. 1996). The diffusion of lipids is studied by confocal microscopy in cells or
fluorometric analysis is performed with cell lysates (Matter and Balda 2003).
The gate function of tight junctions controls the paracellular transport pathway.
Paracellular transport is generally considered as passive transport and is driven by electroosmotic gradient created due to active transport. Epithelial paracellular transport can occur
through two separate pathways: 1) through charge and size selective 4 Å sized pores made
by claudins and 2) large discontinuities in the tight junction which allows large molecules
to pass through irrespective of charge and size (Anderson and Van Itallie 2009). Several
orders of magnitude difference of permeability can be seen between a tight and leaky
epithelium (Anderson and Van Itallie 2009). An epithelium with “tight” tight junctions can
have high electrochemical gradient due to active transport of ions or charged species
(Anderson and Van Itallie 2009). Nearly all leaky epithelia preferentially allow transport
of sodium ions than chloride ions i.e. the ratio of Permeability of Na+ (PNa)/ Permeability
of Cl- (PCl) will be around 10 to 1.5 (Anderson and Van Itallie 2009).
1.5.7.5 Experimental Measurement of Epithelial Paracellular
Permeability
Epithelial permeability can be measured using hydrophilic tracers such as
fluorophore labelled dextrans or radiolabelled inulin or mannitol. Variable sized tracer
molecules can be analysed by labelling dextran molecules with FITC or rhodamine, and
different fluorophore tags allow analysis of more than one tracer in a single cellular
monolayer in one experimental set up (Matter and Balda 2003). In simple ion selective
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experiments, filters with cellular monolayers are tested in the presence NaCl or LiCl to test
for Na or Li permeability. Tracers, such as mannitol (radius= 4.2 Å) in radius, inulin
(radius= 15 Å), and FITC-conjugated dextran molecules (3, 10, 70 kDa, etc), go through
the non-pore pathway i.e., temporary breaks in the tight junction, rather than the pathway
involving claudin pores (Anderson and Van Itallie 2009). Fluorescence of FITC-dextran
molecules that can permeate through epithelial monolayer can be detected by measuring
fluorescence values at time intervals and the transepithelial permeability can be quantified
in terms of the apparent permeability (Papp) values (Nag and Resnick 2017). TER or small
tracer permeability cannot estimate only paracellular permeability but combined
transcellular and paracellular permeabilities. Dextran molecules with size around 4 kDa
can be transported across epithelial monolayer through paracellular pathway as well as
through fluid-phase transcytosis (Matter and Balda 2003). Fluid-phase transcytosis can be
estimated by allowing cells to uptake horseradish peroxidase (HRP) and after washing and
incubating transcytosed HRP can be detected using enzymatic reactions (Miettinen, Matter
et al. 1992; Balda, Whitney et al. 1996). Application of large sized tracers such 40-400 kDa
can show only paracellular transport (Matter and Balda 2003). Thus, by choosing a variety
of tracer molecules, paracellular transport can be estimated.
1.6 Epithelial Electrophysiology
Epithelial transport can be characterized by measuring electrical properties, such as
transepithelial potential difference, transepithelial resistance, short circuit current, and
capacitance (Lewis 1996). Cellular lipid bilayer is resistant to charged molecules, therefore
simple diffusion cannot produce an electrical current, rather transport needed to occur
through ion channels which are pore-forming proteins allowing selective ion-transport,
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although some non-selective ion channels can also be present allowing either all cations or
anions to pass (Nadeau 2017). Some of the majorly used electrophysiological analysis
systems are discussed below.
1.6.1 Transepithelial Electrical Resistance
Transepithelial resistance (TER), also known as transepithelial electrical resistance
(TEER), can be measured by passing a current ΔI across the epithelial layer and measuring
the resultant change in voltage (ΔV) in a current-clamp mode. The TER can also be
measured in a voltage-clamp mode by passing a voltage (ΔV) and measuring the change in
current (ΔI) which is needed to maintain at that voltage (Lewis 1996). The resistance is
determined from Ohm’s law i.e., the resistance is equal to the transepithelial voltage change
divided by transepithelial current change (Lewis 1996).

𝑅𝑚𝑒𝑎𝑠 . =

∆𝑉𝑡
×𝐴
∆𝐼𝑡

Where, A= area of epithelial layer
Unit of resistance is expressed in the units of ohm-cm2. Measured resistance (R
meas.)

is a sum of transepithelial resistance and series resistance of the measuring solution

(Rs). Actual transepithelial resistance TER can be measured by subtracting measuring
solution resistance from total measured resistance i.e., TER= Rmeas. – Rs (Lewis 1996). The
value of the series resistance can be measured by measuring the resistance of an empty cell
culture insert without any epithelial cells. For epithelia with high resistance, the value of
Rs accounts for very minor corrections. Transepithelial conductance= Gt = Gtrc + Gp
Where, Gt= transepithelial conductance, Gtrc= transcellular conductance, and Gp=
paracellular conductance. Electrical resistance is the inverse value of conductance.
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Therefore, transepithelial resistance is calculated as:

𝐺𝑡 =

1
1
1
=
+
𝑇𝐸𝑅 𝑅𝑡𝑟𝑐 𝑅𝑝

Where, TER= Transepithelial Resistance, Rtrc= Transcellular Resistance, and Rp=
Paracellular Resistance (Lewis 1996).
1.6.1.1 Equivalent Electrical Circuit of an Epithelial Monolayer
The transcellular and paracellular resistances act in parallel. The detailed equivalent
electrical circuit of an epithelial monolayer is shown in figure 9. Apical membrane and
basolateral membrane contribute to total resistance separately and they act as series
resistances.

Transcellular resistance, Rtrc is the sum of apical resistance (Ra) and

basolateral resistance (Rb). The paracellular resistance (Rp) is the main contributor in the
total resistance, especially in the beginning of the cellular monolayer barrier formation,
when tight junctions and adherent junctions are not yet formed in between cells (Bertrand,
Durand et al. 1998; Benson, Cramer et al. 2013; ávan der Meer, JungáKim et al. 2015).
Generally, any experimental manipulation causing a change of TER value, indicates the
change of Rp (Matter and Balda 2003). This model is applicable to measurement using DC
currents with frequency of 0 Hz, however AC current with very low frequency can also be
used in this model (ávan der Meer, JungáKim et al. 2015). Total monolayer resistance can
be expressed as:

1
1
1
1
=
+
+
𝑅𝑇 𝑅𝑎 + 𝑅𝑏 𝑅𝑃 𝑅𝑔

Since, Ra and Rb resistances act in series. (Ra+ Rb), Rp, and Rg act all in parallel.

TER = R + R
T

f
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Figure 9: Equivalent circuit model for TER of an epithelial monolayer. (A) Different
resistance components of a confluent epithelial monolayer. Rf= fluid resistance, Ra= apical
membrane resistance, Rb= basolateral membrane resistance, Rp= paracellular resistance,
and Rgap= gap resistance which is absent in a confluent monolayer. (B) Resistances
contributed by epithelial cells of a cellular monolayer.
Rg shows the gap resistance of a partial cell coverage of the cellular monolayer. If
a cellular layer has 99.6% cell coverage or confluence the measured TER value can be 80%
lower than the TER value of a culture with 100% cell coverage or confluence (ávan der
Meer, JungáKim et al. 2015). Thus, a drastic decrease of TER indicates a loss of cellular
confluence and thereby can help to monitor monolayer health.
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1.6.1.2 TER Measurement Methods
For TER measurement, two electrodes are used (one electrode in the upper
compartment and second one in the lower compartment), and a cell culture insert with
cellular monolayer is placed in between. TER can be measured by applying a direct current
(DC) voltage across a cellular monolayer and by measuring the resulting current and then
calculated as the ratio of voltage and current following Ohm’s law. Direct current can
damage electrodes and cells due to charging effects on electrodes and cellular layer. To
avoid this issue, an alternating current (AC) with low frequency (12.5 Hz) is applied
(Srinivasan, Kolli et al. 2015). In a current-clamp mode, first the membrane potential is set
to zero, then an AC current (12.5 Hz) is applied with one pair of electrodes and deflection
of voltage is measured with a second pair of electrodes (Matter and Balda 2003; Srinivasan,
Kolli et al. 2015). TER values are calculated using Ohm’s law R= V/I. A silver-silver
chloride chopstick electrode (such as, STX2 from World Precision Instrument or Millicell
STX probe from Millipore) or a small electrode chamber system (such, Endohm chamber
from World Precision Instrument) connected to an epithelial voltmeter (such as, EVOM
from World Precision Instrument or Millicell-ERS Voltmeter from Millipore) are used to
measure the TER values in cell culture inserts (Matter and Balda 2003; ávan der Meer,
JungáKim et al. 2015). Properly performed, a TER experiment will ensure equal current
distribution throughout the membrane. Use of cell culture media acting as a conductive
interphase ensures a close-to-an-equal drop in the potential throughout the whole
membrane (ávan der Meer, JungáKim et al. 2015).
1.6.1.3 Factors that Can Affect TER Measurements
Transfer of filters into a measurement chamber can cause fluctuation in TER value,
and the fluctuation can be nullified by equilibrating the filter in the measurement chamber
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for around 15 minutes. The same fluid levels need to be maintained in the inner and outer
chamber (Matter and Balda 2003). The cultures or cell culture media should be maintained
at 37°C since temperature strongly affects TER values (Gonzalez-Mariscal, De Ramirez et
al. 1985). For example, lowering of temperature to ambient temperature causes TER value
to increase more than three times in MDCK, kidney epithelial cells (Matter and Balda
2003). Media change or washing right before measure can show a large change in the TER
values (Matter and Balda 2003).
1.6.1.4 Other TER Measurement System
A DC based TER measurement system may have a few drawbacks, such as
restricted measurement range, possible measurement errors due to electrode surface
alterations after prolonged usage, and possible adverse effects on cellular health due to
silver ions released by overused electrodes (ávan der Meer, JungáKim et al. 2015). To
overcome these limitations, complex-impedance based system has been also used to obtain
TER values (Benson, Cramer et al. 2013). Currently, AC based systems: cellZscope
system72 from nanoAnalytics GmbH and the ECIS system from Applied Biophysics are
commercially available to determine TER in Transwell systems (ávan der Meer, JungáKim
et al. 2015).
1.6.2 Impedance Analysis
Another way of monitoring epithelial transport is the use of impedance analysis
which measures frequency dependent characteristics of epithelia by measuring voltage by
applying a small current. Impedance analysis involves modelling of epithelia as an
electrical model made of capacitors and resistors (Lewis, Clausen et al. 1996). Therefore,
impedance measures the resistance of an electric circuit which exhibits sinusoidal signal at
a fixed frequency. Impedance measurements include capacitance i.e., the ability of a
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biological membrane to store charge and acting as a capacitor (Lewis, Clausen et al. 1996).
Therefore, understanding capacitance of membrane may help to understand the information
about membrane area, for example, geometry of epithelial crypts or extracellular structures.
The drawback of impedance analysis is the complexity of coming up with the actual or
physiologically relevant equivalent circuit model to extract meaningful data (Lewis,
Clausen et al. 1996).
1.6.3. Short Circuit Current
The amount of transepithelial movement of total charged species can be quantified
by determining the current that needs to pass through an epithelial layer to reduce the
potential or transepithelial voltage to zero. This current is referred as the short-circuit
current (Isc) (Lewis 1996). In simple terms, the current that short-circuits the tissue is the
Isc. This current can be measured using a voltage-clamp to detect the amount of current
needed to bring the epithelial voltage to zero millivolts (Lewis 1996).
In an Ussing chamber, when identical bathing solution is present on both sides of
epithelial monolayer, and only one specific ion gets actively transported, the Isc is equal to
the rate of transport of that ion. When more than one ion species is involved in the active
transport, then Isc will be equal to the algebraic sum of all active ion transport mechanisms
(Lewis 1996). In the frog skin model to study Na+ transport from a pond to the blood of a
frog, the net Na+ transport was found to be equal to the value of Isc (Koefoed‐Johnsen and
Ussing 1958).
The relation between current and ion transport can be expressed as:
𝐼
𝐽𝑖 = 𝑠𝑐
𝑧𝐹
Where, Ji denotes net flux of ion i, Isc is the short circuit current.
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F= Faraday’s constant and z= valency of the transported species (e.g., Na+ = 1).
Generally, spontaneous electrical potential can be created across an epithelium due
to passive transport forces, such as osmotic and electrochemical gradients. An Ussing
chamber omits the effect of passive transport by clamping the epithelial potential to zero
by passing an external current across the epithelium and thereby eliminates the possible
effects of transepithelial diffusive forces (Clarke 2009). Thus, an Ussing chamber only
detects the active transport process, and the Isc is known to be equivalent to the algebraic
sum of active transport of electrogenic ions (Clarke 2009).
Commercially available electrode systems as used for TER measurement, such as
Endohm chamber or chopstick electrode connected to EVOM or Millicell voltmeters are
used to obtain voltage values. The equivalent current (Ieq) or equivalent short circuit current
(Isceq) can be calculated from voltage and resistance read outs following Ohm’s law i.e.,
I= V/ R (where, I= current, v= voltage, R= resistance) (Resnick and Hopfer 2007; Resnick
2011; Nag and Resnick 2017).
Channel Blockers
Ion channel activity can be isolated by using specific agents that can block the
channel. Use of channel blockers and measurement of electrical current help to get a clear
knowledge about a specific ion channel, omitting the possibility of any background noise.
Tetrodotoxin (TTX) is obtained from puffer fish and acts as a channel blocker for voltage
gated Na+ channels (Nadeau 2017). Other channel blockers have been developed from
snakes, spiders, and insects. In case of ligand-gated ion channels, agonists and antagonists
can be effective in blocking channels. Agonist and antagonists can bind at the same site as
the ligand or somewhere else, disabling channel activity. Most channel blockers can bind
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to various channels with varying binding affinity (Nadeau 2017). In a mouse cortical
collecting duct epithelial cells (Principal cells), application of 10 µmol/L of Na+ channel
blocker, amiloride, decreased Isc by 95% and suggested 95% of Isc is produced due to active
Na+ transport (Resnick and Hopfer 2007).
1.6.4 Other Methods to Study Cellular Electrophysiology
Cellular electrophysiology can be studied to understand electrical features of cells
and activity of ion channels using patch-clamping or lipid bilayer recording. In patch-clamp
technique electrical properties are measured by making direct contact between an electrode
and a cell (Nadeau 2017). The patch refers to the patch of a cell membrane measured using
a current or voltage clamp to detect voltage or current of a biological cell. The electrical
recording of lipid bilayer is similar as the patch-clamp technique, although the physical set
up is different. In this method, a lipid layer orifice separates two chambers of bath. Ion
channels can be implanted onto the lipid layer orifice and electrical properties of the
channel can be evaluated (Nadeau 2017). Measurement of single channel provide better
understanding of channel activity, whereas whole-cell recordings measure hundreds to
thousands of channels. Single channel measurements give a clear knowledge about channel
conductance, and we can understand channel opening and closing modes of action (Nadeau
2017). Thus, by patch-clamp or lipid bilayer method, single channel or multiple channel
activity of a single cell can be detected as compared to an Ussing chamber which detects
all the channel activities of a cellular monolayer.
1.7 Kidney Pathology and Diseases
Kidney diseases can be divided into two categories: acute and chronic. Acute
kidney injury (AKI) does not have an universal definition, rather it is diagnosed on the
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basis of some physiological parameters such as changes of serum creatinine levels or
absolute creatinine level (Mehta, Kellum et al. 2007). A kidney disease can be categorized
as a chronic kidney disease (CKD) when the glomerular filtration rate (GFR) remains
continuously less than 60 mL/minute/ 1.73 m2 during a period of 3 months or longer
(Quigley 2012).
AKI may occur during clinical procedures, such as kidney transplantation and
cardiac surgery (Bellomo, Kellum et al. 2012). Diabetes, hypertension, and obesity are
considered as the leading risk factors for the occurrence of CKD (Coresh, Selvin et al.
2007). In this section, among different kidney diseases, a major emphasis will be given on
polycystic kidney disease.
1.7.1 Acute Kidney Injury
AKI, or acute kidney failure (AKF), is a clinical complication characterized by a
sudden drop (hours to days) of kidney excretory function. AKI or AKF may result in
decreased urine output and accumulation of metabolic acids and increased levels of
phosphate and potassium ions. This diseased state causes an accumulation of products
formed due to nitrogen metabolism, such as creatinine and urea. A small rise of serum
creatinine level was found to cause patient mortality (Bellomo, Kellum et al. 2012). AKI
is known to be caused mainly by hypoxia, ischemia or nephrotoxicity (Basile, Anderson et
al. 2012). AKI has been studied in animal acute ischemic models in which ischemia is
induced by acutely blocking the renal artery. Animal models of these AKI showed kidney
localized adverse reactions such as activation of coagulation system, infiltration of
neutrophils, cytokine release, and damage of the endothelium (Bellomo, Kellum et al.
2012).
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1.7.2 Chronic Kidney Disease
Chronic Kidney Disease (CKD), also known as chronic kidney failure, causes a
gradual loss of kidney function and finally leads to kidney failure. Earlier stages of CKD
show some level of kidney damage, as determined by albuminuria, and compromised
kidney function, detected as GFR by measuring serum creatinine concentration (Levey,
Eckardt et al. 2005). The end stage symptom of CKD is the kidney failure which requires
dialysis and kidney transplantation. CKD is also known to increase the risk of
cardiovascular diseases and can result in other complications (Sarnak, Levey et al. 2003;
Levey, Eckardt et al. 2005; Coresh, Selvin et al. 2007). In the United States, the number of
patients with kidney failure related to CKD more than doubled in 2004 as compared to
1991 (Health 2010).
1.7.2.1 Hypertension in CKD
The renin-angiotensin system (RAS) is one of the major control systems that
regulates the blood pressure as well as fluid balance. Renin is mainly produced and secreted
from the kidney. Plasma renin concentration is adjusted depending on the blood pressure
and salt balance (Sparks, Crowley et al. 2014). Renin cleaves angiotensinogen and creates
angiotensin I. Angiotensin converting enzyme (ACE) converts angiotensin I to angiotensin
II, which controls the blood pressure and flow and thereby regulates glomerular filtration
rate (Sparks, Crowley et al. 2014). In CKD patients, the inability to maintain Na+ balance
can result in hypertension. Secretion of renin can worsen blood pressure related
complications. Increased blood pressure further causes kidney damage and loss of kidney
function (Quigley 2012).
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1.7.2.2 Polycystic Kidney Disease
Polycystic kidney disease (PKD) is a genetic disease which is characterized by the
formation of fluid-filled pouch-like structures, called cysts. These cysts tend to grow larger
over the years causing reduction of kidney function and finally lead to kidney failure
(Deane and Ricardo 2007). Thus, PKD falls under the category of chronic kidney diseases.
In PKD, mutations occur in the PKD1 and PKD2 genes encoding PC1 and PC2 proteins
respectively. Although the genetic cause of PKD is known, the factors which are
responsible for the cyst expansion and disease progression are not clearly understood
(Cowley 2004).
One in every 1000 persons becomes affected by autosomal dominant PKD
(ADPKD) (Gabow 1993), whereas autosomal recessive PKD (ARPKD) occurs around one
in 20,000 live births (Zerres, Rudnik-Schöneborn et al. 1998). Around 50% of ADPKD
patients face end-stage renal disease (ESRD) by the age around 60 years, and most of the
infants with ARPKD who are able to survive the prenatal period encounter chronic kidney
failure when they reach adolescence (Rohatgi, Greenberg et al. 2003). Mutations of PKD1
and defective PC1 cause 85-90% of ADPKD, and the remaining ADPKD is caused due to
the mutations of PKD2 (Wilson 2004). In ADPKD, the cysts become separated from the
nephron and do not communicate with the tubules from which they were formed (Wilson
and Falkenstein 1995). On the other hand, in case of ARPKD, the cysts still remain
connected as the expanded forms of the collecting duct and allow fluid to flow through
them (Osathanondh and Potter 1964). In both ARPKD and ADPKD, kidney cysts expand
over years and cause malfunction of the rest of the functional epithelia and finally lead to
renal failure (Grantham 1996).
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i.

Role of Primary Cilia and Cell Signaling Pathways in PKD

Renal epithelia have primary cilia which may sense fluid flow using PC1 and PC2
proteins and allow influx of Ca2+ in the renal epithelial cells. This Ca2+ influx effect is
amplified due to the release of intracellular Ca2+ stores by epithelial cells (Pazour, San
Agustin et al. 2002; Deane and Ricardo 2007). Increased levels of Ca2+ inside cells
stimulate cell signaling (eg., B-Raf/MEK/ERK pathway) events that may help in
maintaining renal epithelial phenotype (Simons and Walz 2006; Deane and Ricardo 2007).
When ciliary signaling is absent, renal epithelial cells may undergo dedifferentiation which
can lead to cyst formation and expansion, and during this process the level of cAMP is
found to be increased (Belibi, Reif et al. 2004). Increments of extracellular concentration
of Ca2+ were shown to reverse phenotypic abnormalities seen in the cystic epithelial cells
of PKD (Yamaguchi, Hempson et al. 2006) indicating the importance of ciliary flow
sensing. Decreased levels of PC1 protein were shown to result PKD in mice models
(Leeuwen, Dauwerse et al. 2004); whereas decreased levels of PC2 may show early signs
of cystogenesis since reduced PC2 protein levels were found to cause the proliferation of
kidney tubular cells and the fibrosis of the interstitium (Chang, Parker et al. 2006).
In PKD, proteins (such as polycystins (e.g., PC1 and PC2), nephrocystins,
fibrocystin, Wnt signaling proteins, and planar cell polarity (PCP) proteins) were found to
be localized inside the cilium or basal body of the cilium, having altered functions (Pazour,
San Agustin et al. 2002; Yoder, Hou et al. 2002; Veland, Awan et al. 2009). It has been
hypothesized that epithelial cells in the nephron can undergo dedifferentiation and
proliferation, and they are followed by redifferentiation in response to an injury to nephrons
as an attempt to restore tissue function (Bonventre 2003; Guo and Cantley 2010). Renal
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injury repair shares similar cell signaling pathways as PKD (Weimbs 2006; Weimbs 2007).
In the Oak Ridge polycystic kidney mouse model, renal cilia were found to be much
shorter as compared to a normal mouse renal cilia (Pazour, Dickert et al. 2000; Yoder,
Tousson et al. 2002), possibly implying a relationship between flow sensing and PKD. In
mouse models, kidney specific inhibition of ciliogenesis, i.e., the formation of cilia, was
found to result in a PKD-like phenotype (Lin, Hiesberger et al. 2003). Ciliary flow sensing
was found to affect active Na+ transport in the normal mouse kidney cortical collecting
duct epithelial monolayers (Resnick and Hopfer 2007; Resnick 2011). These findings
suggested the importance of primary cilia and their flow sensing function in the context of
PKD.
In PKD, mammalian target of rapamycin (mTOR) and signal transducer and
activator of transcription 6 (STAT6) signaling pathways remain activated even under
normal conditions (Low, Vasanth et al. 2006; Becker, Saez et al. 2010). In normal renal
epithelial cell cultures, fluid flow induced by mild shaking retained the STAT6 in the
cilium, and it prevented the translocation of STAT6 to cellular nucleus (Low, Vasanth et
al. 2006). Thus, flow sensing of cilia can control cell division in kidney tubules (Singla and
Reiter 2006), and in PKD this mechanism may be impaired. Fluid flow is also known to
maintain differentiation of renal epithelial cells by blocking canonical Wnt signaling due
to the elevated levels of inversin, a ciliary protein (Simons, Gloy et al. 2005; Deane and
Ricardo 2007). Fluid flow is known to cleave the C-terminal domain of the PC1 protein,
followed by the translocation into the cellular nucleus. This nuclear localization is thought
to affect transcription of different genes (Chauvet, Tian et al. 2004; Deane and Ricardo
2007). PC1 is known to control cell proliferation since PC1 regulates the mTOR cell
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signaling pathway, and this signaling pathway can be abnormally activated in case of PKD
(Shillingford, Murcia et al. 2006). Combined activities of PC1 and PC2 control the cell
cycle by regulating the JAK-STAT pathway (Bhunia, Piontek et al. 2002). Thus, different
cell signaling mechanisms directly or indirectly related to cilia and ciliary flow sensing are
responsible for controlling renal epithelial phenotype and gene expression and may be
associated with PKD (Deane and Ricardo 2007).
ii.

Alterations of Epithelial Transport in PKD

As discussed previously under the epithelial transport section, the collecting duct
of the nephron helps in fine-tuning salt concentration by reabsorbing salt and water. In the
collecting duct epithelial cells, Na+ enter cells through ENaC, and with help of basolateral
Na+/ K+-ATPase, these Na+ move to the basolateral side and K+ enter the cells (Wilson,
Dillingham et al. 1985). Na+ are reabsorbed from urine to blood through this mechanism.
In mouse disease models of ARPKD, Na+/ K+-ATPase was detected in the apical
membrane of cystic epithelial cells (Avner, Sweeney et al. 1992) suggesting similar Na+
secretion can occur in case of ADPKD (Rohatgi, Greenberg et al. 2003). In the cystic
epithelial cells of ADPKD patients, Na+/ K+-ATPase expression was also found to be in
the apical side (Wilson, Sherwood et al. 1991; Rohatgi, Greenberg et al. 2003). Thus, the
mislocalization of Na+/ K+-ATPase can be seen in both ADPKD and ARPKD.
Another study using immunohistochemistry reported that in human cystic kidney
tissue and in mouse kidney cysts, Na+/ K+-ATPase α1 catalytic subunit expression levels
were significantly reduced in intermediate and large cysts (Yu, Kanzawa et al. 2008). This
finding suggested that active Na+ transport may be diminished in PKD. The fluid
accumulation and cyst expansion involve transepithelial fluid and solute secretion inside
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the cyst lumen as opposed to the absorptive function of normal renal epithelial cells (Yu,
Kanzawa et al. 2008). In kidney cysts, Cl- are believed to be actively secreted using
Na+/K+/2Cl– cotransporter, NKCC1 (Lebeau, Hanaoka et al. 2002; Thomson, Mentone et
al. 2003) and apical c-AMP stimulated chloride channels, CFTR (Brill, Ross et al. 1996;
Hanaoka, Devuyst et al. 1996). In the cyst lumen, Na+ are thought to be secreted
paracellularly due to the electrochemical gradient created by the active Cl- transport. The
accumulation of Na+ and Cl- results in the secretion of water in the cyst lumen by the
process of osmosis involving water channels AQP1 and AQP2 (Devuyst, Burrow et al.
1996; Yu, Kanzawa et al. 2008). Thus, the secretion and accumulation of salt and water
within the cysts can promote cyst expansion.
Experiments using microcysts formed by growing cells on collagen scaffolds
showed that cells were capable of absorption as well as secretion similar to the epithelia
from the intestine and trachea (Alton and Smith 1995; Greger, Bleich et al. 1997; Sullivan,
Wallace et al. 1998). Chloride ions are secreted actively using Na+/K+/2Cl– cotransporter
in the basolateral membrane and CFTR channel in the apical membrane as shown in figure
10 (Sullivan, Wallace et al. 1998). Two separate studies showed that they were able to
reduce equivalent current or apical to basolateral Na+ movement of kidney cysts by adding
the sodium channel blocker, amiloride (Perrone 1985; Wilson, Sherwood et al. 1991).
Thus, active Na+ transport may still be present in kidney cysts. However, according to
another study using ADPKD monolayers, Ieq remained unaffected even at 10 times higher
concentration of amiloride

or with other active sodium transport blocking agents,

indicating the possible contribution of active chloride transport (Sullivan, Wallace et al.
1998). Thus, the contribution of active Cl- transport in PKD may be debatable to some
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extent. However, the application of a CFTR inhibitor, CFTRinh-172 (Ma, Thiagarajah et
al. 2002) was found to slow the cyst expansion in the MDCK cell culture cyst model, whole
embryonic kidney organ culture, and mouse ADPKD model (Li, Findlay et al. 2004;
Magenheimer, John et al. 2006; Yang, Sonawane et al. 2008). These findings strongly
support the role of active Cl- transport in the PKD progression.

Figure 10: Epithelial Transport in PKD. Figure credit (Sullivan, Wallace et al. 1998).
Chloride and water secretion seen in secretory epithelia (Liedrke 1989). The same secretory
mechanism is believed to be involved in cystic epithelia of PKD (Sullivan, Wallace et al.
1998).
iii.

Alterations of Epithelial Junctional Complex in PKD

a) Abnormal Adherens Junctions in PKD
Adherens junctions (AJ) keep cells attached by binding to actin filaments using
cadherins and catenins. Spot-like adherens junctions, which allow cells stay attached to
cellular extracellular matrix (ECM), are called the focal adhesions (FA). In ADPKD cystic
epithelial cells, lateral AJ and FA show abnormalities. At the FA of an ADPKD epithelium,
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the phosphorylation of focal adhesion kinase (FAK) is diminished and results in altered
protein composition of FA (Wilson, Geng et al. 1999; Wilson 2011). Impaired
phosphorylation of FAK complex leads to alteration in the cell shape, adhesion, and
migration as seen in both ADPKD and ARPKD (Wilson, Geng et al. 1999; Israeli, Amsler
et al. 2010; Elliott, Zheleznova et al. 2011; Wilson 2011).
In ADPKD, E-cadherin remains absent from the lateral membrane of AJ since Ecadherin undergoes internalization (Charron, Nakamura et al. 2000) similar to as seen in
the epithelial to mesenchymal transition (Thiery and Sleeman 2006). In normal kidney
epithelial cells, PC1 protein helps in forming a complex at the adherens junction with Ecadherin and β-catenins in order to maintain cell adhesion or polarity (Huan and van
Adelsberg 1999). Increased phosphorylation of PC1 is seen in ADPKD cells causing
disruption PC-1/PC-2/E-cadherin/β-catenin complex (Roitbak, Ward et al. 2004).
Moreover, in ADPKD, the disruption of this complex is enhanced since the E-cadherin is
internalized and replaced by embryonic isoform N-cadherin (Roitbak, Ward et al. 2004).
E-cadherin plays a crucial role in maintaining adherens junction and thereby controls the
junctional complex (Capaldo and Macara 2007). In ADPKD, the function of the adherens
junctions is impaired mainly due to insufficient presence and stability of E-cadherin and
can affect polarity of epithelial cells leading to cyst formation (Roitbak, Ward et al. 2004).
The disruption of adherens junctions can alter the function of the epithelial tight junctions
(Yu, Kanzawa et al. 2008).
b) Alteration of Tight Junctions in PKD
Cluadin-7 is known to be expressed in distal nephron and creates a transport barrier
for both cations and anions (Alexandre, Lu et al. 2005; Yu, Kanzawa et al. 2008).
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Overexpression of claudin-7 was shown to decrease Cl- permeability and increase Na+
permeability in porcine kidney epithelial cells (Alexandre, Lu et al. 2005). These findings
suggested claudin-7 acts as a barrier against Cl-, whereas forming pores that allow Na+
through the paracellular space (Alexandre, Lu et al. 2005). In kidney cysts from human
ADPKD patients, as well as in mouse kidney cysts, claudin-7 was found to be present in
abundance (Yu, Kanzawa et al. 2008). It can be inferred that claudin-7 in the tight junctions
of the cysts acts as a barrier preventing paracellular back-leak of Cl- and allows Cl- to be
secreted only through transcellular transport pathway. The transcellular Cl- movement can
drive Na+ movement paracellularly and water through osmosis into the cyst lumen (Yu,
Kanzawa et al. 2008). Thus, claudin-7 in the tight junctions may contribute to cyst
expansion.
iv.

Abnormal Protein Sorting System and Cell Polarity in PKD
In the mouse model, lack of MALS-3, a PDZ-protein which interacts with polarity

complex, resulted in cyst and fibrous tissue formation in the kidney (Olsen, Funke et al.
2007). As shown in figure 11, Na+/ K+-ATPase were found to be mislocalized in the apical
membrane due to the apical mislocalization of trafficking protein syntaxin-4, and the
membrane stabilizing proteins, ankyrin and fodrin (Wilson, Sherwood et al. 1991; Torkko,
Manninen et al. 2008). The activation of Erb2 by phosphorylation causes alterations in the
apico-basal polarity, and the overexpression of activated Erb2 leads to kidney cyst
formation (Aranda, Haire et al. 2006; Wilson 2011). Membrane proteins are formed in the
endoplasmic reticulum and undergo processing in the Golgi apparatus, followed by sorting
to be directed and delivered by apical or basolateral vesicles (Wilson 2011).

The

trafficking of proteins in the right membrane domain is believed to be contributed by at
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least partly by small G proteins belonging to Rab/sec family along with exocyst complex.
Some Rab/sec family proteins (such as Rab 8, Rab 10, Rab 11, Rab 14, syntaxin-3) are
known to control the delivery and transport of proteins onto the apical membrane whereas
other Rab/sec family proteins, such as Rab6 and syntaxin-4, are known to cause
localization and trafficking in the basolateral membrane (Wilson 2011). In ADPKD cells,
abnormalities were found in Rab6/Rab8 trafficking proteins and syntaxin-4 proteins. These
abnormalities in the kidney cystic epithelia affect the vesicle trafficking complex, known
as the exocyst, and can cause defects in the mechanisms involving the apical docking and
maintenance of membrane protein-tethering domain (Wilson 2011).

Figure 11: Polarized membrane associated proteins in normal kidney and cystic
(ADPKD) kidney epithelial cells. Figure credit (Wilson 2011). In ADPKD, Na+/ K+ATPase α1/β2, ErbB1/2 rab6/8 syntaxin 4, and ankyrin/fodrin are mislocalized onto the
apical membrane and MALS-3 is absent from apico-lateral polarity complex. In the lateral
adherens junction (AJ) of ADPKD cells, E-cadherin is substituted by N-cadherin and the
pFAK is also diminished from focal adhesions (FA) of ADPKD cells (Wilson 2011).
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In ADPKD cells, various changes are also noticed in the cellular cytoskeleton such
as actin microfilaments, microtubules, and cytokeratin scaffolds. These cytoskeletal
structures are known be associated with the process of vesicle transport and trafficking and
stability of the membrane domain. Therefore, the alterations of cellular cytoskeleton are in
agreement with the abnormal protein sorting system as seen in ADPKD cells (Oriolo, Wald
et al. 2007; Wilson 2011). Thus, the renal epithelial polarity or functional phenotype can
be impaired in PKD.
1.8 Role of Hypoxia on Cellular Functions and Diseases
1.8.1 Hypoxia and Hypoxia Inducible Factors
Oxygen (O2) is crucial for the survival and normal function of mammalian cells and
tissues. The lack of adequate O2 supply creates a condition called hypoxia, which is known
to be associated with various kidney pathologies such as AKI. Therefore, it is important to
understand how cells adjust to hypoxic conditions. Hypoxia inducible factors (HIF)
regulate cellular and tissue responses in an environment lacking sufficient availability of
O2 (Andringa and Agarwal 2014). HIF-1 and HIF-2 transcription factors are heterodimeric
helix-loop-helix Per-Arnt-Sim (PAS) domain proteins (Haase 2009). These transcription
factors form dimers and bind to the DNA of the target gene resulting in the activation of
transcription (Semenza 2000). The α subunit is the O2 sensitive and regulatory subunit, and
β is the constitutively expressed subunit of HIF (Haase 2006). The binding of the HIF
heterodimer to a hypoxia response element (HRE) on a regulatory region of a hypoxia
responsive gene causes HIF-regulated transcription (Haase 2006). HIF-1 and HIF-2 have
very little similarity in their functions (Haase 2006). HIF activation occurs when the α
subunit is translocated into the nucleus and dimerizes with the β subunit and followed by
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the binding of transcriptional cofactors, such as p300 (Haase 2006). Hypoxia was found to
cause fast accumulation of HIF-1α protein without a significant rise in the HIF-1α mRNA
levels (Huang, Arany et al. 1996). HIF-1α is known to be expressed almost in all types of
tissues in humans, mice, other rodents, whereas the expression of HIF-2α is known to be
more selective and is expressed primarily in the endothelium and interstitial cells of the
kidney (Semenza 2000; Haase 2006). HIF is known to be involved in the regulation of
different kidney function related processes, such as metabolism of glucose, angiogenesis,
erythropoiesis, migration of cells, and cell-cell and cell-matrix interactions (Haase 2006).
Various HIF target genes (> 100 genes) have been identified. These HIF-regulated genes
include the genes that enhance O2 delivery by promoting angiogenesis, for example
vascular endothelial growth factor (VEGF), VEGF receptor-1 (Flt-1), and endoglin
(CD105), the genes that enhance systemic delivery of O2, such as erythropoietin (EPO),
and the genes that favor anaerobic glucose metabolism, such as GLUT-1 (Haase 2006).
Thus, HIF can control diverse cellular functions.
1.8.1.1 HIF Degradation by O2 Sensing
During normoxia (i.e., normal O2 level), HIF-1α and HIF-2α proteins undergo
ubiquitin and proteasome-mediated degradation, and therefore these proteins cannot
accumulate. HIF-α proteins have an oxygen-dependent degradation domain (ODD),
containing a sequence of 200 amino acids, which plays an important role in the O2 mediated
degradation of HIF-α (Huang, Gu et al. 1998; O’Rourke, Tian et al. 1999). In normoxic
condition, the ubiquitination and degradation of HIF-α is controlled by the binding of the
tumor suppressor protein: the von Hippel-Lindau protein (pVHL) to the ODD domain of
HIF-α (Maxwell, Wiesener et al. 1999; Kamura, Sato et al. 2000). The pVHL- mediated
HIF degradation mechanism requires hydroxylation of specific proline residues (e.g.,
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proline residue at the position 564) within the ODD, and thereby proline hydroxylation is
important in determining HIF-α levels and the downstream hypoxia responsive gene
transcription (Epstein, Gleadle et al. 2001; Ivan, Kondo et al. 2001; Jaakkola, Mole et al.
2001; Masson, Willam et al. 2001; Yuan, Hilliard et al. 2003).
1.8.1.2 Cobalt Prevents HIF Degradation
The metal cobalt (Co2+) can stabilize HIF by preventing HIF degradation
irrespective of the O2 concentration. As shown in figure 12A, when a sufficient level of O2
is present, HIF-specific hydroxylases cause hydroxylation of HIF-α and induce HIF-α
degradation. Even during an adequate O2 level, Co2+ can bind and block the iron binding
sites on those proline hydroxylases (PHD), causing the inactivation of hydroxylase
enzymatic function as shown in figure 12B (Epstein, Gleadle et al. 2001; Yuan, Hilliard
et al. 2003). Moreover, as suggested in the figure 12B, Co2+ can still prevent the
degradation of HIF-α even if the HIFs are already hydroxylated. Co2+ can directly bind to
the hydroxylated HIF-α and inhibit the interaction between HIF-α with pVHL, and thereby
block the ubiquitination and degradation of HIF-α (Yuan, Hilliard et al. 2003). Similar to
Co2+, dimethyloxallylglycine (DMOG) acts as the competitive inhibitor of PHD (Bruick
and McKnight 2001), and iron chelator desferrioxamine (DFX) prevents the activity of
PHD and thereby they can stabilize HIF by preventing its degradation (Hirsilä, Koivunen
et al. 2005). Thus, using chemicals such as cobalt chloride (CoCl2) and DFX, HIF can be
stabilized even in the presence of adequate O2, and the effects of HIF stabilization can be
studied.
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Figure 12: Mechanisms of HIF-α degradation or stabilization. Image credit (Yuan,
Hilliard et al. 2003). (A) Current model of HIF-α and O2 sensing. In the HIF-specific
hydroxylase, iron acts as a cofactor. When adequate level of O2 is present, PHD causes
hydroxylation of proline residue at 564 in the peptide sequence of HIF. Hydroxylated HIF
undergoes pVHL-mediated ubiquitination and is followed by proteasome guided
degradation. B. Co2+ can prevent HIF hydroxylation by conjugating with iron-binding site
of HIF hydroxylase and making the enzyme inactive. Moreover, in case HIF-α is already
hydroxylated, Co2+ can bind directly to the hydroxylated HIF and can block the interaction
between HIF-α and pVHL, and thereby prevents the degradation of HIF-α (Yuan, Hilliard
et al. 2003).
1.8.2 O2 Utilization and the Effect of Hypoxia in Kidney
Around 20 % of total cardiac output (CO) goes to the kidney, but still the O2
tensions are found to be low in the kidney. For example, in the kidney medulla, O2 tension
is only 5 mm Hg (Lübbers and Baumgärtl 1997). Most O2 in the kidney is used by the
mitochondrial respiratory chain to produce ATPs which are mainly used in the function of
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Na+/ K+-ATPase to drive reabsorption of Na+ and other transport processes such as the
passage of glucose and amino acids across cellular membranes (Haase 2013). Hypoxia
causes a severe energy depletion and critical changes of metabolism (Devarajan 2006).
Hypoxia results in the disruption of cellular cytoskeleton, leading to mislocation of
polarized proteins, such as integrins and Na+/ K+-ATPase in the kidney (Nangaku and
Eckardt 2007).
1.8.3 HIF Activation or Hypoxia in Kidney Diseases
Kidney hypoxia is found in PKD, diabetic kidney, ageing kidney, kidney injuries,
and others (Nangaku 2006; Tanaka, Kato et al. 2006; Rosenberger, Khamaisi et al. 2008;
Palm and Nordquist 2011). HIF-α stabilization is seen in both acute and chronic kidney
diseases (Haase 2006). In diabetic nephropathy, the degree of HIF-activation was found be
in correlation with the level of kidney injury (Higgins, Kimura et al. 2007).
Pharmacological activation of HIF shows a protective effect in AKI, whereas similar HIFactivation can show reno-protective and pathological effects in CKD (Bernhardt, Wiesener
et al. 2007; Haase 2013; Andringa and Agarwal 2014). Previous data showed that the
timing of the pharmacologic activation of HIF is crucial in the renoprotective effects (Yu,
Fang et al. 2012).
1.8.3.1 Hypoxia in CKD
a) Causes of Hypoxia in CKD
Chronic ischemia (i.e., obstructed or restricted blood flow) is seen in the
tubulointerstitium. The damage to renal arterioles and arteries and the deformation and
decrease in the number of capillaries can cause intense tubulointerstitial injury due to the
ischemic-hypoxic condition (Choi, Chakraborty et al. 2000; Kairaitis, Wang et al. 2005;
Nangaku 2006).
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I.

Role of Fibrosis in Hypoxia
In CKD kidney fibrosis may cause reduced O2 supply due to the decreased blood

supply by peritubular capillaries (Nangaku 2006). Moreover, the formation of kidney
interstitial fibrotic tissue layer in between peritubular capillaries and tubular cells decreases
the efficiency of O2 diffusion from the capillaries to the cells (Nangaku 2006).
II.

Role of Glomerulosclerosis in Hypoxia
During early stages of CKD, glomerulosclerosis causes a decrease in the blood

supply and stagnant blood inside peritubular capillaries. These events further induce the
loss of the capillaries and localized hypoxic condition, promoting tubulointerstitial injuries
(Nangaku 2006).
III.

Role of Vasoactive Substances in Hypoxia
During early stages of CKD, with normal glomerular structure and function, the

imbalance of vasoactive substances, such as angiotensin II, may result in an intrarenal
vasoconstriction, leading to kidney-localized hypoxia (Nangaku 2006). The activation of
the renin-angiotensin system is known to cause the vasoconstriction of efferent arterioles,
leading to a hypoxic condition in the tubulointerstitium. The administration of angiotensin
II was found to reduce the numbers of peritubular capillaries in rats (Lombardi, Gordon et
al. 1999; Nangaku 2006). In patients with type II diabetes and normalbuminuria, the
reduced levels of peritubular capillary flow showed a correlation with the tubular
dysfunction (Futrakul, Vongthavarawat et al. 2005). This finding suggested that the chronic
hypoxia may lead to ESRD in CKD patients (Nangaku 2006).
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IV.

Role of Anemic Condition in Hypoxia
The O2 delivery (DO2) in the kidney or other organs is calculated using the

equation: DO2= CO × (% Sat × 1.39 × [Hb])
where, CO= cardiac output, % Sat= the percentage of hemoglobin saturated with O2, [Hb]
= the concentration of hemoglobin with units of grams per liter, and 1.39= the value of the
hemoglobin binding constant. The anemic conditions of CKD patients can cause decreased
levels of DO2, and thereby can result in the kidney-localized hypoxia (Nangaku 2006).
V.

Role of Oxidative Stress in Hypoxia
Angiotensin II is known to be elevated in kidney diseases and creates oxidative

stress by stimulating the NADPH oxidase. Moreover, the level of EPO decreases in CKD.
The presence of superoxide causes decrease in the nitric oxide (NO) level. The NO
suppresses mitochondrial respiration and the lack of NO elevates mitochondrial respiration
process and can contribute to hypoxia (Nangaku 2006). Mitigation of oxidative stress was
shown to prevent hypoxia by enhancing the delivery of O2 to renal tissue in a study using
a diabetic nephropathy model (Palm, Cederberg et al. 2003).
b) Effects of Hypoxia in CKD
Tubular cells under hypoxia are known to induce epithelial-mesenchymal
transdifferentiation and be transformed into myofibroblasts (Manotham, Tanaka et al.
2004). Hypoxia is known to cause apoptosis of tubular cells as well as results in the ECM
deposition and fibrosis due to the deficiency of matrix metalloproteinases (MMPs), other
proteases and lysosomal enzymes (Tanaka, Hanafusa et al. 2003; Nangaku 2006) . Thus,
hypoxia can cause renal necrosis and fibrosis, resulting in the loss of renal function.
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1.8.3.2 Hypoxia in Kidney Cysts
Kidney cysts in ADPKD and ARPKD are known to expand over years and finally
lead to kidney failure. The factors responsible for the cyst expansion and disease
progression are not well understood (Cowley 2004). When kidney cysts grow, they can
compress the adjacent blood vessels, decreasing the blood and O2 supply. Moreover, the
fluid inside the cysts is stagnant. Therefore, kidney cysts can be hypoxic environments.
Higher levels of serum EPO were detected in ADPKD as compared to other kidney
diseases (Eckardt, Möllmann et al. 1989). Arteriovenous EPO levels and cystic fluid EPO
levels were found to be higher than normal in kidney cysts (Eckardt, Möllmann et al. 1989).
New blood vessel formation, i.e., angiogenesis, is seen in polycystic kidneys due to the
higher expression level of VEGF and VEGF receptors. Angiogenesis can allow enough
nutrient and O2 supply for cellular proliferation in order for cyst to expand (Bello-Reuss,
Holubec et al. 2001; Wei, Popov et al. 2006). HIF-1α and HIF-2α proteins were found to
show strong expression levels in rat kidney cysts similar to a kidney from a normal rat
under hypoxia (Bernhardt, Wiesener et al. 2007). In cysts from human ADPKD patients,
HIF-1α protein expression was detected in the cystic epithelial cells of renal medulla and
HIF-2α protein was found to be expressed in the interstitial and endothelial cells.
Consistent with the increased expression levels of HIF-1α, elevated levels of VEGF were
found in the kidney cysts and collecting duct in PKD (Bernhardt, Wiesener et al. 2007).
The mRNA levels of HIF effector molecules: heme oxygenase-1 (HO-1), Glut-1, and EPO
were found to be higher in kidney cysts as compared to normal kidneys under normoxia
and hypoxia (Bernhardt, Wiesener et al. 2007). In cystic kidney, HO-1 and Glut-1 protein
levels were also found to be higher in the polycystic kidney than a kidney from a rat under
systemic hypoxia (Bernhardt, Wiesener et al. 2007). In the cystic kidney epithelial cells,
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Glut-1 and VEGF proteins were detected. The angiogenic factor, endoglin is an indicator
of new blood vessels and the protein expression levels of endoglin were consistent with
HIF-2α expression levels in the cysts of a human kidney (Bernhardt, Wiesener et al. 2007).
Thus, the kidney cysts were found to be hypoxic and the HIF pathway seemed to remain
continuously upregulated in the cysts. The kidney-localized hypoxia in the cysts showed
signs of a higher level of hypoxia (i.e., chronic hypoxic response) as compared to a normal
kidney from an individual encountering systemic hypoxia.
1.8.3.3 Effect of HIF-1α on Kidney Cyst Growth and Ion Transport
Forskolin is known to stimulate the growth of cysts having secretory functions
(Magenheimer, John et al. 2006). In MDCK in vitro cyst models, the stabilization of HIF1α by PHD inhibitors increased the level of GLUT-1 and promoted the forskolin-stimulated
cyst growth. The knock down of HIF-1α by short hairpin RNA (shRNA) against HIF1α or
the application of HIF-1α inhibitor was found to prevent cyst growth and also inhibited the
stimulation of cysts with forskolin (Buchholz, Schley et al. 2013). Similarly, in embryonic
mouse kidneys, the stabilization of HIF-1α was shown to increase Glut-1 and promoted
cyst growth, and the inhibition of HIF-1α decreased Glut-1 and resulted in the formation
of smaller cysts (Buchholz, Schley et al. 2013).

In the rat kidney cyst models, the

correlation between Glut-1 and cystic index supported the role of HIF-1α on the in vivo
cyst growth. In the MDCK in vitro cystic model, even the treatment with selenium, insulin,
dexamethasone, transferrin for two weeks could not regain the ENaC or active Na+
transport. The application of CFTR inhibitor, CFTRinh-172 was found to prevent in vitro
cyst growth (Buchholz, Schley et al. 2013). The stimulation of cystic epithelial cells with
extracellular ATP molecules is known to increase intracellular concentration of Ca2+
promoting cyst growth due to the stimulation of purinergic receptors (Paulmichl and Lang
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1988). The HIF1α deficient in vitro cysts could not grow in response to ATP or PHD
inhibitor. These results suggested that the stabilization of HIF-1α induces calciumactivated chloride secretion, leading to cyst expansion. Ionomycin, which is an ionophore,
is known to cause an increase in intracellular Ca2+ concentration for a relatively extended
period of time. In the presence of ionomycin, the Isc was generated due to the luminal Clsecretion process in normal MDCK cells, and this Isc was abolished in cells in which HIF1α was knocked down (Buchholz, Schley et al. 2013). Thus, in the MDCK in vitro cyst
model, active Cl- secretion seems to be the major active transport which is regulated by
HIF-1α.
1.8.4 Effects of Hypoxia on Active Na+ Transport and Cellular Junctions
1.8.4.1 Effects of Hypoxia/ Ischemia or HIF-stabilization on Renal
Epithelial Cells
The comparison of Isc values in the kidney collecting duct monolayers showed that
as compared to an ambient O2 concentration of 20%, an O2 concentration of 40%, increased
the ENaC activity by 50%. Similarly, when the ambient 20% O2 concentration was reduced
to 8%, ENaC activity was found to decrease by 40%. As compared to 8% O2, 40% O2
showed higher surface expressions as well as higher levels of matured forms of β and γ
ENaC subunits (Husted, Lu et al. 2010). Thus, an O2 concentration can regulate the ENaC
activity of renal epithelial cells (Husted, Lu et al. 2010).
Actin organization of renal epithelial cells of the proximal tubule was found to be
affected by ischemia (White, Doctor et al. 2000).

In renal epithelial monolayers,

chemically induced hypoxia-mimetic condition created by ATP depletion resulted in the
disruption of F-actin cytoskeleton organization and tight junctions and endocytosis of Na+/
K+-ATPase. Spectrin (called fordin in epithelial cells) network connects actin cytoskeletal
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to the cellular surface membrane. The dissociation of fordin and ankyrin from actin
cytoskeleton causes fordin and ankyrin to become dispersed throughout the cellular
cytoplasm (Molitoris, Dahl et al. 1996). Similarly during ischemia, the disruption of the
cellular cytoskeleton can lead to the dissociation of Na+/ K+-ATPase from fordin and
cytoskeleton, and Na+/ K+-ATPase becomes free to be distributed to the apical membrane
of the proximal tubule (Molitoris, Dahl et al. 1992). The reabsorption of ions and water by
proximal tubule cells is normally maintained due to the lipid and protein polarity in the
apical and basolateral membranes. An ischemic injury decreases sodium reabsorption by
kidney proximal tubular cells due to the apical redistribution of Na+/ K+-ATPase from the
basolateral side. The loss of membrane polarity due to ischemia can cause disruption of the
tight junctions and actin cytoskeleton (Molitoris 1991). In vitro, apical redistribution of
renal Na+/ K+-ATPase was found to transport Na+ ions from basolateral to apical side
(Molitoris 1993).
In the VHL deficient clear cell renal cell carcinoma (CCRCC) cell line, the
expression of VHL which is known to promote HIF1α degradation, increased the
expression of claudin-1, E-cadherin, and occludin proteins. Immunofluorescence for ZO1
showed intact tight junctions when VHL was present. The application of small interfering
RNAs (siRNAs) against HIF-1α was shown to promote ZO1, claudin-1, and occludin based
junctional assembly in the VHL deficient renal epithelial cells. The in vivo kidney cysts
formed due to VHL deficiency showed diminished levels of claudin-1 and occludin
proteins. Inactivation of VHL in the kidney epithelium was shown to down-regulate cell–
cell adhesion molecules involved in AJs and tight junctions. Similar to HIF-1α-SiRNAs,
histone deacetylase inhibitor sodium butyrate, which is known to inhibit HIF activation,
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was able to restore ZO1, claudin-1, occludin, and E-cadherin in these VHL- deficient renal
epithelial cells (Harten, Shukla et al. 2009).
Thus, HIF-1α or hypoxia can alter renal epithelial tight junctions and active Na+
transport.
1.8.4.2 Effects of Hypoxia on Alveolar Epithelial Cells
In the human and rat alveolar cells, the active Na+ transport was found to decrease
in response to hypoxia (Mairbäurl, Wodopia et al. 1997; Mairbäurl, Mayer et al. 2002).
The decreased numbers of membrane-bound ENaC under hypoxia can cause a decrease in
the ENaC activity in alveolar epithelial cells (Wodopia, Ko et al. 2000; Jain and Sznajder
2005). In the alveolar epithelial cells, short-term (1 hour) hypoxia was shown to decrease
Na+/ K+-ATPase due to the endocytosis of Na+/ K+-ATPase. A prolonged hypoxia produces
reactive oxygen species (ROS) activating PKC-ζ molecules which cause endocytosis of
Na+/ K+-ATPase by a process involving phosphorylation of the serine reside at the position
18 of the N-terminus of Na+/ K+-ATPase (Dada, Chandel et al. 2003). During the severe
hypoxia, not the intracellular Na+/ K+-ATPase, but the Na+/ K+-ATPase in the plasma
membrane of alveolar epithelial cells were found to decrease around 50% within 2 hours
in order to minimize oxygen consumption (Jain and Sznajder 2005). Thus, hypoxia was
shown affect the expression or activity of apical ENaC and basolateral Na+/ K+-ATPase,
causing a decrease in the active Na+ transport and resulting in reduced ability of alveolar
epithelium to clear alveolar edema fluid (Vivona, Matthay et al. 2001; Planès, BlotChabaud et al. 2002; Dada, Chandel et al. 2003).
Hypoxia was also found to decrease ZO1 and occludin protein levels, affect the
organization of actin cytoskeleton, and cause mislocalization of occludin from tight
junctions to the cell interior in alveolar epithelial cells. Consistent with the effects on
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cellular junctions, hypoxia was found to increase transepithelial electrical conductance in
the alveolar epithelial monolayers (Bouvry, Planes et al. 2006; Caraballo, Yshii et al.
2011).
Thus, in alveolar epithelial cellular monolayers, hypoxia affects the active Na+
transport and epithelial tight junctions.
1.8.4.3 Effects of Hypoxia or HIF-stabilization on Endothelial Cells
Hypoxia was shown to alter tight junctions and permeability of other cell types,
such as brain microvessel endothelial cells and intestinal epithelial cells (Xu, Lu et al. 1999;
Yamagata, Tagami et al. 2004; Engelhardt, Al‐Ahmad et al. 2014). The stabilization of
HIF-1α by hypoxia or chemically using CoCl2, DFX or DMOG was shown to disrupt the
barrier function of brain microvessel endothelial cells due to alterations of tight junctions
caused by the delocalization and elevated levels of tyrosine phosphorylation of tight
junction proteins. The application of a HIF-1α inhibitor was shown to restore the barrier
function in endothelial cells under hypoxia. In the endothelial cells, under hypoxia with
1% O2, ZO1 protein levels were found to decrease significantly after 48 hours (Engelhardt,
Al‐Ahmad et al. 2014). HIF-1 is known to bind to a HRE in the 5’ flanking region of the
VEGF gene and stimulates the transcription of VEGF (Forsythe, Jiang et al. 1996). The
tight junction proteins ZO1 and occludin are known to be phosphorylated by VEGF in
endothelial cells (Antonetti, Barber et al. 1999). The elevated level of VEGF was shown to
decrease the expression of occludin and induce dissociation of ZO1 and occludin from tight
junctions in the endothelial monolayers (Wang, Dentler et al. 2001). Thus, hypoxia or HIF
stabilization can alter tight junctions of endothelial cells.
In summary, HIF stabilization or hypoxia can affect tight junctions, and thereby
may affect the paracellular transport in endothelial and epithelial cells. The active or
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transcellular transport in renal and alveolar epithelia was also shown to be modified by
hypoxia or HIF.
1.9 Research Hypothesis and Significance
As described above, hypoxia or HIF-stabilization can affect active transport of renal
and alveolar epithelial cells and passive transport of epithelial and endothelial cells. Cyst
expansion, stagnant fluid accumulation, and inadequate vascular supply can result in
localized chronic ischemia-hypoxia in cysts and as well as in normal epithelia adjacent to
a cyst as discussed previously. HIF-1α is known to be a major regulator of cellular response
to hypoxia. Active Cl- secretion by kidney cystic epithelia was shown to be affected by
HIF-1α as mentioned earlier. Normal epithelia near a cyst encounter the ischemic-hypoxic
environment created by cysts, and we aim to understand whether this ischemic-hypoxic
condition or HIF-stabilization may act as a major contributor in PKD progression by
affecting the transport properties of normal renal epithelial cells (Nag and Resnick 2018).
We hypothesize that in normal renal epithelia near a cyst, the stabilization of HIF1α can alter active and passive transport of normal epithelia, transforming the normal
absorptive epithelial phenotype to a secretory cyst-like and paracellularly leaky phenotype,
and may contribute to cyst expansion (Nag and Resnick 2018).
The findings of this study can be broadly applicable to other kidney diseases or
pathologies related to ischemia-hypoxia, e.g., AKIs and CKDs.
In addition, renal cilia are believed to have an important role in PKD progression
and ciliary flow-sensing is known to regulate active Na+ transport in renal epithelial
monolayers as discussed before. Renal ciliary lengths and biomechanical property were
shown to be affected due to HIF-stabilization as mentioned earlier. In this current study,
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we have not investigated the specific contribution of cilia to the effect of HIF-stabilization
on renal transepithelial transport. Future studies, involving comparisons among
transepithelial transports in ciliated and deciliated epithelial monolayers with or without
HIF-stabilization, can help to understand the role of cilia and ciliary flow-sensing in this
context.
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CHAPTER II
MATERIALS & METHODS
2.1 Cell Culture
Experiments were performed using two cell lines, a mouse cell line (Kolb, Woost
et al. 2004) developed by microdissection from the cortical collecting duct (mCCD 1296
(d)) of a heterozygous offspring mouse carrying a transgene, temperature-sensitive SV40
large T antigen under the control of an interferon-γ response element (Nag and Resnick
2017), and another cell line, a commonly used MDCK epithelial cell line (ATCC CRL
2935). Both cell types were grown onto collagen-coated and suspended membrane cell
culture inserts. The cultures of mCCD cell line maintain the major phenotypic features,
such as contact inhibition, tight junction formation, cell polarity, and directed salt and water
transport, similar to the characteristics of primary cortical collecting duct cultures (Nag and
Resnick 2017). Most of the experiments were performed using these mCCD cells.
2.1.1 mCCD Cell Culture
mCCD cells were allowed to grow until confluence under the incubation conditions
of 33°C and 5% CO2. The growth medium was formulated by adding the following media
constituents at final concentrations: Dulbecco’s Modified Eagle Medium (DMEM) without
glucose and Ham’s F12 at a ratio of 1:1, 5 mg/ml transferrin, 5 mg/ml insulin, 10 mg/ml
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epidermal growth factor (EGF), 4 mg/ml dexamethasone, 15 mM 4-(2-hydroxyethyl)- 1piperazineethanesulfonic acid (HEPES), 0.06 w/v% NaHCO3, 2 mM L-glutamine, 10
ng/ml mouse interferon-γ, 50 µM ascorbic acid 2- phosphate, 20 nM selenium, 1 nM 3,3′,5triiodo-L-thyronine (T3), and 5% fetal bovine serum (FBS). The fully grown cellular
monolayers were incubated in an incubation condition of 39°C and 5% CO2 to promote
differentiation. For cells to differentiate, FBS and growth factors (insulin, EGF, and
interferon-γ) were withdrawn from the apical differential media (APDM) and only growth
factors were withdrawn from the basolateral differentiation media (BLDM) (Nag and
Resnick 2017). Antibiotics, Penicillin-streptomycin (stock concentration of 10 mg/ml,
100X) and gentamycin (stock concentration of 50 mg/ml, 1000X) were added to cell
culture media with final concentrations of 1X.
Cells were first grown onto collagen-coated suspended membrane cell culture
inserts having 30 mm diameter (Millipore PICM03050, area= 4.71 cm2), inside a 6-well
cell culture plate (Falcon# 35116). When sufficient cellular numbers (> 80% confluence)
were achieved, cells were then passaged at a dilution of 1:3 onto suspended membrane cell
culture inserts having 12 mm diameter (Millipore PICM 01250, area= 1.13 cm2), within a
24-well cell culture plate (Falcon# 353047). Next, the cells were grown to confluence and
were allowed to differentiate resulting in a ciliated functional epithelial monolayer that
maintained a directed salt and water transport (Nag and Resnick 2017).
2.1.2 MDCK Cell Culture
MDCK epithelial cells were cultured in a growth medium containing DMEM and
Ham’s F-12 in a 1:1 ratio, 15 mM HEPES, 0.06 w/v% NaHCO3, 2 mM L-glutamine, and
10% FBS. Upon confluence, FBS was reduced to 1% to promote differentiation and
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ciliogenesis. Penicillin-streptomycin and gentamycin were added to MDCK cell culture
media as described previously. During both growth and differentiation, MDCK cells were
maintained in an incubator at 37°C and 5% CO2. MDCK cells were first grown onto 60 mm
tissue culture dishes (Celltreat# 229660) and after reaching confluence, cells were passaged
onto collagen coated small cell culture inserts (area= 1.13 cm2) inside a 24-well plate as
discussed above. These MDCK cells were first grown and then the monolayers were
differentiated for at least 3 days prior to performing permeability studies. MDCK
monolayers do not display directed salt and water transport as mCCD monolayers, but
MDCK monolayers do express a functional cilium early, after 3 days of serum starvation
(Resnick 2016).
2.1.3 Cell Culture Experimental Designs
Figures 13 and 14 show schematic timelines of the cell culture experiments. Day 0
is defined as the starting point, when confluent monolayers are switched to differentiation
conditions. Upon entering differentiation culture conditions, over time mCCD monolayers
develop functional characteristics, such as the development of a directed Na+ transport and
the emergence of functional primary cilia, after approximately 5 days. As shown in figure
13, mCCD monolayers are considered fully differentiated after 7-10 days having stable
electrophysiological properties and remain viable for an additional 24 days (Nag and
Resnick 2017). By contrast, MDCK cells express primary cilia after 3 days in
differentiation conditions and are only viable for an additional 7 days as shown in figure
14. Throughout the experiment, the apical media volume was restricted (100 µl) so that the
thin fluid layer could allow adequate diffusion of O2 and maintain a normoxic culture
condition (Resnick 2011; Nag and Resnick 2017).
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Figure 13: mCCD cell culture time line (Nag and Resnick 2017).

Figure 14: MDCK cell culture time line.
2.1.4 Application of fluid flow
The presence of fluid flow was shown to alter active Na+ transport in mCCD
monolayers (Resnick and Hopfer 2007; Resnick 2011). Fluid flow in mCCD cell cultures
was generated by placing the cell culture plates onto an orbital plate shaker (IKA MS3
digital) and operating the shaker at 4.2 Hz (̴ 250 RPM) (Nag and Resnick 2017).
2.2 CoCl2 Treatment
CoCl2 hexahydrate (S93179 from Fisher Scientific) was dissolved in a sterile 1X
Phosphate Buffer Saline (PBS) to prepare 100 mmol/L CoCl2 stock solution, which was
diluted in APDM or BLDM or MDCK differentiation media to obtain the final desired
concentration of 100 µmol/L. Experiments were carried out with CoCl2 added to APDM,
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BLDM, or to both APDM and BLDM (Nag and Resnick 2017). CoCl2 was used in order
to stabilize or prevent degradation of HIF1α in mCCD and MDCK monolayers (Verghese,
Zhuang et al. 2011) (Nag and Resnick 2017).
A preliminary experiment was performed to study the effect 30 µmol/L of HIF-1α
inhibitor, methyl 3-[[2-[4-(2-adamantyl) phenoxy] acetyl] amino]-4-hydroxybenzoate
from San Cruz Biotechnology (Catalog no. sc-205346) on FITC-dextran permeability in
MDCK monolayers in which HIF1α was stabilized using CoCl2.
2.3 Fluorescein isothiocyanate (FITC)-dextran Permeability Assay
Anionic FITC-dextran molecules with two different molecular weights (3 kDa and
70 kDa), D 3305 and D 1823 (Molecular Probes, Life Technologies) in Hanks’ Balanced
Salt Solution (HBSS), 1X (21-023-CM, Cellgro, Mediatech) were used to measure the
transepithelial permeability.

According to the manufacturer (Molecular Probes), the

specific lots consist of 1 mole of FITC per mole of 3 kDa dextran (Lot# 1709577 and
1485224) and 7 moles of FITC per mole of 70 kDa dextran (Lot # 1583589) (Nag and
Resnick 2017).
2.3.1 Generation of Calibration Graphs
The stock concentration of 120 µmol/L of both 3 kDa and 70 kDa dextran was
serially diluted in 1X HBSS buffer to formulate eight different concentrations, ranging
from 120 µmol/L to (120 × 10-8) µmol/L to create a calibration graph of FITC-dextran
concentrations versus fluorescence intensities. Each concentration was prepared in four
replicates, and then 100 µL solutions of each replicate at different concentrations were
added into a 96-well plate, and fluorescence values were detected using a fluorescence
plate reader (Perker Elmer Life Sciences/ Wallac Victor Multilabel Counter and Wallac
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1420 Manager software) at 490 nm excitation and 530 nm emission. These calibration
graphs were used to determine the unknown FITC-dextran concentrations from the
fluorescence intensity values in renal epithelial permeability experiments (Nag and
Resnick 2017).
2.3.2 Experimental Procedure and Sample Collection
In the FITC-dextran permeability experiments, the cell culture inserts with cellular
monolayers were first transferred into a 12-well plate for easier manipulation. These cell
culture inserts were gently washed with an HBSS buffer (HyClone, Catalog No.
SH30268.02) three times to remove any residual media. Then, as shown in figure 10, 100
µl of FITC-dextran in the HBSS buffer was added to the apical side and 1 ml of the HBSS
buffer was added to the basolateral side of the cell culture inserts. The 12-well plate with
the cell culture inserts were placed inside a cell culture incubator maintained at 37°C and
5% CO2. A volume of 100 µl of buffer sample was collected from the basolateral side every
10 minutes, for a total of 70 minutes, to detect FITC-dextran transport from the apical to
basolateral side as shown in figure 15. Each of the collected sample from the 12-well plate
was deposited onto a 96-well plate. The fluorescence intensity value of the sample was
measured using the plate reader with the same settings as described previously, and then
the sample was added back to the basolateral side of the cell culture insert to maintain a
constant fluid volume as shown in figure 15. After finishing up the transport experiment
with 3 kDa FITC-dextran, the cell culture inserts were washed with HBSS buffer thrice,
and the 70 kDa FITC-dextran transport was performed in the same way. In the beginning
of each experiment, the concentration of initial stock solutions of 3 kDa and 70 kDa FITCdextran molecules were determined from the calibration graphs. Each replicate of the
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sample was individually plotted to calculate the permeability value. The average
permeability of 3-5 replicates was calculated and shown in the results (Nag and Resnick
2017).

Figure 15: Experimental procedure of FITC-dextran permeability assay.
2.3.3 Quantification of Epithelial Monolayer Permeability
There are various published methods that are used to determine transepithelial
permeability (Siflinger‐Birnboim, del Vecchio et al. 1987; Artursson 1990; Abbott, Revest
et al. 1997; Gaillard, Voorwinden et al. 2001; Matter and Balda 2003; Balda and Matter
2007; Yuan and Rigor 2010). Our quantification of an epithelial monolayer permeability
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is based on the relationship between the time-dependent changes in tracer particles, such
as FITC-dextran, and the transepithelial permeability. The derivation used in the
quantification is shown below. This derivation considers all the physiological parameters
(such as the area of the cellular monolayer and apical and basolateral fluid volumes)
relevant to the experimental setup. However, this derivation, like other methods, cannot
distinguish between transcellular and paracellular pathways (Nag and Resnick 2017).
Following Fick’s first law of diffusion (Fick 1855), the mass flux of a tracer from
the apical compartment passing through a semipermeable surface (area = ‘A’) to the
basolateral compartment can be expressed using the equation:
dM𝑏𝑙
= P A [C(t)𝑎𝑝 − C(t)𝑏𝑙 ]
dt

(1)

Where ‘Mbl’ is the total mass of tracer particles in the basolateral side, ‘P’ is the
permeability with units of length/time, ‘C(t)ap’ is the time-dependent concentration of
tracer particles in the apical compartment, and ‘C(t)bl’ is the time-dependent concentration
of tracer particles in the basolateral compartment (Nag and Resnick 2017).
With our experimental design, we can assume that the fluid volumes in the apical
and basolateral sides stayed constant, and any possible changes were negligible during the
time of the experiment (̴ 80 minutes). Thus, as the apical and basolateral fluid volumes
remain constant, dividing by the basolateral fluid volume ‘Vbl’ and using the equation of
conservation of mass M0 = C(t)apVap + C(t)blVbl, we obtain
𝑉𝑎𝑝 + 𝑉𝑏𝑙
dC𝑏𝑙 P A 𝑀0
=
[
− C(t)𝑏𝑙
]
dt
𝑉𝑏𝑙 𝑉𝑎𝑝
𝑉𝑏𝑙
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(2)

In the beginning of the experiment, when the tracer (FITC-dextran) was just added
to the apical side (i.e., at time t = 0 second), the basolateral concentration of the tracer was
Cbl(0) = 0. Now, we can use this initial experimental condition to find the solution of this
equation.
1
1
C(t)𝑏𝑙 = C0 [1 − Exp [−𝑃𝐴 ( +
) 𝑡]]
𝑉𝑏𝑙 𝑉𝑎𝑝

(3)

where ‘C0’ is the initial tracer concentration and C0 = M0/(Vap+Vbl). For convenience, we
combine all the constant parameters as a single constant and denote it as the constant B =
A (1/Vbl + 1/Vap) and reorganize the equation to solve for the permeability:

Pt=−

𝑙𝑛(1 − 𝐶(𝑡)𝑏𝑙 ⁄𝐶0 )
𝐵

(4)

Thus, from the measurements of the basolateral concentrations of FITC-dextran
‘C(t)bl’ as a function of elapsed time ‘t’ (unit: seconds), we calculate the permeability ‘P’
as the slope of a best-fit line. The values of the parameters used in the calculation of
permeability values are shown in table 2 (Nag and Resnick 2017).
Table II: FITC-dextran permeability calculation parameters.
Parameter

Value

Initial FITC-dextran concentration= C0

Variable

Area of semipermeable filter= A

1.13 cm2

Volume of fluid in apical chamber= Vap

100 µL

Volume of fluid in basolateral chamber= Vbl

1 mL

‘B’ (see equation 4) = constant= A (1/Vbl + 1/Vap)

12.43 cm-1
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2.4 Renal Epithelial Electrophysiology
The measurements of transepithelial voltage and resistance values were carried out
using Endohm chambers (ENDOHM-24SNAP or ENDOHM-12) from World Precision
Instruments (WPI) connected to a Millicell-ERS voltmeter from Millipore or EVOM2
epithelial voltmeter from WPI. Both voltmeters were calibrated using a test resistor of 1
kΩ from WPI to ensure accurate resistance read outs. The resistance values were recorded
using the voltmeter in a current-clamp mode. The Endohm chamber was first cleaned with
70% ethanol for 10 minutes, followed by rinsing in distilled water. The chamber was then
exposed to UV within our laminar cell culture hood for an hour. A volume of basolateral
differentiation media sufficient to connect both sets of Ag/AgCl electrodes was added to
the chamber, and electrodes immersed in the media were allowed to equilibrate for at least
three to eight hours, until the voltage readings became stabilized.
As discussed previously, epithelial monolayers were created on permeable
membrane cell culture inserts, and then the cells were differentiated so that the cells
maintain primary cilia and show functional electrophysiological properties. Once the
Endohm-voltmeter measurement system was equilibrated and ready to use, the cell culture
inserts with differentiated epithelial monolayers were transferred one by one onto the
Endohm chamber to record cellular electrophysiological properties. This Endohm chamber
has two sets of concentric electrodes: one for voltage measurement and another for current
as shown in figure 16. The electrodes are made of Ag/AgCl and are considered to be safe
for biological applications since Ag is known to dissolve slowly and is known to be nontoxic (Nadeau 2017).
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The electrical read outs are acquired from the voltmeter as resistance and voltage
values. The TER values are presented with a unit of Ω-cm2 or kΩ-cm2 by multiplying raw
resistance values with the area (1.13 cm2) of the cell culture insert. The short circuit
equivalent current (Ieq) was calculated from voltage and resistance read outs using Ohm’s
law, I= V/R. Ieq values were expressed as µA/ cm2 by dividing obtained Ieq values by the
area (1.13 cm2) of the filter. The values of Ieq relative to the control group are presented.
Greater than 95% of the Ieq in mCCD monolayers was inhibited by the apical application
of 10 µmol/L amiloride. Thus, the Ieq value in mCCD monolayers is considered
proportional to ENaC activity or active Na+ transport (Resnick and Hopfer 2007; Resnick
2011; Nag and Resnick 2017). The monolayers of MDCK cells did not produce any
detectable voltage values, and hence MDCK cells were not used to study Ieq or active ion
transport. To exclude samples that lost confluence or may have otherwise been damaged,
any mCCD culture possessing a TER value below a resistance threshold of 1000 Ω-cm2
was discarded. Similarly, any MDCK culture with a TER value below a resistance
threshold of 150 Ω-cm2 was also omitted from the studies. Before collecting
electrophysiological read outs, 100 µl of APDM was gently added to cell culture inserts in
addition to the 100 µl of APDM already present to ensure electrical contact between the
upper electrodes and apical fluid (Nag and Resnick 2017). Thus, electrophysiological
analyses were performed.
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Figure: 16: Electrophysiological Endohm chamber was used in the measurement of
transepithelial transport (Image credit: Dr. Andrew Resnick). Ciliated epithelial
monolayers were grown and differentiated onto permeable membrane and these
monolayers were transferred to Endohm chamber to obtain Ieq and TER values.
2.5 Western Blot
2.5.1 Cell Lysate Preparation
Whole cell lysates were prepared using RIPA 1X cell lysis buffer. The original
stock of 10X RIPA buffer from Cell Signaling Technology (Product no. 9806) was first
diluted in molecular biology grade protease-free water (Fisher Scientific, Product no. BP
2819) to prepare 1X buffer. The Halt Protease Inhibitor Cocktail from Thermo Scientific
(Product no. 78430) was added at a final concentration of 1X. The RIPA buffer cell lysis
protocol from Cell Signaling Technology was followed to prepare whole cell lysates (Nag
and Resnick 2017). The protein levels of EPO, ZO1, and Na+/ K+-ATPase α1 subunit were
compared in the whole cell lysates.
Nuclear extracts were prepared using NE-PER Nuclear and Cytoplasmic Extraction
Reagents from Thermo Scientific (Product no. 78833). The cells were treated with trypsin
to detach and then centrifuged to form cellular pellets and the pellets were washed with
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PBS buffer twice. For a confluent mCCD monolayer on a large cell culture insert (area=
4.71 cm2) 56 µL Cytoplasmic Extraction Reagent I (CER I), 3 µL Cytoplasmic Extraction
Reagent II (CER II), and 28 µL Nuclear Extraction Reagent (NER) were used. The Halt
Protease Inhibitor Cocktail was added to the CER I and NER as instructed by the
manufacturer. The protocol from Thermo Scientific was followed to separate cytoplasmic
components to obtain nuclear extracts. During the cell lysate or nuclear extract preparation,
samples were maintained on ice or at 4°C to minimize any possible protein degradation.
The HIF-1α protein levels were compared in the nuclear extracts.
The protein concentration in each sample was determined using Bradford assay
using Coomassie Plus Protein Assay Reagent from Thermo Scientific (Product No.
1856210). Before loading the samples in the wells of the polyacrylamide gels, sample
buffer was added and samples were heated for 6 minutes at 95°C (Nag and Resnick 2017).
2.5.2 Sodium Dodecyl Sulfate (SDS) Polyacrylamide Gel Electrophoresis
(SDS-PAGE)
Twelve percent acrylamide-bisacrylamide gels and 4% stacking gels were used. In
each well of the gel, same amount (30 µg) of proteins were loaded. The samples were run
in a 1X running buffer containing SDS, glycine, and Tris Base for 2.5 hours at 100 volts.
The gels were put onto methanol preactivated polyvinylidene difluoride (PVDF)
membranes. Using a wet transfer method, the transfer was performed for 2 hours at 100
volts in a cold transfer buffer containing 20% methanol. The membrane was blocked for
1-2 hours in 6% non-fat dry milk in 1X Tris-buffered Saline-Tween 20 (TBST) buffer at
room temperature. The concentrations of primary and secondary antibodies were
formulated in 6% non-fat dry milk in TBST. The following antibody concentrations were
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used: mouse monoclonal beta-actin (Novus Biologicals# NB600-501) at a concentration of
1:10,000, mouse monoclonal HIF-1α (Santa Cruz Biotechnology# sc-13515) at a
concentration of 1:200, mouse monoclonal EPO (Santa Cruz Biotechnology# sc-80995) at
a concentration of 1:200, mouse monoclonal Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) (Santa Cruz Biotechnology# sc-166545) at a concentration of 1:1000, rat
monoclonal ZO1 (Developmental Studies Hybridoma Bank at University of Iowa#
R26.4C) at a concentration of 1:100, mouse monoclonal Na+/ K+-ATPase α1 subunit
(Developmental Studies Hybridoma Bank at University of Iowa# a6F) at concentration of
1:600. Secondary HRP-conjugated anti-mouse and anti-rat antibodies were used at a
concentration of 1:2000. The membranes were kept in primary antibody at 4°C overnight
on a shaker and after washing steps these membranes were incubated with secondary
antibody for 2 hours at the room temperature on a shaker. After incubation in primary or
secondary antibodies, the membranes were washed with 1X TBST buffer for every 10
minutes for a total of 40 minutes and during the washing steps the membranes were kept
on the shaker. A chemiluminescence detection kit (Amersham ECL Prime Western
Blotting Detection Reagent) from GE Healthcare (Catalog no. RPN 2232) was used. The
luminol and peroxide solutions were mixed in a ratio of 1:1 and the mixture was evenly
spread onto the membrane. The membranes were read using an Odyssey FC Imaging
System from LI-COR Biosciences using Image Studio Software version 2.1.

The

following membrane exposure times were found to be optimum to detect different proteins:
membranes probed for ZO1 and Na+/ K+-ATPase α1 subunit with 5 minutes’ exposure, the
membranes probed for HIF-1α and EPO with 10 minutes’ exposure, membranes probed
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for beta-actin with 1-minute exposure, and membranes probed for GAPDH with 2 minutes’
exposure.
To compare beta-actin levels in the membrane which was first analyzed for EPO
levels, a stripping buffer, Restore Plus Western Blot Stripping Buffer from Thermo
scientific (Product no. 46430), was used. Antibodies were stripped from the membrane
for 10 minutes, followed by washing with 1X TBS and 1X TBST buffers, and the
membrane was blocked again before the addition of the primary antibody, i.e.
monoclonal beta-actin antibody. As described above, the membrane was treated in the
same way with a secondary antibody and the detection reagents to find beta-actin protein
levels (Nag and Resnick 2017).
2.5.3 Densiometric Analysis
The LI-COR Image Studio Software was used to measure band intensities in order
to perform densiometric analysis (Nag and Resnick 2017). In the same membrane, the ratio
of the band intensity of protein of interest obtained from a sample and the band intensity
of beta-actin or GAPDH of the same sample was first calculated for a control sample (i.e.,
the lysate prepared from cells without CoCl2 treatment). Similarly, the ratio was calculated
for a CoCl2-treated sample. The fold increase or decrease of the treated sample ratio was
calculated by dividing the treated sample ratio with the control sample ratio. The control
sample ratio after dividing by the same sample ratio is assigned a value of 1, and the results
as folds of increase or decrease of treated samples as compared to the control samples are
shown. Average values of densitometric fold changes with standard errors for 3-6 replicates
are presented.
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2.6 Cellular Metabolic Activity Assay
The yellow colored tetrazolium salt, 3-(4,5-dimethythiazol2-yl)-2,5-diphenyl
tetrazolium bromide (MTT), is known to be reduced by the mitochondrial succinate
dehydrogenase enzyme of viable cells to produce purple colored formazan crystals
(Mosmann 1983). A Cell Titer 96 Non-Radioactive Cell Proliferation Assay (MTT) G4000
(Promega) kit was used to check if cellular metabolic activity was affected by the addition
of CoCl2. In brief, BLDM was removed and APDM was replaced with 150 µl of fresh
APDM to which 20 µl of MTT dye solution was added and the culture was incubated for
four hours. Next, 150 µl of MTT solubilization/stop (acidic isopropanol) solution was
added to the apical compartment and the culture was incubated for an additional 4 hours.
Vigorously pipetted formazan crystals, formed by viable cells, were dissolved into the
solution, and 200 µl of the homogenized solution was then transferred into a 96-well plate.
Sample absorbance values were detected at 570 nm using an absorbance plate reader
(Perker Elmer Life Sciences/ Wallac Victor Multilabel Counter and Wallac 1420 Manager
Software). The average absorbance of 4 replicates are shown in the graph. Using trypan
blue dye and a hemocytometer, cell enumeration was performed and a calibration graph
was generated from cell seeding densities and absorbance values (Nag and Resnick 2017).
MTT assay compares cellular metabolic activities and can be an indirect indicator of
cellular viability (Jover, Ponsoda et al. 1994).
2.7 Statistical Analysis
Microsoft Excel 2016 was used to calculate values of mean or average and standard
deviation. Standard error of mean (SEM) was calculated from standard deviation (σ) as
𝑆𝐸𝑀 =

σ
√𝑛

where, n = number of replicates. Values of SEM are shown in all the graphs.
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A type three (i.e., two-sample unequal variance and heteroscedastic) and a two-tailed
Student’s t-test was performed using Microsoft Excel to compare level of any significant
difference between two groups, and IBM-SPSS software was used to perform a One-way
ANOVA with post-hoc Tukey to compare among more than two groups (Nag and Resnick
2017). The Pearson’s linear correlation analysis was also carried out using the SPSS
software.
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CHAPTER
III. RESULTS & DISCUSSION
3.1 Results
3.1.1 CoCl2 Stabilizes HIF1α in the Nucleus of Renal Epithelial Cells
Western blots were performed to show that the addition of 100 µmol/L CoCl2 to
our culture media increased nuclear HIF-1α in mCCD cells (Figures 17A & 17B) and
MDCK cells (Figures 18A and 18B). Nuclear stabilization of HIF1α was found to cause a
slight increase of HIF-1α effector molecule EPO levels in the whole cell extracts prepared
from mCCD cells (Figures 19A and 19B) (Nag and Resnick 2018) and MDCK cells
(Figures 20A and 20B). These findings are in agreement with previous studies (FISHER
and Langston 1967; Fandrey, Frede et al. 1997; Verghese, Zhuang et al. 2011). According
to densiometric analysis we found a significant increase in HIF-1α in the nuclear extracts
of both mCCD and MDCK cells (Figures 17B and 18B). However, the slight increase of
EPO levels was not statistically significant in mCCD or MDCK cells (Figures 19B and
20B). We did not notice any effect of fluid flow on EPO levels of mCCD cells along with
CoCl2 (Figures 19A and 19B)
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GAPDH gene has a HRE and its level can be elevated by nuclear stabilization of
HIF-1α (Graven, Yu et al. 1999; Lu, Gu et al. 2002). The beta-actin mRNA level was found
to be elevated by hypoxia (Zhong and Simons 1999). Thus, increased level of HIF1α by
CoCl2 may increase the protein levels of our loading controls: GAPDH and beta-actin, and
the densitometric analysis of our western blots may underestimate the effect of the
application of 100 µmol/L CoCl2 on HIF1α and EPO protein levels to some extent.
3.1.1.1 CoCl2 Stabilizes HIF-1α in the Nucleus of mCCD Cells
Nuclear HIF1α

Normalized Fold Change in HIF1α Level

B

*
4
3.5
3
2.5
2
1.5
1
0.5
0
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CoCl2

Figure 17: HIF-1α was stabilized in the nucleus of mCCD cells by 100 µmol/ L CoCl2.
(A) Shows the western blots for HIF1α and GAPDH (loading control) in the nuclear
extracts prepared from cells treated with CoCl2 or without CoCl2 (Control) for 4 hours. (B)
Shows the densiometric analysis of the HIF-1α bands, Student’s t-test, P= 0.004, N= 3.
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3.1.1.2 CoCl2 Stabilizes HIF-1α in the Nucleus of MDCK Cells

A

Nuclear HIF1α

B
Norrmalized Flod Change in HIF1α
Level
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Figure 18: HIF-1α was stabilized in the nucleus of MDCK cells by 100 µmol/ L CoCl2.
(A) Shows the western blots for HIF-1α and beta-actin (loading control) in the nuclear
extracts prepared from cells treated with CoCl2 or without CoCl2 (Control) for 4 hours. (B)
Shows the densiometric analysis of the HIF1α bands, Student’s t-test, P = 0.01, N= 3.
3.1.1.3 CoCl2 Slightly Increases EPO Production in mCCD Cells

A

Normalized Fold Change in EPO Level

B
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Flow

Figure 19: EPO protein level was slightly increased in mCCD cells by 100 µmol/ L
CoCl2. (A) Shows the western blots for EPO and beta-actin (loading control) in the whole
cell extracts prepared from cells treated without CoCl2 (Control), with CoCl2, and CoCl2
with fluid flow for 24 hours. (B) Shows the densiometric analysis of the EPO bands, Oneway ANOVA, P > 0.05, N= 3.
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3.1.1.4 CoCl2 Slightly Increases EPO Production in MDCK Cells
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Figure 20: EPO protein level was slightly increased in MDCK cells by 100 µmol/ L
CoCl2. (A) Shows the western blots for EPO and beta-actin (loading control) in the whole
cell extracts prepared from cells treated without CoCl2 (Control), with CoCl2, and CoCl2
with fluid flow for 24 hours. The lanes between the ladder and the bands are spliced out
(following American Journal of Physiology Guidelines) to show the bands or samples of
interest. (B) shows the densiometric analysis of the EPO bands, Student’s t-test, P > 0.05,
N= 3.
3.1.2 Cellular Metabolic Activity: MTT Assay
3.1.2.1 MTT Calibration Graphs
Cells were seeded onto cell culture inserts with an area of 1.13 cm2 at different
mCCD cell seeding densities ranging from 104 to 7 × 105 cells per insert. MTT assay was
performed in mCCD cells in growth condition (figure 21A) and in mCCD cells in fully
differentiated condition (figure 21B). The calibration graphs showed that MTT absorbance
values increase with initial cell seeding density. A logarithmic trend line was used to fit the
scatter plot of cell seeding density versus MTT absorbance values. Our calibration graphs
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show that we can detect changes in cellular metabolic activities and we may detect cellular
cytotoxicity due to the addition of CoCl2.
These mCCD cells express thermolabile the simian virus 40 (SV40) large tumor
(T) antigen (TAg) under the control of major histocompatibility complex H-2Kb promoter,
which is induced by interferon γ (IFN γ). In the permissive temperature of 33 °C and in a
growth medium containing of IFN γ, cells continuously proliferate. Under non-permissive
temperature around 39°C and in a differentiation medium without IFN γ, mCCD cells stop
proliferating and start to differentiate (Jat, Noble et al. 1991; Whitehead, VanEeden et al.
1993; Resnick and Hopfer 2007). At high cell seeding densities, we do not notice any
difference of MTT absorbance values, most likely due to the equal level of cellular
confluence achieved by high cell seeding densities.
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MTT Assay Calibration, mCCD Cells in GM for 3 Days
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MTT Assay Calibration, mCCD Cells in DM for 9 Days
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Figure 21: Cell seeding number versus MTT absorbance calibrations, N= 3-4. (A)
Shows mCCD cells with specific cell seeding numbers after 3 days in growth media (GM)
(B) Shows mCCD cells with specific cell seeding numbers in 3 days in growth media and
9 days in differentiation media (DM).
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3.1.2.2 Effect of 100 µmol/L of CoCl2 on Cellular Metabolic Activity
An MTT assay determines cellular metabolic activity and can indirectly reflect the
number of viable cells present (Mosmann 1983; van Meerloo, Kaspers et al. 2011). MTT
absorbance values showed that there were no significant differences between control and
CoCl2 treatment groups both in the presence or absence of fluid flow after 3 days (figure
22A). MTT results indicate that the addition of 100 µmol/L CoCl2 to our culture media did
not have any effect on cellular metabolic activities and can indicate equivalent cellular
viability (Nag and Resnick 2018) or no significant cytotoxic effect up to 4 days of treatment
(figures 22A and 22B). After 9 days of CoCl2 treatment, cellular metabolic activity was
found to decrease and indicated decrease in cellular viability or cytotoxic effects (figure
22C). It is to be emphasized that all our epithelial transport analyses were performed within
3 days of CoCl2 treatment and the cytotoxic effect of 9 days of CoCl2 treatment is not
applicable to our study.
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MTT Absorbance of Differentiated mCCD
Monolayers after 3 Days of CoCl2 Treatment
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Figure 22: Effect of CoCl2 on cellular metabolic activity of mCCD
cells. (A)nand (B)
e
show that MTT absorbance values do not significantly change with
o the additionc of 100
µmol/L CoCl2 up to 3-4 days, indicating cell viability may have
e
f remained unchanged
o
during 4 days of treatment, either in the presence or absence of
fluid
flow,
One-way
F
f CoCl2
ANOVA, P > 0.05, N= 3-5. (C) Shows that the treatment of cells owith 100 µmol/L
F
for 9 days causes significant decrease in the MTT absorbancer i.e., cellular metabolic
o
activity. One-way ANOVA, P < 0.0001, N= 3-4.
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3.1.3 FITC-dextran Permeability
3.1.3.1 Calibration Graphs and Permeability Calculation
Figures 23 and 24 show calibration graphs of fluorescence intensities versus
different concentrations of 3 kDa and 70 kDa FITC-dextran molecules. As shown in figure
23, fitting a power-law curve to the 3 kDa FITC-dextran data obtains the equation y =
5.67*104 x0.767. Similarly, 70 kDa FITC-dextran data yields a power law fit y = 6.13*105
x0.813 as shown in figure 24.

Power law curve fitting was chosen because at low

concentrations, the proportional change of fluorescence intensity is related to the
proportional change of FITC concentration (Ohannesian and Streeter 2001).
To calculate permeability value for each sample, a graph was generated for that
sample by plotting ln [1- (Ct- C0)] versus time t in seconds as shown in figure 25. Here, Ct
represents FITC-dextran concentration at time t (0- 4200) seconds for measurements
obtained at intervals of every 600 seconds. C0 is the initial concentration in the apical side.
The concentration (C0 and Ct) values of 3 kDa FITC-dextran were obtained from the
equation of figure 23. The permeability value was calculated for a specific sample using
the specific graph. For example, as shown in figure 25, permeability value was calculated
from slope of the linear trend line. The slope of the line is 4 × 10-7 sec-1 and dividing this
slope by the constant B = 12.43 cm-1, we can calculate the permeability value for this
specific sample. Thus, we obtain a 3 kDa FITC-dextran permeability value of 3.22 × 10-8
cm/sec.
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3 kDa FITC-dextran Calibration Graph
Fluorescence value, arbitrary units
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Figure 23: Concentration vs florescence intensity calibration graph of FITC-dextran,
3 kDa (N= 4). Using the equation of this graph, we can determine FITC-dextran (3 kDa)
concentration from a fluorescence intensity value.

70 kDa FITC-dextran Calibration Graph
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Figure 24: Concentration vs florescence intensity calibration graph of FITC-dextran,
70 kDa (N= 4). Using the equation of this graph, we can determine FITC-dextran (70 kDa)
concentration from a fluorescence intensity value.
104

Transepithelial Permeability of 3 kDa FITC-dextran
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Figure 25: 3 kDa FITC-dextran transepithelial permeability acquired from
fluorescence intensity measurements. Slope= 4× 10-7 sec-1, corresponding to
Permeability = 3.22 × 10-8 cm/sec.
3.1.3.2 FITC-dextran Permeability in mCCD and MDCK Epithelial
Monolayers
Using the approach shown in figure 25, the permeability of a cell-free collagencoated cell culture insert was found to be (1.21 ± 0.46) × 10-5 cm/s (3 kDa) and (1.01 ±
0.40) × 10-6 cm/s (70 kDa) as shown in figure 26.

Permeability, cm/sec
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Membrane without Cells
1.0E-04

1.0E-05

*
1.0E-06

1.0E-07

3 kDa
70 kDa
Molecular Sizes of Dextran
Figure 26: Permeability of FITC-dextran through empty cell culture inserts without
cells, Student’s t-test, P < 0.0001, N= 8.
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As mCCD epithelial cells differentiate, they undergo ciliogenesis, and the cells start
to form tight junctions and gain functional properties, such as directed transport of salt and
water. Figure 27 presents the data on transepithelial permeability of mCCD monolayers
during this differentiation phase. As per our expectation, 3 kDa FITC-dextran permeability
at day 1 (i.e., 24 hours after the onset of differentiation) was found to be significantly higher
(8 times) as compared to a fully differentiated mCCD monolayer after 10 days of
differentiation as shown in figure 27A. This finding provides some evidence that the
principal path of 3 kDa FITC-dextran diffusion in mCCD monolayers is through
paracellular pathway, as tight junctions may form early during the differentiation process
(Koizumi, Kojima et al. 2007). By contrast, the permeability of 70 kDa FITC-Dextran
showed no changes during differentiation (Figure 27B) (Nag and Resnick 2017).
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Figure 27: Transepithelial permeability of FITC-dextran molecules in mCCD
monolayers under differentiation. (A) Shows that 3 kDa FITC-dextran transepithelial
permeability at the onset of differentiation (day 1) is significantly higher as compared to
fully differentiated mCCD monolayers (day 10), One-way ANOVA, P < 0.05, N=3-6. (B)
Shows that the permeability of 70 kDa FITC-dextran does not change significantly during
differentiation, One-way ANOVA, P > 0.05, N= 3-6.
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Fully differentiated mCCD monolayers showed 3 kDa FITC-dextran permeability
of (5.36 ± 1.67) × 10-9 cm/s and 70 kDa FITC-dextran permeability of (1.56 ± 0.89) × 10-9
cm/s as shown in figure 28. Permeability values of 3 kDa and 70 kDa FITC-dextran
molecules in the differentiated mCCD monolayers are significantly decreased when
compared to the cell-free insert (figures 26 and 28), demonstrating the importance of
cellular tight junctions in regulating the transport through paracellular pathways (Nag and
Resnick 2017). The monolayer permeability values of differentiated mCCD cells remained
stable.
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Figure 28: Transepithelial permeability of fully differentiated mCCD monolayers,
Student’s t-test, p < 0.02, N= 8.
As shown in figure 29, once cells are fully differentiated, MDCK monolayers
showed 3 kDa permeability of (2.64 ± 1.11) × 10-8 cm/s and 70 kDa permeability of (5.75
± 2.15) × 10-10 cm/s and these monolayer permeability values of MDCK cells remained
stable.
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Figure 29: Transepithelial permeability of fully differentiated MDCK monolayers,
Student’s t-test, P < 0.001, N= 7-8.
3.1.3.3 HIF-stabilization by CoCl2 Increases Transepithelial
Permeability
We studied the effect of HIF-stabilization by CoCl2 on monolayer permeability.
CoCl2 was found to alter the transepithelial permeability of FITC-dextran molecules
through fully differentiated mCCD monolayers. An addition of 100 µmol/L of CoCl2 for
48 hours increased 3 kDa FITC-dextran permeability to (4.02 ± 3.15) × 10-7 cm/s and the
addition of 100 µmol/L CoCl2 for 72 hours increased the transepithelial permeability
further to (9.05 ± 8.13) ×10-7 cm/s as shown in figure 30A. The treatment of CoCl2
increased the transepithelial permeability of 70 kDa FITC-dextran to (1.99 ± 2.13) ×10-8
cm/s at 48 hours and (7.24 ± 6.47) ×10-8 cm/s at 72 hours as shown in figure 30B. The
treatment with CoCl2 increased 3 kDa FITC-dextran permeability more than 100-fold and
70 kDa FITC-dextran nearly 40-fold after 72 hours. Thus, HIF-stabilization by CoCl2
significantly affected permeability of 3 kDa and 70 kDa FITC-dextran molecules in
differentiated mCCD monolayers (Nag and Resnick 2017).
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Effect of CoCl2 on 3 kDa FITC-dextran Permeability in
mCCD Monolayers
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Figure 30 A: Effect of CoCl2 on permeability of 3 kDa FITC-dextran in differentiated
mCCD monolayers. CoCl2 was added on day 0. Data shows that CoCl2 treatment for 48
hours (Day 2) and 72 hours (Day 3) increased the permeability of differentiated mCCD
monolayers. CoCl2 treatment significantly (One-way ANOVA, P = 0.02, N= 4-5) increased
monolayer permeability on day 3. No statistically significant difference was found between
control groups.
Effect of CoCl2 on 70 kDa FITC-dextran Permeability in
mCCD Monolayers
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Figure 30 B: Effect of CoCl2 on permeability of 70 kDa FITC-dextran in
differentiated mCCD monolayers. CoCl2 was added on day 0. Data shows that CoCl2
treatment for 48 hours (Day 2) and 72 hours (Day 3) increased the permeability of
differentiated mCCD monolayers. CoCl2 treatment significantly (One-way ANOVA, P =
0.02, N= 4-5) increased monolayer permeability on day 3. No statistically significant
difference was found between control groups.
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Similarly, we investigated the effect of HIF-stabilization by 100 µmol/L CoCl2 in
MDCK monolayers. Figure 31A shows 3 kDa FITC-dextran permeability increased for
MDCK monolayers: (3.65 ± 0.96) × 10-8 cm/sec after 48 hours of incubation and (3.62 ±
0.46) × 10-8 cm/sec after 72 hours of incubation. Treatment with CoCl2 for 72 hours
significantly increased 70 kDa FITC-dextran permeability as well, to (1.61 ± 0.0) × 10-9
cm/sec as shown in figure 31B. The treatment with CoCl2 increased the permeability of 3
kDa and 70 kDa dextran molecules in MDCK monolayers around 2-3 folds. The effect of
HIF-stabilization by CoCl2 on the transepithelial permeability of MDCK monolayer was
statistically significant, but the fold changes were much less in MDCK monolayers as
compared to mCCD monolayers.
Effect of CoCl2 on 3 kDa FITC-dextran Permeability in
MDCK Monolayers
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Figure 31 A: Effect of CoCl2 on permeability of 3 kDa FITC-dextran in differentiated
MDCK monolayers. CoCl2 was added on day 0. Data shows that CoCl2 treatment for 48
hours (Day 2) and 72 hours (Day 3) significantly (One-way ANOVA, P ˂ 0.0001, N= 412) increased the permeability of differentiated MDCK monolayers. No statistically
significant differences were found among control groups.
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Effect of CoCl2 on 70 kDa FITC-dextran Permeability in
MDCK Monolayers
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Figure 31 B: Effect of CoCl2 on permeability of 70 kDa FITC-dextran in
differentiated MDCK monolayers. CoCl2 added on day 0. Data shows that CoCl2
treatment for 72 hours (Day 3) significantly (One-way ANOVA, P ˂ 0.025, N= 3-4)
increased the permeability of differentiated MDCK monolayers. No statistically significant
difference was found between control groups.
The table below summarizes our permeability measurements:
Table III: Summary of 3 kDa and 70 kDa FITC-dextran permeability values.
3 kDa, P (cm/sec)

70 kDa, P (cm/sec)

Cell-free insert

(1.61 ± 0.61) × 10-5

(1.41 ± 0.94) × 10-6

mCCD w/o CoCl2 (control)

(8.53 ± 4.46) × 10-9

(1.93 ± 1.65) × 10-9

mCCD w/ 48h CoCl2

(4.02 ± 3.15) ×10-7

(1.99 ± 2.13) ×10-8

mCCD w/ 72h CoCl2

(9.05 ± 8.13) × 10-7

(7.24 ± 6.47) ×10-8

MDCK w/o CoCl2 (control)

(1.41 ± 0.40) × 10-8

(5.63 ± 0.21) × 10-10

MDCK w/ 48h CoCl2

(3.65 ± 0.96) ×10-8

Did not measure

MDCK w/ 72h CoCl2

(3.62 ± 0.46) ×10-8

(1.61 ± 0.0) × 10-9
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3.1.3.4 Effect of HIF-1α Inhibitor Along with CoCl2
A preliminary experiment was performed in MDCK monolayers to see if an
inhibitor of HIF-1α can affect the cellular permeability along with CoCl2. In this
experiment, an HIF-1α inhibitor was applied at a concentration 30 µmol/L as suggested by
the supplier (Santa Cruz Biotechnology). We would like to emphasize that the HIF-1α
inhibitor was not sequentially added; rather the inhibitor was added at the same time when
CoCl2 was added. The HIF-1α inhibitor alone did not show any significant effect in altering
3 kDa and 70 kDa FITC-dextran permeability on day 3 as shown in figures 32A and 32B.
HIF-1α is known to be degraded under normoxic conditions, and, therefore, an HIF-1α
inhibitor under normoxia does not show any effects on transepithelial permeability as
expected. However, we made an interesting observation that the permeability of 3 kDa
FITC-dextran increased more than 40-fold when monolayers were incubated with CoCl2
and HIF-1α inhibitor for 72 hours (figure 32A). The treatment with CoCl2 alone was found
to increase 3 kDa FITC-dextran permeability only around 3-fold. Therefore, it is tempting
to speculate that the application of an HIF-1α inhibitor along with the stabilization of
HIF1α by CoCl2 creates a chaotic cellular condition which may drastically affect tight
junctions and shows a drastic increase in 3 kDa FITC-dextran permeability. However, we
did not notice such an effect with 70 kDa FITC-dextran permeability (figure 32B).
Application of the HIF-1α inhibitor is further discussed under the section of future
directions.
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Combined Effect of CoCl2 and HIF-1α Inhibitor on 3 kDa FITCdextran Permeability in MDCK Monolayers
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Figure 32 A: Effect of HIF-1α inhibitor along with CoCl2 on 3 kDa FITC-dextran
permeability in differentiated MDCK monolayers. Treatment started on Day 0.
Combined application of 100 µmol/L of CoCl2 and 30 µmol/L of HIF1α inhibitor for 72
hours (Day 3) drastically increased (40 folds) 3 kDa FITC-dextran permeability and this
increase was statistically significant (One-way ANOVA, P < 0.0001, N=3-4). The
application of CoCl2 alone for 72 hours increased the permeability around 3 folds. The
application of HIF-1α inhibitor alone did not have any significant effect.
Combined Effect of CoCl2 and HIF-1α Inhibitor on 70 kDa FITCdextran Permeability in MDCK Monolayers
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Figure 32 B: Effect of HIF-1α inhibitor along with CoCl2 on 70 kDa FITC-dextran
permeability in differentiated MDCK monolayers. Treatment started on Day 0.
Combined application of 100 µmol/L of CoCl2 and 30 µmol/L of HIF1α inhibitor for 72
hours (Day 3) increased 70 kDa permeability around 2 folds and the application of CoCl 2
alone for 72 hours (Day 3) increased 70 kDa FITC-dextran permeability around 3 folds
(One-way ANOVA, P < 0.0001, N= 3-4). The application of HIF-1α inhibitor alone did
not have any significant effect.
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3.1.4 HIF-stabilization by CoCl2 Decreases ZO1 Protein Level
ZO1 protein is known to link tight junction strand proteins to the actin cytoskeleton,
and thereby ZO1 maintains the integrity of tight junctions and controls transport through
paracellular routes (Denker and Sabath 2011). In mCCD cells, HIF-stabilization by CoCl2
decreased ZO1 protein levels as seen in the western blot (figure 33 A). The densiometric
analysis demonstrates significant reductions in ZO1 protein levels due CoCl2 treatment as
shown in figure 30B. Fluid flow along with CoCl2 did not seem to have any additional
effect. Decreased level of ZO1 due to HIF-stabilization by CoCl2 is consistent with the
increased permeability of FITC-dextran molecules through mCCD monolayers (Nag and
Resnick 2017).
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Figure 33: ZO1 protein level in mCCD cells was decreased due to treatment with 100
µmol/ L CoCl2. (A) Shows the western blots for ZO1 and beta-actin (loading control) in
the whole cell extracts prepared from cells treated without CoCl2 (Control), with CoCl2,
and CoCl2 with fluid flow for 24 hours. (B) Shows the densiometric analysis of the ZO1
bands, One-way ANOVA, P < 0.0001, N= 4.
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3.1.5 Transepithelial Electrophysiology Results
3.1.5.1 TER Results
I. Development of TER During Cellular Growth
As shown in figure 31, TER values start to develop from the growth phase in mCCD
cells. Increases in the TER value corresponds to the increment of transcellular resistance
due to increase in cellular numbers during the growth phase as well as contributed by the
cellular junctions.
Development of TER Values of mCCD Cells in Growth Condition
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Figure 34: Development of TER values in growth condition of mCCD cells, N= 3-48.
II. Effect of Fluid Flow on TER of mCCD Monolayers
Fluid flow was applied during differentiation of mCCD monolayers. As shown in
Figure 35, the presence of fluid flow did not seem to have any permanent effect on
differentiating (up to day 8 i.e., D8) and in differentiated mCCD monolayers (e.g., day 8
or D8 and onwards). Figure 35 also shows the variability and possible range of TER
values.
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Figure 35: Effect of fluid flow on TER of differentiating or differentiated mCCD
monolayers. Differentiation up to day 7-8 (D7 or D8) and differentiated on day 8 onwards,
N= 7-46.
III. Effect of HIF-stabilization by CoCl2 on TER of Renal Epithelial Monolayers
Due to the integrity of tight junctions, an untreated confluent and fully
differentiated mCCD monolayer maintains a TER value around 3 kΩ-cm2. As shown in
figure 36A and 36B, extended application of CoCl2 results in a significant decrease in TER
value at day 2 and 3. This decrease in TER value due to CoCl2 treatment is consistent with
the decreased level of ZO1 and increased permeability of FITC-dextran molecules. HIFstabilization by CoCl2 in mCCD monolayers cultured without fluid flow (figure 36A)
showed an average TER value reduction after 30 hours, whereas in HIF-stabilized
monolayers cultured with fluid flow (figure 36B), the average TER value was found to
decrease after 48 hours. The TER of mCCD monolayers was found to decrease 4-fold in
the absence of fluid flow and 3-fold in the presence of fluid flow due to HIF-stabilization
by CoCl2. Statistical analysis suggests that the effect of HIF-stabilization in lowering TER
values was favored when fluid flow was absent (Nag and Resnick 2017).
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Figure 36: Effect of CoCl2 on TER of differentiated mCCD monolayers. CoCl2 was
added on day 0 in the absence (A) or presence (B) of chronic steady fluid flow, N= 416, One-way ANOVA. * denotes significant change (p < 0.05) between a control and CoCl2
treatment at a specific time-point. # denotes CoCl2 treatment causes significant change (p
< 0.05) between CoCl2 treated sample at a specific time point with control or CoCl2 treated
sample at a different time point. One-way ANOVA shows no significant (P > 0.05) TER
changes among control groups in (A) or (B). Data in (A) shows that application of 100
µmol/L CoCl2 significantly decreased TER values of differentiated mCCD monolayers
after 48 hours (2 days) and 72 hours (3 days) without fluid flow. In figure (B) with fluid
flow, at a specific time points of Day 2 and Day 3, statistical significance (P > 0.05) was
not detected between control and CoCl2. However, we noticed CoCl2 treatment group value
was significantly (P < 0.05, denoted by #) decreased as compared to control value at a
different time point. TER on Day 3 of CoCl2 treated group was significantly decreased as
compared to Day 2 control. Similarly, TER on Day 2 of CoCl2 treated group was
significantly decreased as compared to Day 1 control.
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In contrast to mCCD monolayers, a confluent and fully differentiated monolayer of
MDCK cells has a TER value around 200-400 Ω-cm2. Figure 37 demonstrates that the
TER values of MDCK monolayers increase due to HIF-stabilization by CoCl2 treatment.
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Figure 37: Effect of CoCl2 on differentiated MDCK monolayers without fluid flow.
CoCl2 was added on day 0 in the absence of fluid flow. TER values increased significantly
at Day 2 and Day 3 of CoCl2 treatment (One-way ANOVA, P < 0.0001, N= 3-9). No
statistically significant differences were found among control groups.
The Table below summarizes our TER measurements:
Table IV: Summary of TER values.
TER w/o flow

TER w/ flow

[Ω-cm2]

[Ω-cm2]

mCCD w/o CoCl2

5502 ± 2870

5699 ± 665

mCCD w/ CoCl2, 72 h

1356 ± 202

1881 ± 506

MDCK w/o CoCl2

208 ± 14

Did not measure

MDCK w/ CoCl2, 72 h

410 ± 35

Did not measure

HIF-stabilization in MDCK monolayers increased FITC-dextran permeability but
also increased TER value instead of decreasing it. We further investigated this finding by
statistical analysis. We combined all the data of 3 kDa FITC-dextran and 70 kDa FITC119

dextran permeability and TER values of fully differentiated and untreated mCCD and
MDCK monolayers. We analyzed the data to find correlation between TER and
permeability. The summary of the correlation shown in the table below:
Table V: Pearson’s correlation between TER values and 3 kDa or 70 kDa FITCdextran permeability in mCCD and MDCK monolayers.
Cell Type

mCCD

TER versus 3
kDa Dextran
Permeability:
Pearson’s
Linear
Correlation
Coefficient, r
-0.5

Statistical
Significance of
3 kDa Dextran
vs TER
Correlation

P < 0.0001,

TER versus 3
kDa Dextran
Permeability:
Pearson’s
Linear
Correlation
Coefficient, r
-0.54

N = 56
MDCK

0.21

Statistical
Significance of
70 kDa Dextran
vs TER
Correlation

P < 0.0001,
N = 56

P = 0.32,

-0.36

N = 24

P = 0.3,
N =13

TER is known to maintain an inverse relation with permeability. In mCCD
monolayers, Pearson’s correlation coefficient (r) values were -0.5 and -0.54 for 3 kDa and
70 kDa dextran, respectively (table 5). These values suggest fair or moderate correlation
between FITC-dextran permeability and TER values in mCCD monolayers. The
permeability and TER correlation was statistically significant in mCCD cells. In the case
of MDCK monolayers, the 3 kDa FITC-dextran and TER showed a positive r value,
indicating that the inverse correlation was not maintained (table 5). TER and 70 kDa FITCdextran showed a weak correlation. Moreover, in the MDCK monolayer, the correlation
was not statistically significant as shown in table 5. Thus, the TER values of mCCD
monolayers can be an indicator of FITC-dextran permeability, but not for MDCK
monolayers (Nag and Resnick 2018).
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3.1.5.2 Ieq Results
I. Effect of Fluid Flow on Ieq of mCCD Monolayers
The presence of fluid flow was found to decrease Ieq values. The effect of fluid
flow in lowering Ieq values was consistent both in differentiating and differentiated mCCD
cellular monolayers as shown in figure 38. This finding agrees with previous reports
(Resnick and Hopfer 2007; Resnick 2011). Active Na+ transport is mainly responsible for
Ieq in mCCD monolayers and active Na+ transport can be regulated by functional cilia and
fluid flow.

Effect of Fluid Flow on Ieq of mCCD Monolayers
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Differentiation up to day 7-8 (D7 or D8) and differentiated on day 8 onwards,
N= 7-46.
II. HIF-stabilization by CoCl2 Alters Ieq of mCCD Monolayers
The effect of HIF-stabilization by CoCl2 on Ieq was found to be more prominent in
mCCD monolayers cultured in the absence fluid flow (Figure 39A) as compared to
monolayers cultured in the presence of fluid flow (Figure 39B). Treatment with CoCl2 in
the absence of fluid flow showed a significant decrease of normalized Ieq values after 30
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hours or 1.2 days (Figure 39A). Due to CoCl2 treatment for 3 days in monolayers not
exposed to fluid flow, Ieq values showed a significant change and, very interestingly, a
positive mean Ieq value of 0.9 µA/ cm2 was detected. Movement of positively charged Na+
from the apical to basolateral side results in a negative value of Ieq. Thus, a positive Ieq
value suggests that the net active ion transport may be occurring in the opposite direction,
and the monolayer may have become secretory. It is tempting to interpret this finding as a
confirmation of our hypothesis that the stabilization of HIF-1α for an extended period can
transform a normally absorptive renal epithelial monolayer into a secretory monolayer.
Analysis of normalized Ieq values of mCCD monolayers cultured with chronic fluid
flow showed that the normalized Ieq values were significantly reduced at day 2 in response
to CoCl2 treatment as shown in figure 39B. Control samples had a mean Ieq value of -2.6
µA/ cm2, whereas CoCl2 treated samples showed mean Ieq values of 0.1 µA/ cm2 and 0.2
µA/ cm2 after 2 and 3 days, respectively.
When figures 39A and 39B are compared, it is to be noted that HIF-stabilization by
CoCl2 significantly altered Ieq values in the monolayers without fluid flow after 30 hours,
whereas in the monolayers cultured with fluid flow, significant changes occurred after 48
hours. In monolayers without fluid flow, CoCl2 treatment for 72 hours showed a more
prominent change. Therefore, it can be inferred that the lack of fluid flow may have
intensified the effect of HIF-stabilization (Nag and Resnick 2017). However, with our EPO
western blots, we were unable to find any direct contribution of fluid flow in HIFstabilization.
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Figure 39: Effect of CoCl2 on Ieq of differentiated mCCD monolayers. (A) Without
fluid flow. (B) With chronic steady fluid flow. CoCl2 was added on day 0. Data shows
that application of 100 µmol/L CoCl2 significantly decreased Ieq values of differentiated
mCCD monolayers after 48 hours (2 days) in both (A) and (B). Interestingly, after 3 days
of treatment, Ieq value switched to the positive direction. Current values are plotted as
normalized Ieq (i.e., relative to average control Ieq values) as discussed in methods, N = 416, One-way ANOVA. * denotes significant change (P < 0.05) between a control and
CoCl2 treatment at a specific time-point. # denotes significant change (P < 0.05) between
a CoCl2 treated sample at a specific time point with a control or CoCl2 treated sample at a
different time point. In figure (A) and (B), CoCl2 treatment shows a gradual decrease of
negative Ieq. Some of these gradual decreases of Ieq are statistically significant (e.g., figure
(A) Day 1 CoCl2 vs Day 1.2 CoCl2; figure (A) Day 1.2 CoCl2 vs Day 2 CoCl2; figure (B)
Day 1 CoCl2 vs Day 2 CoCl2) and were denoted by #. In figure (B) Day 3 CoCl2 shows a
statistically significant decrease as compared to Day 2 Control (denoted by #).
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3.1.5.3 CoCl2 Acts on Basolateral Side of mCCD Cells
In our mCCD cells, the transporter responsible for Co2+ uptake has not been clearly
identified. In mammalian cells, the divalent metal cation transporters Slc11a1 and Sla11a2
are believed to be responsible for Co2+ uptake (Gunshin, Mackenzie et al. 1997; Forbes and
Gros 2003). We found that mCCD monolayers cultured in the presence of fluid flow
exposed to apical CoCl2 treatment showed an initial, transient, increase in TER values but
no chronic change to TER values as shown in Figure 40A. Apical treatment with CoCl2,
did not have any effect on Ieq values of mCCD monolayers (figure 40B). However, when
CoCl2 was withdrawn from the apical media and added to the basolateral media, we noted
significant dose-dependent decreases in both TER and Ieq values, as shown in figure 41A
and 41B. Basolateral treatment with 100 µmol/L CoCl2 showed significant decreases in
TER and Ieq values after 2 days of treatment as shown in figure 41A and 41B. The effect
of CoCl2 on cellular electrophysiology (TER and Ieq) when added to basolateral media was
similar as the effect of CoCl2 when added to both apical and basolateral media. Thus, it is
interesting to find that CoCl2 affects the electrophysiological properties of our monolayers
only when it is added in the basolateral media, potentially identifying the site of Co2+
uptake (Nag and Resnick 2017).
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Effect of Apical Application of CoCl2 on TER of mCCD
Monolayers
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Figure 40: Effect of CoCl2 added to apical media of differentiated mCCD monolayers
cultured in the presence of chronic steady fluid flow. (A) TER and (B) Ieq
measurements. Data shows that application of CoCl2 in apical media does not cause any
chronic changes in TER values (A) or Ieq values (B) of differentiated mCCD monolayers,
One-way ANOVA, N = 5-8. In the TER and Ieq data, One-way ANOVA shows no
significant (P > 0.05) TER and Ieq changes among any control groups. In the TER plot (A),
* denotes a significant change (P < 0.05) between 0 µmol/L CoCl2 and 100 µmol/L CoCl2
treatment at Day 0.4 (6 hours). # denotes a significant difference (P < 0.05) between a
CoCl2 treated sample at a specific time point and a CoCl2 treated or control (0 µmol/L
CoCl2) sample at a different time point. # are marked onto any noticeable significant
changes due to CoCl2 treatment. There is no significant effect (P > 0.05) of apical
application of 0, 50, or 100 µm CoCl2 on Ieq of mCCD monolayers.
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Effect of Basolateral Application of CoCl2 on TER of mCCD
Monolayers
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Figure 41: Effect of CoCl2 when withdrawn from apical media and added to
basolateral media of differentiated mCCD monolayers in the presence of chronic
steady fluid flow. (A) TER and (B) Ieq measurements. Data shows that application of
100 µmol/L of CoCl2 to basolateral media significantly decreased TER values (A) and Ieq
values (B) of mCCD monolayers in a dose-dependent manner after 2 days of treatment (N
= 5-6). In the TER and Ieq data, One-way ANOVA shows no significant (p > 0.05) TER
and Ieq changes among control groups. * denotes significant change (p < 0.05) among 0,
50, and 100 µmol/L CoCl2 treatment at a specific time-point. # denotes CoCl2 treatment
causes significant change (p < 0.05) between CoCl2 treated sample at a specific time point
and CoCl2 treated or control sample at a different time point. In figure (A) we do not see
statistically significant decrease of TER, * (p < 0.05) on day 2 or day 3 by 50 or 100 µmol/L
CoCl2 as compared to control (0 µmol/L CoCl2) on that specific day. However, we notice
some significant decrease of TER as compared to control at a different time point. For
example, on day 3, 100 µmol/L CoCl2 causes a significant decrease in the TER value when
compared to 0 µM CoCl2 TER value on day 2, denoted by #. In figure (B) we notice
significant loss of Ieq with 100 µmol/L CoCl2 treatment on day 2 and significant loss of Ieq
with both 50 and 100 µM CoCl2 treatment on day 3. Any noticeable significant changes
due to CoCl2 treatment are denoted by #.
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3.1.6. HIF-stabilization by CoCl2 Decreases Na+/ K+- ATPase α1 Subunit
Protein Level
The catalytic subunit α of Na+/ K+-ATPase is known to be mainly responsible for
active transport of Na+. Using western blot, we notice that HIF-stabilization by CoCl2
decreases Na+/ K+-ATPase α1 subunit level in our mCCD cells as shown in figure 42A.
Densiometric analysis confirms the significant decrease of Na+/ K+-ATPase α1 due to HIFstabilization (figure 42B). The presence or absence of fluid flow along with HIFstabilization did not seem to have any additional effect on Na+/ K+-ATPase α1 level
(figures 42A and 42B) (Nag and Resnick 2017). The decrease of Na+/ K+-ATPase α1
subunit level due to HIF-stabilization is consistent with the loss of Ieq i.e., decreased active
Na+ transport from apical to basolateral side in mCCD monolayers.
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Figure 42: Na+/ K+-ATPase α1 subunit protein level in mCCD cells was decreased due
to treatment with 100 µmol/ L CoCl2. (A) Shows the western blots for Na+/ K+-ATPase
α1 subunit and beta-actin (loading control) in the whole cell extracts prepared from cells
treated without CoCl2 (Control), with CoCl2, and CoCl2 with fluid flow for 24 hours. (B)
Shows the densiometric analysis of the ZO1 bands, One-way ANOVA, P = 0.001, N= 3.
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3.2 Discussion
3.2.1 100 µmol/L CoCl2 Stabilizes HIF-1α without Any Detectable Cellular
Cytotoxic Effects until 4 Days
In our mCCD and MDCK monolayers 100 µmol/L CoCl2 was found to stabilize
HIF-1α in the nucleus and also resulted in a slightly increased production of EPO. We
detected EPO by western blot in the cell lysates. We think that the EPO was mostly released
in the cell culture media and since we did not analyze EPO levels in cell culture media, we
may have underestimated the effect of HIF-stabilization by CoCl2 in increasing EPO
production by mCCD and MDCK cells. A concentration of 100 µmol/L CoCl2 was
previously reported to stabilize HIF-1α in the nucleus of MDCK cells (Verghese, Zhuang
et al. 2011). Other studies showed cobalt can increase EPO production (FISHER and
Langston 1967; Fandrey, Frede et al. 1997). CoCl2 was previously shown to prevent
cellular growth of mouse embryonic fibroblasts at a concentration of 100 µmol/L.
However, MTT assay showed 100 µmol/L CoCl2 did not have any significant cytotoxic
effect on fibroblasts after 72 hours (Vengellur and LaPres 2004). Similarly, using an MTT
assay we did not notice any effect on the cellular metabolic activity of mCCD cells by 100
µmol/L CoCl2 up to 4 days of CoCl2 treatment. All our epithelial transport experiments
were carried out within 3 days of CoCl2 treatment, and during this time CoCl2 did not seem
to have any cytotoxic effect. MTT assay may show a delayed response to indicate cytotoxic
effects or may be unable to detect small variation in cellular viability (Page, Bejaoui et al.
1988; Sieuwerts, Klijn et al. 1995). In this context, it is important to point out that we
ensured that all our mCCD monolayers maintained a threshold TER value of 1 kΩ- cm2
during epithelial transport experiments. Any small gap due to loss of cells (0.4 % loss of
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cellular coverage) would cause 80% decrease in TER value (ávan der Meer, JungáKim et
al. 2015). We did not notice such a drastic change of TER values in our monolayers due to
CoCl2 treatment up to 3 days, supporting our MTT assay results that CoCl2 treatment may
not have affected number of viable cells at least up to 3-4 days.
As discussed previously, in kidney cystic epithelia of rats and humans, protein
levels of HIF-1α and mRNA levels of HIF-α target genes, such as EPO, Glut-1, and VEGF
were found to be elevated (Bernhardt, Wiesener et al. 2007). Using CoCl2, we prevented
degradation of HIF-1α in monolayers of mCCD and MDCK epithelial cells to understand
the role of hypoxia or HIF-stabilized environment as experienced by normal renal epithelial
cells in a hypoxic environment created by cysts in PKD (Nag and Resnick 2017).
In our study, we considered that the cell culture in a regular incubator with 5% CO2
as cells under normoxia. The normal atmospheric O2 is around 20%. In a normal cell culture
incubator, the percent of O2 is similarly around 20%. The alveolar cells normally encounter
around 20% O2 and arterial blood has O2% around 10-13% and O2% is other organs is
around 1-8%. In vivo kidney medulla was reported to encounter around 1% O2 (Lübbers
and Baumgärtl 1997). Therefore, renal epithelial cell culture maintained in a CO2 incubator
may experience a hyperoxic environment, rather than a normoxic environment (Wenger,
Kurtcuoglu et al. 2015). Future work can address this limitation using an O2 controlling
chamber or incubator.
3.2.2 Effect of Fluid Flow with HIF-stabilization
Chronic fluid flow alone did not seem to have any effect on TER values of mCCD
monolayers, but the presence of flow showed consistently decreased Ieq value, i.e,
decreased Na+ transport, and this finding is consistent with previous reports (Resnick and
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Hopfer 2007; Resnick 2011). Our results of electrophysiological analysis suggest that the
presence of chronic fluid flow may blunt HIF-stabilized altered transepithelial transport.
TER and normalized Ieq values decreased more rapidly in the absence of fluid flow as
compared to monolayers cultured in the presence of fluid flow. It is tempting to suggest
that monolayers cultured in the absence of fluid flow may be hypoxic to some extent and
may already have increased HIF-1α to some extent. However, we maintained a thin apical
fluid thickness that ensures adequate O2 availability to the monolayer. Our western blots
did not show any additional effect of the presence or absence of fluid flow along with CoCl2
on protein levels of EPO, ZO1, and Na+/ K+-ATPase. Therefore, renal epithelial response
to fluid flow seems to be independent of HIF-1α (Nag and Resnick 2017).
3.2.3 HIF-stabilization by CoCl2 Alters Transcellular and Paracellular
Transport
We presented our method of quantification of FITC-dextran permeability and
showed permeability as a stable function of mCCD and MDCK epithelial monolayers. In
MDCK C-7 epithelial cell monolayers with TER value of around 4000 Ω-cm2, 4 kDa FITCdextran apparent permeability (Papp) value was reported to be around 2×10-9 cm/sec (Gekle,
Wünsch et al. 1994; Kaiser, Pereira et al. 2015). In our mCCD monolayers with TER value
around 3000 Ω-cm2, 3 kDa permeability value was found to be (8.53 ± 4.46) × 10-9 cm/sec.
Thus, our calculated permeability values agree with previous reports. Using 3 kDa and 70
kDa FITC-dextran molecules, we were able to identify that the size selectivity was
maintained in both mCCD and MDCK epithelial monolayers. 3 kDa FITC-dextran can be
transported through epithelial monolayers either by fluid-phase transcytosis or by
paracellular transport, whereas large 70 kDa dextran molecules are known to be transported
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only through the paracellular pathway (Matter and Balda 2003). Thus, changes in 70 kDa
FITC-dextran transport through mCCD and MDCK monolayers due to HIF-stabilization
represent changes in the paracellular pathway. Increased permeability of anionic FITCdextran from apical to basolateral side suggests increased paracellular transport which can
also be indicative of increased water permeability.
In the mammalian kidney, paracellular permeability is known to decrease from the
proximal tubule to the collecting duct due to the expression of different claudins and higher
levels of occludin and ZO1 proteins (Gonzalez-Mariscal, Namorado et al. 2000; Denker
and Sabath 2011). Paracellular transport through epithelial tight junctions is known to be
driven by the ion gradient created by transcellular active transport. Proximal tubule is a
leaky epithelial monolayer with a high paracellular permeability and low TER. The
proximal tubule is known to be more than 100 fold more permeable than the collecting duct
(Denker and Sabath 2011). In our mCCD monolayers HIF-stabilization for 72 hours with
CoCl2 resulted in a 100-fold increase of 3 kDa FITC-dextran permeability and 40-fold
increase of 70 kDa FITC-dextran permeability. Therefore, HIF-stabilized collecting duct
epithelial monolayers appear to behave as monolayers from a more permeable region of
the kidney, such as proximal tubule.
The cortical collecting duct is responsible for 0.5% salt reabsorption and helps in
fine-tuning water and salt balance in the body. In mCCD monolayers, Ieq primarily shows
the active Na+ transport through ENaC channels since more than 95% of Ieq is known to be
blocked by 10 µmol/L of Na+ channel blocker amiloride (Resnick and Hopfer 2007;
Resnick 2011). We noticed that HIF-stabilization by CoCl2 caused a loss of Ieq values after
48 hours, indicating diminished active Na+ transport. The decreased protein level of Na+/
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K+-ATPase α1 subunit was consistent with the loss of active Na+ transport. Similar
observations were previously reported in kidney collecting duct epithelial monolayers, in
which hypoxia was shown to decrease ENaC activity and thereby decreased Ieq of the
monolayers (Husted, Lu et al. 2010). Moreover, in the HIF-stabilized mCCD monolayers
without fluid flow, we noticed a switch in the direction of the current after 72 hours,
suggesting that the direction of net ion transport was opposite as compared to the normal.
Thus, we noticed our absorptive mCCD monolayer transformed to a secretory monolayer
due to HIF-stabilization.
In renal epithelial monolayers, hypoxia mimetic condition, created by depletion of
ATP, caused disruption of actin cytoskeleton organization and tight junctions and
endocytosis of Na+/ K+-ATPase (Molitoris, Dahl et al. 1996). Similarly, we found that the
Na+/ K+-ATPase catalytic subunit α1 level decreased in our mCCD cells, supporting the
loss of active Na+ transport as observed by the loss of negative Ieq value in our mCCD
monolayers. We also noticed that permeability increased and ZO1 protein level decreased
in our mCCD monolayers, indicating alteration of tight junctions. In renal carcinoma cells,
HIF-1α was shown to regulate tight junctions by altering normal protein levels of claudin1 and occludin and normal localization of ZO1, claudin-1, and occludin (Harten, Shukla et
al. 2009).
Ischemic injury was shown to decrease sodium reabsorption by kidney proximal
tubule due to apical redistribution of Na+/ K+-ATPase α-subunit from basolateral side
(Molitoris 1991; Molitoris, Dahl et al. 1992). In vitro apical redistribution of Na+/ K+ATPase was shown to be functional in switching Na+ transport from the basolateral to
apical side (Molitoris 1993). In our mCCD monolayers, HIF-α stabilization in the absence
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of fluid flow showed a positive Ieq value which indicated that ions, most likely Na+, are
actively transported in the opposite direction. This switch in the direction of active ion
transport could be due to the similar redistribution of Na+/ K+-ATPase to the apical side in
our mCCD cells.
Previous studies in alveolar epithelial cells reported similar observations as our
results in renal epithelial cells (Mairbäurl, Mayer et al. 2002). Hypoxia was shown to
decrease active Na+ transport in rat alveolar epithelial monolayers and also decrease TER
of monolayers, increasing monolayer permeability of 4 kDa FITC-dextran (Mairbäurl,
Mayer et al. 2002; Bouvry, Planes et al. 2006). We noticed that HIF-stabilization by CoCl2
increased permeability of 3 kDa and 70 kDa FITC-dextran permeability both in our mCCD
and MDCK monolayers. We also noticed that TER values of mCCD monolayers also
decreased due to HIF-stabilization. In contrast, in MDCK monolayers, TER and FITCdextran permeability both increased due to HIF stabilization. As mentioned previously, in
MDCK monolayers, TER did not seem to be a good indicator of FITC-dextran permeability
(Nag and Resnick 2018). MDCK monolayers were reported to show increased TER values
as well as increased permeability of 3, 4 and 40 kDa FITC-dextran permeability in different
studies (Balda, Whitney et al. 1996; McCarthy, Francis et al. 2000; Van Itallie, Fanning et
al. 2009).
Hypoxia was shown to affect the expression or activity of apical ENaC and
basolateral Na+/ K+-ATPase causing decrease in active Na+ transport of alveolar epithelia
(Vivona, Matthay et al. 2001; Planès, Blot-Chabaud et al. 2002; Dada, Chandel et al. 2003).
Alveolar Na+/ K+-ATPase activity is known to be decreased in response to hypoxia by
endocytosis, which involves phosphorylation and ubiquitination of α1 subunit (Dada,
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Chandel et al. 2003). The phosphorylation of Na+/ K+-ATPase is known to be mainly driven
by PKC (Feschenko, Stevenson et al. 2000; Dada, Welch et al. 2007).
Hypoxia was also reported to alter tight junctions and thereby showed increased
permeability of monolayers of brain microvessel endothelial cells and intestinal epithelial
cells (Xu, Lu et al. 1999; Yamagata, Tagami et al. 2004; Engelhardt, Al‐Ahmad et al.
2014), further supporting our findings that HIF-stabilization can decrease monolayer
resistance and can increase FITC-dextran permeability.
Hypoxia was found to decrease ZO1 protein levels in the monolayers of alveolar
epithelial cells (Bouvry, Planes et al. 2006). ZO1 protein level was shown to decrease in
brain microvascular endothelial cells through HIF-1α (Engelhardt, Al‐Ahmad et al. 2014).
Similarly, we also noticed decreased level of ZO1 protein in our mCCD cells due to
stabilization of HIF-1α. Hypoxia can affect the actin cytoskeleton organization and can
result in occludin mislocalization from tight junctions to the cellular interior in alveolar
epithelial cells (Bouvry, Planes et al. 2006). Stabilization of HIF-1α was shown to affect
the integrity of tight junctions of brain microvascular endothelial cells due to the
mislocalization and tyrosine phosphorylation of tight junction complex proteins, such as
ZO1 and occludin (Engelhardt, Al‐Ahmad et al. 2014).
Thus, our results demonstrating altered transepithelial permeability are relevant and
are supported by other findings demonstrating that epithelial tight junction morphology is
regulated by HIF, with claudins (Saeedi, Kao et al. 2015), occludins (Caraballo, Yshii et
al. 2011), and ZO1 (Engelhardt, Al‐Ahmad et al. 2014) being specific targets. Similarly,
our electrophysiological results are in agreement with previous reports (Husted, Lu et al.
2010; Caraballo, Yshii et al. 2011).
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We think VEGF may be a key player in altering renal epithelial tight junctions due
to HIF-stabilization as seen in alveolar epithelial cells (Song, Kim et al. 2017). VEGF is
known to be expressed in the renal tubules. VEGF-A mRNA was detected in the epithelial
cells of glomerulus, distal tubules, and collecting ducts of humans and rodents (Bacic,
Edwards et al. 1995; Tufro, Norwood et al. 1999; Karihaloo, Karumanchi et al. 2005).
VEGF has a HRE and is elevated in response to HIF (Forsythe, Jiang et al. 1996). Cystic
epithelial cells were found to be hypoxic and showed higher protein levels of VEGF
(Bernhardt, Wiesener et al. 2007). Occludin, ZO1, and claudins are known to maintain
integrity of tight junctions. Hypoxia was shown to decrease levels of occludin in
endothelial cells (Brown and Davis 2005) and ZO1 in alveolar epithelial cells (Bouvry,
Planes et al. 2006) and endothelial cells (Engelhardt, Al‐Ahmad et al. 2014). VEGF is
known to cause phosphorylation of multiple serine and threonine residues of occludin
involving activation of PKC (Antonetti, Barber et al. 1999; Harhaj, Felinski et al. 2006).
Such a phosphorylation of occludin is known to modulate ubiquitination of occludin
(Murakami, Felinski et al. 2009). VEGF is also known to cause tyrosine phosphorylation
of ZO1 (Antonetti, Barber et al. 1999).

Ischemia was shown to promote tyrosine

phosphorylation of occludin in brain endothelial cells (Kago, Takagi et al. 2006). Tyrosine
phosphorylation of occludin was shown to disrupt tight junctions due to the decreased
interaction with ZO proteins (Kale, Naren et al. 2003). Phosphorylation of ZO1 and
occludin correlated to increased permeability of endothelial cells (Antonetti, Barber et al.
1999). Therefore, we think that in our mCCD cells, HIF-stabilization may have increased
VEGF level causing alterations of renal epithelial tight junctions and increasing
paracellular permeability through similar mechanisms.
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By introducing point mutations and replacing serine and threonine residues of
occludin and tyrosine residues of ZO1 with alanine residues if we can block the effect of
HIF-stabilization by CoCl2, we can investigate if the phosphorylation of tight junction
proteins are directly involved in the effect of HIF-stabilization on altered epithelial
transport. We suspect that the loss and mislocalization of tight junction proteins may cause
mislocalization and apical distribution of Na+/ K+-ATPase to the apical membrane and may
cause movement Na+ in the opposite direction. If by blocking the effect of HIF on tight
junction proteins, the effect of HIF-stabilization on Na+/ K+-ATPase can be blocked, then
we can confirm whether the HIF-stabilization affects Na+/ K+-ATPase directly or
indirectly. By inhibiting the action of VEGF, if the effect of HIF-stabilization can be
blocked, we can confirm the direct effect of HIF-stabilization on tight junction protein. We
suspect that the decreased level and loss of Na+/ K+-ATPase is also directly contributed by
phosphorylation and ubiquitination of Na+/ K+-ATPase α1 subunit. By introducing point
mutations of amino acid at the phosphorylation site of Na+/ K+-ATPase α1 subunit, if we
can prevent the loss of Na+/ K+-ATPase due to HIF-stabilization by CoCl2, the direct effect
of HIF-stabilization on Na+/ K+-ATPase α1 subunit can be verified.
3.3 Conclusion
In summary, in mCCD monolayers, we noted that HIF-stabilization by CoCl2
caused a loss of negative Ieq and showed a positive Ieq value in the absence of fluid flow,
indicating that there was a switch in the direction of net Na+ movement through active
transport. Thus, our absorptive mCCD epithelial monolayer may have transformed into a
secretory monolayer. The loss of Ieq was consistent with decreased level of Na+/ K+ATPase α1. We suspect that the apical redistribution of Na+/ K+-ATPase α1 may be
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responsible for the switch in the direction of active ion transport. In mCCD monolayers,
HIF-stabilization showed a significant decrease of the TER values and increase in 70 kDa
paracellular permeability. Decreased level ZO1 was consistent with increased paracellular
permeability and decreased TER in mCCD monolayers. In MDCK monolayers, HIFstabilization also showed significant increase of 70 kDa paracellular permeability. Thus,
HIF stabilization seems to affect both the transcellular and paracellular pathways of kidney
epithelial monolayers. Increased FITC-dextran permeability through cellular monolayers
of mCCD and MDCK indicated altered selective epithelial barrier function. Moreover, we
identified that Co2+ uptake occurs via basolateral side of monolayers. In conclusion, we
have provided evidence in support of our hypothesis that HIF-stabilization can reverse net
sodium transport and increases permeability of renal epithelial monolayers. Thus, chronic
stabilization of HIF, as experienced by normal epithelial cells near to a cyst, can transform
normal absorptive phenotype of epithelial cells to a leaky and secretory cyst-like phenotype
and may contribute to cyst expansion and PKD progression.
3.4 Future Directions
1. Using immunocytochemistry, possible Na+/ K+-ATPase redistribution from
basolateral to apical side due to HIF-stabilization can be checked.
2. If functional Na+/ K+-ATPase pumps are redistributed to the apical membrane,
apical application of ouabain will be able to block the positive Ieq seen due to HIFstabilization.
3. Occludin protein level can be decreased due to HIF-stabilization as known in the
literature. This can be checked by western blots.
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4. Under the discussion section, we pointed out that VEGF may be the key player in
altering renal epithelial tight junctions due to HIF-stabilization. By checking VEGF
level after HIF-stabilization can establish the direction connection between HIFstabilization and altered tight junctions. We suspect that the redistribution of Na+/
K+-ATPase occurs as an indirect response to the alteration of actin cytoskeleton and
tight junctions by HIF-stabilization. The direct effect of VEGF on tight junctions
and indirect on Na+/ K+-ATPase can be better understood by using an anti-VEGF
antibody.
5. By introducing point mutations of phosphorylation sites of ZO1 and Occludin, the
effect of HIF-stabilization by CoCl2 through VEGF can be confirmed.
6. By causing point mutations of amino acid at the phosphorylation site of Na+/ K+ATPase α1 subunit, the direct effect of HIF-stabilization by CoCl2 on the decreased
level of Na+/ K+-ATPase can be investigated.
7. Use of a chemical inhibitor against HIF-1α will help to strengthen the connection
between HIF-stabilization and altered transepithelial transport. The cellular
monolayers will be pretreated with the inhibitor, followed by the treatment with
CoCl2. HIF1α inhibitor (Santa Cruz Biotechnology, sc-205346) used in a
preliminary study can be used. Other, HIF-inhibitors such as chetomin and
echinomycin, can be used depending on the effectiveness.
8. Study using another HIF-stabilizer such as, iron chelator DFX may also further
strengthen the connection between HIF-stabilization and altered transepithelial
transport.
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9. Use of a hypoxic chamber will help to understand the effect low O2 level on
transepithelial transport in our mCCD monolayers. The expected findings of active
epithelial transport in a hypoxic chamber may be similar to the study reported
previously (Husted, Lu et al. 2010) and somewhat consistent with our current
findings.
10. Comparisons among transcellular and paracellular transports in ciliated and
deciliated mCCD monolayers with or without HIF-stabilization will help us
understand the role of ciliary flow-sensing on altered transepithelial transport due
to HIF-stabilization.
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